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Abstract
In the present work, concepts for the continuous synthesis of enantiopure, long-chain,
aliphatic (R)-2-alcohols ((R)-2-octanol to (R)-2-decanol) starting from the correspond-
ing 2-ketones were elaborated. The alcohol dehydrogenase from Lactobacillus brevis
(LbADH) is the catalyst of choice with so far unmatched enantioselectivity. For reac-
tion engineering the main challenge is the low solubility of substrates and products in
aqueous solutions which is mandatory for activity and stability of LbADH. Strategies
to overcome this challenge for synthesis were elaborated based on previous work. Later,
these strategies were applied in continuous experiments. The most interesting systems
are a monophasic approach using an ionic liquid (IL, TEGO IL K5) as solubiliser as
well as a biphasic approach with an organic solvent (methyl-tert-butylether, MTBE) as
substrate and product reservoir.
For LbADH catalysed reduction the reduced nicotinamide cofactor NADPH is compul-
sory as hydride source. NADPH cannot be used in stoichiometric amounts for economic
reasons. Therefore, the cofactor is regenerated in situ. The applicable cofactor regener-
ation systems were chosen for the actual synthesis mode.
In the biphasic synthesis, a substrate-coupled cofactor regeneration using 2-propanol was
used. In miniaturised continuous experiments with a continuous exchange of the organic
phase, a total runtime of 320 h with turnover numbers (TON) of TONLbADH = 186·103
and TONNADP = 26·103 were achieved. With this setup a conversion of only 31% were
achieved. In consequence, the main focus was shifted to the monophasic approach.
In the monophasic synthesis mode, the cofactor regeneration was carried out enzyme-
coupled with a glucose dehydrogenase from Bacillus spec. (GDH) and glucose as hydride
donor. Enzymes were retained by ultrafiltration in an enzyme membrane reactor (EMR).
With this setup a remarkably long total runtime of up to 1150 h with turnover numbers
of TONLbADH = 46·106 and TONNADP = 26·103 were achieved.
The key values for the monophasic approach were much better compared to the ones ob-
tained in the biphasic approach. For this reason, the monophasich approach was chosen
for a computer-aided optimisation using a process model based on initial rates and cofac-
tor stabilities In total, the costs could be reduced from 150 e/kgproduct to 52 e/kgproduct
and the enviromental impact was decreased with the E-Factor (kgwaste/kgproduct) from
130 to 30.
The monophasic reduction of 2-ketones in an enzyme-membrane reactor is therefore a
good possibility to produce enantiopure alcohols. The low solubility of the substrates
and products can be overcome using the IL TEGO IL K5. Costs as well as envormental
impact render the results attractive for the production of fine chemicals such as the
sparingly soluble long-chain enantiopure aliphatic alcohols.

Zusammenfassung
In der vorliegenden Arbeit wurden Konzepte zur kontinuierlichen Reduktion langket-
tiger, aliphatischer 2-Ketone (2-Octanon bis 2-Decanon) zu den entsprechenden enan-
tiomerenreinen Alkoholen ((R)-2-Octanol bis (R)-2-Decanol) untersucht. Dabei zeigte
sich das die Alkoholdehydrogenase aus Lactobacillus brevis (LbADH) besonders geeignet
ist die Substrate mit hoher Enantioselektivita¨t zu reduzieren. Die reaktionstechnische
Herausforderung ist dabei die Schwerlo¨slichkeit der eingesetzten Substrate im wa¨ssrigen
Medium damit zu vereinbaren, dass die LbADH fu¨r die katalytische Aktivita¨t Wasser
beno¨tigt. Basierend auf einer umfangreichen Literaturrecherche wurden Synthesestrate-
gien mit der LbADH zur Bewa¨ltigung dieser Schwerlo¨slichkeit identifiziert und diese
spa¨ter im kontinuierlichen Versuch getestet. Hier sind besonders die einphasige Synthese
mit einer ionischen Flu¨ssigkeit (engl.: ionic liquid, IL) als Lo¨sungsvermittler (TEGO IL
K5) und die zweiphasige Synthese mit einem organischen Lo¨sungsmittel (Methyl-tert-
Butylether, MTBE) als Substrat- und Produktreservoir zu nennen.
Die LbADH beno¨tigt den reduzierten Nicotinamidcofaktor NADPH als Hydridquelle.
Da dieser allein schon unter Wirtschaftlichkeitsgesichtspunkten nicht sto¨chiometrisch
eingesetzt werden kann, wurden fu¨r die reduktive in situ Regenerierung des Redoxme-
diators angepasste Cofaktorregenerierungsysteme verwendet.
Bei der zweiphasigen Synthese wurde die Cofaktorregenerierung substratgekoppelt mit
2-Propanol als Reduktionsmittel durchgefu¨hrt. In miniaturisierten kontinuierlichen Ex-
perimenten mit Austausch der organischen Phase konnten Gesamtlaufzeiten von bis zu
320 h bei Zyklenzahlen bis TONLbADH = 186·103 und TONNADP = 26·103 erzielt werden.
Aufgrund des niedrigen Umsatzes von 31% wurde der Schwerpunkt auf die einphasige
Reaktionsfu¨hrung gelegt.
Bei der einphasigen Reaktionsfu¨hrung in einem Enzymmembranreaktor wurde die Cofak-
torregenerierung enzymgekoppelt mit einem zweiten Enzym, der Glucosedehydrogenase
(GDH) aus Bacillus spec. und Glucose als Reduktionsmittel durchgefu¨hrt. Hier sind
insbesondere die Gesamtlaufzeiten von bis zu 1150 h bei Zyklenzahlen von TONLbADH
= 46·106 und TONNADP = 26·103 hervor zu heben.
Aufgrund der insgesamt besseren Kennzahlen wurde die einphasige Synthese weiter ver-
folgt und einer computergestu¨tzten Optimierung unterworfen. Zur Modellerstellung
wurden unter anderem Cofaktorstabilita¨ten und Anfangsreaktionsgeschwindigkeiten herange-
zogen. Insgesamt konnten so die Produktionskosten von 150 e/kgProdukt auf 52 e/kgProdukt
und der E-Faktor (= kgAbfall/kgProdukt) von 130 auf 30 gesenkt werden.
Die einphasige Reduktion von 2-Ketonen im Enzymmembranreaktor ist demnach eine
gute Mo¨glichkeit enantiomerenreine Alkohole herzustellen. Das Problem der Schw-
erlo¨slichkeit kann gut mit der verwendeten IL umgangen werden. Es konnte dadurch
exemplarisch gezeigt werden, dass Kosten und E-Faktor fu¨r die Produktion von Fein-
chemikalien attraktiv sind.
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1 Introduction and Motivation
1.1 Introduction
As early as 1984 the administration of racemic mixtures of drugs and pesticides has
been questioned.9 For the distribution of, for example, 500 kg of a racemic pesticide,
economic and ecologic reasons clearly indicate the need for enantiopure active agents.
In the case of drugs, when for example only 50 mg are distributed, environmental and
ecological reason are of less importance. In the best case for an active pharmaceutical
ingredient one enantiomer is not active, but if administered with the active enantiomer
still representing metabolic ballast. This is regarded as bad practice and enantiopure
products are preferred.9 Thalidomide is a very prominent, although not very well-chosen
example highlighting the need for enantiopure drugs and thus enantiopure intermediates
for the development of such drugs. (R)-Thalidomide is the desired enantiomer which has
sedative effects, while the (S )-enantiomer has teratogenic properties. Administration of
only one enantiomer seems to solve the problem, but the (R)-enantiomer racemises in
vivo and thus can still cause fetal malformations.45,135 To prevent harmful effects, the
American Food and Drug Administration (FDA) and the European Medicines Agency
(EMA) have published guidelines for the development and investigation of chiral drugs,
where the investigation of both enantiomers is mandatory if a racemic drug or a single
enantiomer which racemises in vivo is administered.2,3 These guidelines date back to
1992 and 1994 but are still valid for the development of new drugs. Thus, also in the
future, an increasing need for enantiopure substances is to be expected and one of the
most important chiral intermediates are molecules containing a chiral alcohol motif.
When dealing with chiral substances, the absolute stereo configuration22 is important,
but a measure of the enantiomeric purity of the substance is needed as well. When the
purity of an enantiomer is to be rated, a commonly used measure is the enantiomeric ex-
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cess (ee) which can be calculated when the amounts (or concentrations) of the respective
substances can be determined.
eeR =
nR − nS
nR + nS
eeS =
nS − nR
nS + nR
(1.1)
A more precise, although less commonly used value concerning mixtures with low amounts
of the undesired enantiomer is the enantiomeric ratio (erR =
mR
mS
). To achieve better
comparability with previously published studies, in this work ee is used throughout.
1.1.1 Use of chiral alcohols
Chiral aliphatic alcohols are important intermediates for the fine chemical and pharma
industry. They can be used for several purposes. A general use of chiral alcohols is the
Mitsunobu reaction or inversion. This reaction can be used to transform alcohols into
the corresponding carboxylic or phosphoric esters.122 If the starting material is a chiral
alcohol, inversion at the chiral C-atom can be observed. This has been demonstrated
with the transformation of (R)-2-octanol to the corresponding thiolacetate followed by
reduction to the thiol.195 Despite the high utility of this kind of reaction, it requires
toxic and expensive reagents,197 and the commercial use of this reaction is negligible.29
On the occasion of a roundtable initiated by the ACS Green Chemistry Institute (GCI)
and global pharmaceutical corporations, the Mitsunobu reaction was listed as one of the
reactions to be adapted in order to be greener and reduce the use of toxic reagents.29
If this reaction can be carried out catalytically one day, the need for chiral alcohols as
starting material will increase as well.
Aditionally, the direct use of enantiopure aliphatic alcohols has also been described.
(R)-2-octanol for example serves as one substrate for the synthesis of bent-core liquid
crystals which consist of chiral banana-shaped molecules.113 (R)-2-octanol is introduced
into the molecule by a Mitsunobu reaction in which the absolute stereo configuration is
inverted. The resulting liquid crystals posses unique optical properties which are tunable
by changing the temperature, irradiation or electric field. These materials are interesting
for reflective displays, color reflectors and filter, tuneable lasers, molecular sensors, and
other biomedical application (see Mathews et al. 113 and references cited therein).
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Figure 1.1: Strategies for the direct synthesis of chiral alcohols with the respective start-
ing material
Chiral 2-alkanols from (R)-2-pentanol to (R)-2-heptanol can also serve as cosurfactants
in microemulsion electrokinetic chromatography to improve the resolution of basic drugs
such as ephedrine, norephedrine, N-methyl-ephedrine, nadolol, and propanolol.224
1.1.2 Synthesis of chiral alcohols
In the following section, the different chemical methods available to synthesise enan-
tiopure alcohols are discussed in view of the synthesis of aliphatic, non-branched chiral
alcohols. The advantages and disadvantages are illustrated in view of the general char-
acter and purity of the resulting product. The strategies covered in this section are
(Figure 1.1):
• Asymmetric reduction
• Resolution
• Dihydroxylation
• C-C bond formation
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Figure 1.2: (S )-BINAP-Ligand for asymmetric reduction of functionalised ketones with
noble metal catalysts136
Although aliphatic non-branched chiral alcohols seem to be simple molecules, their syn-
thesis is not straightforward. In the last century, a number of chemical routes for the
synthesis of chiral alcohols were elaborated. These are generally the asymmetric reduc-
tion of ketones, resolution of racemic mixtures, syn-dihydroxylation with OsO4, and the
aldol reaction/benzoine reaction. The most elegant method is the reduction of ketones
into the corresponding alcohols. Several methods have been established such as asym-
metric transfer hydrogenation using Ru/BINAP catalysts (Figure 1.2), the reduction
according to Corey, Bakshi, and Shibata (CBS-reduction) using chiral modified borane
adducts, and asymmetric hydrogenation using biocatalysts. The asymmetric reduction
of ketones using Ru/BINAP/H2 systems was investigated and developed since the last
decades of the 20th century with great success. Today, a great variety of ketones can be
enantioselectively converted into the corresponding alcohols. For a long time, ketones
which lack any Lewis basic functionality were hard to convert. Since the 1990s, even so-
called ‘simple’ ketones can be reduced using appropriate chiral diphosphanes together
with chiral diamines as ligands.135 Using this catalyst system, even the enantioselec-
tive reduction of linear allylic ketones, for example 3-nonene-2-one is possible yielding
the corresponding (R)-alcohol in 97% ee.137 Ketones possessing no additional functional
group besides the carbonyl function (linear, aliphatic ketones) are much harder to reduce
enantioselectively. 2-Hexanol from 2-hexanone was obtained in its (S )-form with 76% ee
and in the case of 2-nonanol from 2-nonanone, the ee was negligible at 1% .136 A com-
parison between Ru-catalysed and biocatalytic reduction with Saccharomyces cerevisiae
for a number of functionalised ketones can be found in Zeror et al. 221 . Depending on the
substrate, generally a higher ee can be achieved when the biocatalyst is used compared
to the Ruthenium catalyst.
4
1.1 Introduction
The enantioselective CBS reduction with chiral oxazoborolidines using BH3-THF adducts
or catecholborane as stoichiometric reducing agent has also been investigated with great
success for the reduction of a large variety of prochiral ketones.30,31 As for Ru-catalysed
transfer hydrogenation, the synthesis of enantiopure aliphatic and non-branched alco-
hols remains a challenge. With a chiral proline derivative and BH3-THF as reduction
equivalent, (R)-2-octanol and (R)-2-dodecanol were synthesised with 76% and 75% ee,
respectively.86 These values are remarkable, but far from allowing technical implemen-
tation. The same is true for a similar approach using a tartaric acid-derived boronic
ester. Here, ee of 56% and 60% were achieved for (R)-2-hexanol and (R)-2-octanol, re-
spectively. Another approach uses a chiral alternative of the Meerwein-Ponndorf-Verley
reduction. 2,4-Dinitrobenzenesulfonic acid was used as the catalyst and anti -pentane-
2,4-diol served as the hydride donor. With this approach, (R)-2-heptanol, (R)-2-octanol,
and (R)-2-nonanol were synthesised with ee of 51-52% and yields between 50% and
64%.114
Much better results were achieved when using biocatalysts. Alcohol dehydrogenases
(ADH) are enzymes which belong to the enzyme class (E.C.) of oxidoreductases (E.C. 1).
They catalyse the enantioselective reduction of ketones into the corresponding alcohols.
Many of these are (S )-selective such as ADH from R. erythropolis,54 Candida parap-
silosis,144 Thermoanaerobicum brockii,123 as well as horse liver ADH;123 the achieved ee
values are generally ≥95%, but (R)-selective ADH are also available such as ADH from
Lactobacillus kefir 32 and Lactobacillus brevis (see chapter 2).
To sum up, catalytic routes for the enantioselective reduction of ketones are useful
strategies for the conversion of functionalised ketones. Aliphatic, non-branched ketones
remain a challenge as the resulting product ee are not competitive and only biocatalysts
feature sufficient selectivity to achieve technical relevant product ee.
In addition to enantioselective reduction, the resolution of racemic mixtures is a widely
applied method. Three possibilities can be distinguished:
1. Static resolution
2. Kinetic resolution
3. Dynamic kinetic resolution (DKR)
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The first, ‘static’ or conventional resolution of the desired product can be achieved for
example by crystallisation as tartrates or by chromatographic methods.28 Using these
methods, at least 50% of the starting material is lost, and high salt or solvent loads may
arise.
The second method is the kinetic resolution of a racemic mixture of the desired alcohol.
This method is based on the non-equal reaction rates of the enantiomers; the best re-
sults are achieved when the quotient E of the reaction rates is at least between 50 and
100.71 However, as for conventional resolution, industrially relevant ee for the alcohol are
only accessible when quantitative conversion (=50% or better35) can be achieved. Eco-
nomically, this method contains an intrinsic drawback compared to the enantioselective
reduction of ketones, due to the generally higher price for racemic alcohols compared to
the corresponding ketones (see Table 1.1). A more favorable method is the kinetic res-
olution of a racemic starting material into the desired alcohol. This can be for example
enantioselective ester hydrolysis. Using this approach, the ee of the product alcohol is
high from the beginning (depending on the catalyst selectivity) and can drop slightly
when 50% conversion is approached. Again, the approach is limited to 50% conver-
sion, if the starting material or the distomer (= unwanted enantiomer185) cannot be
racemised in situ.71 An example of a naturally occurring in situ racemisation is the
keto-enol tautomerism. In molecules which tautomer readily, this can be used if the cat-
alyst selectively converts one of the keto-enantiomers.80,103 This third alternative route
is called dynamic kinetic resolution (DKR) and theoretically quantitative conversion is
possible.71 The kinetic resolution is typically performed by a biocatalyst. Racemisation
can be achieved thermally, with a base catalyst, with and acid catalyst, via a Schiff base,
with an enzyme, or via redox and radical reactions.71 When a second chemical catalyst
is used for racemisation, compatibility issues may occur.
(Kinetic) Resolution is a useful but sometimes a more complicated alternative to the
direct reduction of ketones. The possibly higher price of the starting material, as well as
the need for in situ racemisation of the substrate can lead to a generally more complex
and thus less cost-efficient process compared to direct reduction.
Asymmetric syn-dihydroxylation using OsO4 catalysts is rarely used in large-scale ap-
plications. Although, techniques for the production of immobilised and thus non-toxic
OsO4 catalysts have been developed, these are far from being used on an industrial
scale.5 Nevertheless, the products from OsO4 catalysed dihydroxylation are vicinal di-
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Table 1.1: Prices for 2-ketones, racemic and enantiopure 2-alcohols, prices in e/kg
(prices from Sigma-Aldrich, 20.02.2013)
Carbon backbone 2-ketone (±)-2-alcohol (R)-2-alcohol (S )-2-alcohol
C8 15 41 22,250 24,900
C9 82 330 83,900 88,600
C10 406 2,700 86,400 -
ols. Thus, this method is not suitable to synthesise the desired aliphatic 2-alcohols. The
same is true for the benzoine as well as for the aldol reaction. The benzoine reaction or
condensation yields α-hydroxyketones when two aromatic aldehydes react under cyanide
catalysis. Modern catalysts can include triazolium salts and give products with medium
to good ee.183 Nevertheless, in the example given, only aromatic aldehydes are converted,
and again, the products, chiral α-hydroxyketones are not the desired ones. The same is
true for the biocatalytic alternative using benzaldehyde lyases (BAL). One variant from
Pseudomonas fluorescens, for example requires one aromatic aldehyde donor, whereas
the acceptor aldehyde can be aliphatic.130
The aldol reaction is an alternative for the enantioselective synthesis of alcohols from
aldehydes. But again, the resulting β-hydroxy ketone is not the desired product and
often undergoes water elimination yielding an allylic ketone. Thus, none of these, neither
the OsO4-catalysed dihydroxylation, the benzoine reaction, or the aldol reaction lead to
the desired aliphatic mono-functionalised alcohols.
Comparing all reactions leading to chiral alcohols, only the reduction of ketones and
(kinetic) resolution can lead to the desired aliphatic mono-functionalised alcohols as
products. The direct reduction of ketones is the most efficient and straightforward one
in this case. As shown above, chemical routes are successfully used for this reduction
step, but lack enantioselectivity with the substrates used here. A direct comparison
between metal and bio catalysis shows the general superiority of biocatalysis in view of
enantioselectivity with all the substrates aimed for in this study.221
1.1.3 Biocatalysis
For the production of enantiopure 2-alkanols, the analysis of possible approaches renders
biocatalysis the only sufficiently enantioselective alternative (see section 1.1.2). Besides
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this very special advantage, biocatalysis is assigned some intrinsic advantages compared
to conventional catalysis, e.g. high selectivity, mild reaction conditions, and low envi-
ronmental impact.158,203
The main advantage in industrial scale biocatalytic production of chemicals is the often
higher chemical precision compared to conventional catalysts. This allows for example,
the targeted production of a single stereoisomer, fewer side reaction, easier separation
of products, and less pollution.158 These general advantages have to be considered with
care. Whole-cell catalysts for example, can lead to side reactions, or reduced enantiopu-
rity of the products, as other metabolic pathways or other enzymes may be present. The
easier separation of biocatalytically produced substances holds only for sufficiently high
product concentrations.203 Extraction of low concentration product solutions may lead
to large amounts of polluted waste-water and/or organic solvents. But generally, bio-
catalysts feature high substrate selectivity, good enantio- and regioselectivity, as well as
functional group selectivity.158 The latter was demonstrated by the selective reduction of
ketones by an alcohol dehydrogenase from Lactobacillus brevis (LbADH) in the presence
of an aldehyde. No primary alcohol was found in the product solution.21 All these aspects
make biocatalysis very attractive for chemical production, and there are examples using
enzymes as catalyst for the production of bulk chemicals, such as high fructose corn
syrup and acrylamide.107,185 Despite these prominent examples of biocatalytical bulk
chemical production, in view of the excellent chemo-, regio-, and enantioselectivity, bio-
catalysts are predetermined for use in pharmaceutical149 and fine chemical production.
Nonetheless, even for high-price products, some process metrics need to be minimally
achieved. The most important ones are the product concentrations of at least 50-100
g/L and catalyst productivity of 1000 gproduct/gbiocatalyst.
149 Typically, some of the most
important challenges arise from these requirements. Given the natural environment of
enzymes, product concentrations of 50-100 g/L may strongly inhibit enzyme activity and
productivity is strongly dependent on stability. In view of physiological regulation, evo-
lutionary pressure does not necessarily lead to high stability of a protein under process
conditions. If the envisaged production enzyme does not possess sufficient stability and
activity in presence of high substrate and product concentrations, reaction and protein
engineering are mandatory to develop an industrial viable process.149,203
Protein engineering can be very successful as demonstrated by the example of benzalde-
hyde lyase,148 but generally it is highly resource consuming. An average of ten years
can pass from the initial idea to the (revised) industrial process.203 In addition, the suc-
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cess of protein engineering is not guaranteed. For example Lactobacillus brevis alcohol
dehydrogenase reduces 2-ketones enantioselectively into the corresponding (R)-alcohols,
is very stable, and possesses a broad substrate scope.104 However, it is dependent on
the nicotineamide cofactor nicotinamide adenine dinucleotide phosphate (NADP) as the
redox equivalent. The alternative cofactor nicotinamide adenine dinucleotide (NAD)
is desirable for cost reasons. Both reduced cofactors, NADH and NADPH are too ex-
pensive to be used in stoichiometric amounts198 and nowadays, a number of efficient
methods for in situ reductive cofactor regeneration are available.198 Still, the oxidised
cofactor NADP+ is at least one order of magnitude more expensive than the correspond-
ing NAD+.1 Attempts to change the cofactor preference of LbADH from NADP(H) to
NAD(H) were in vain51,110,112,155,162 and a commercial variant accepting NAD(H) is not
yet available. Thus, in these cases and depending on the envisaged scale of the process,
reaction engineering, and the careful assessment of process alternatives might be more
successful.
Another reason to prefer reaction/process engineering tools instead of protein engineer-
ing can lie in intrinsic properties of the reaction system. The 2-alkanones targeted in
this study as well as the corresponding 2-alkanols are poorly water-soluble.95,96 Thus,
protein engineering will probably not improve the synthesis. Instead, measures to in-
crease substrate and/or product solubility have to be taken, which are inaccessible by
protein engineering.
A general issue when using isolated enzymes is cofactor regeneration to provide redox
equivalents. As mentioned above, the reduced cofactors NADH and NADPH are too
costly to be used in stoichiometric amounts. The in situ regeneration of oxidised co-
factors can be achieved using electrochemistry, photochemistry, or enzymatic methods.
Enzymatic methods such as substrate-coupled or enzyme-coupled methods are often
favoured.205 When performing substrate-coupled cofactor regeneration, only one enzyme
is used. This enzyme not only catalyses the main reaction, for example ketone reduc-
tion, but also cofactor regeneration by catalysing the alcohol oxidation of an excess of
a much cheaper regeneration substrate. When substrate-coupled cofactor regeneration
is used, the regeneration substrate has to be structurally similar to the main substrate,
otherwise it is not accepted by the enzyme. A regeneration substrate which is often used
with alcohol dehydrogenases is 2-propanol.33,42,205
In the case of an enzyme-coupled approach with a second enzyme for regeneration,
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the regeneration substrate can be structurally different from the main substrate.205 An
enzyme which is often used for the regeneration of NAD+ is formiate dehydrogenase
(FDH).33,205 This is often favoured over substrate-coupled regeneration because the re-
sulting product is CO2 which is gaseous and can thus be easily removed from the re-
action system.33,205 The same is true when glucose dehydrogenase (GDH) is used for
cofactor regeneration. This enzyme oxidises glucose to gluconic-acid-δ-lactone (GDL)
while NAD(P)+ is reduced to NAD(P)H. The formation of gluconic-acid-δ-lactone is
followed by non-catalytic hydrolysis to gluconic acid. Thus, gluconic-acid-δ-lactone in
aqueous solutions, is irreversibly withdrawn from the equilibrium which is favourable for
the overall conversion.205
The decision regarding which of the methods for cofactor regeneration should be applied
is strongly dependent on the process mode and availability of the respective regeneration
enzymes. Also, the compatibility of process conditions such as temperature, pH, ion
strength, etc. will play a decisive role.
1.1.4 Process design considerations
When aiming for a biocatalytic process for the production of the aliphatic (R)-2-alcohols
desired for this work, the main challenge is the low solubility of the substrates and prod-
ucts and the required aqueous medium for the biocatalyst. Conventionally, catalysis
is classified into heterogeneous, homogeneous, and biocatalysis.219 Currently, a number
of examples using immobilised, thus heterogeneous, biocatalysts (mostly enzymes) are
available (Sheldon 179 and references cited therein) as well as examples using homoge-
neously dissolved enzymes and whole cells. As a result, using biocatalysts offers the same
process alternatives with some of the same restrictions as conventional catalysis. Thus,
the same process options to overcome low solubility are available when using biocatalysts
and conventional catalysts (see Figure 1.3). One possibility is to use biphasic systems,
where the substrate is dissolved in a non-water miscible liquid (the non-reactive phase)
and the product is extracted into this phase. The catalyst is dissolved in the aqueous,
the reactive phase. The other possibility is to enhance substrate and product solubility
in the aqueous solution by adding a solubiliser. In this case, all substrates, products,
and the catalyst are homogeneously dissolved in the aqueous phase.
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Figure 1.3: Process considerations for the elaboration of a flow scheme for a biocatalytic
process; I.E.= isolated enzyme; W.C.= whole cell; IMM= immobilised cat-
alyst; DSP = down stream processing
For the implementation of a biphasic process, the choice of the non-reactive phase is
crucial.42,192,194 This can be either an ionic liquid42 (IL) or an organic solvent.192,194 An IL
has successfully been used in the synthesis of (R)-2-octanol using LbADH as the catalyst
with substrate-coupled cofactor regeneration using 2-propanol as the second substrate.42
Due to the altered partition behavior of the regeneration product acetone using the IL
compared to using methyl-tert-butyl-ether (MTBE) as second phase, the reaction was
accelerated. A drawback of this approach is the often higher viscosity of IL compared to
organic solvents. This can be an issue if a continuous setup is intended. In this case an
organic solvent can be advantageous. It has been shown, that the type of organic solvent
is crucial for biocatalyst stability.192,194 The continuous synthesis of 2-phenylethanol for
example using carbonyl reductase from Candida parapsilosis (CpCR) was more stable
when n-heptane was used as the non-reactive phase compared to the synthesis using
cyclohexane as the non-reactive phase.192 A direct influence of the organic solvent on
enzyme stability has also been observed by Villela-Filho et al. 194 . When LbADH was
investigated, organic solvents containing an ether function were beneficial regarding
stability and among ether function-containing substances, MTBE led to outstanding
stability of LbADH.
If a monophasic process is envisaged, for the choice of the solubiliser, the same is true
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Figure 1.4: Structure of the ionic liquid AMMOENGTM101
as for the choice of the non-reactive phase in the biphasic system. The nature and
concentration of the solubiliser are crucial for the success of the process. Generally,
water-miscible organic solvents, non-ionic and ionic surfactants/water-miscible IL can
be used. Water-miscible organic solvents might hinder extractive down-stream process-
ing (DSP) and distillation depending on the boiling point of the substances involved.
Own preliminary work has shown, that employing a water-miscible IL led to very good
results in batch and continuous mode,94,95 and did not hinder DSP via extraction.94
As a result, a biphasic approach using MTBE as non-reactive phase and a monophasic
approach using a water-miscible IL (AMMOENGTM101 Figure 1.494,95) are the most
promising process alternatives when poorly water soluble substrates are to be converted
biocatalytically.
Both, the continuous monophasic and biphasic approach entail special requirements
concerning cofactor regeneration. In the monophasic approach, it is mandatory to use
a regeneration system with a water-soluble regeneration substrate in order to guaran-
tee a sufficient regeneration velocity in the aqueous phase. Furthermore, the substrate
should be able to pass through an ultrafiltration membrane often used in biocatalytical
processes. By fulfilling both of these criteria, continuous dosage and removal of the
regeneration substrate and product are possible. In the case of a biphasic continuous
process, the regeneration substrate must be soluble in the organic solvent to allow for
continuous dosage and removal. A regeneration substrate soluble only in water cannot
be provided in a sufficient amount for stable continuous synthesis. In addition, the re-
generation product is in this case probably also water-soluble and will thus accumulate
in the aqueous phase, unfortunately shifting the equilibrium. Thus, for monophasic syn-
thesis, a water-soluble substrate is needed, while for the biphasic approach, a substrate
soluble in the respective organic solvent and ideally also soluble in the aqueous phase
is required. Low product solubilities in the aqueous phase are beneficial for biphasic
12
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synthesis.
Enzyme preparation and enzyme retention in continuous syntheses are closely related.
Immobilisation of the enzyme leads to easily separable preparations. Many lipases have
been immobilised with great success even resulting in preparations with higher activity
and/or stability than the corresponding soluble preparation.134 In contrast, oxidoreduc-
tases are more prone to losing performance during the immobilisation step; in addition,
methods to immobilise lipases cannot be applied to oxidoreductases without further
modifications.163 Regarding the use of oxidoreductases, it is therefore more straight-
forward to use isolated enzymes or whole cells. Both can be retained in the reaction
volume by using (ultra)filtration membranes. In the case of biphasic setups, further
means for catalyst retention are not necessary, as the enzymes (and cells) are generally
water-soluble and ionic, thus will not leave the reactor with the organic phase.
Down-stream processing is substantially dependent on the flow scheme of the process
and on the physical properties of the substances involved such as boiling point, melting
point, hydro- and lipophilicity (Table 1.2) as well as on the purity/conversion achieved
in the respective process. Options for down-stream processing include distillation, crys-
tallisation, extraction, chromatography and adsorption. In the case of a biphasic process,
distillation is probably the method of choice depending of the substances involved. Tak-
ing the reaction system 2-octanone/2-octanol with 2-propanol/acetone for cofactor re-
generation as an example, all substances except 2-octanone and 2-octanol possess boiling
points far below 100◦C. Thus, it is no issue to remove MTBE, 2-propanol, and acetone.
The separation of 2-octanone and 2-octanol is then more challenging and, certainly re-
quires the use of fractionated distillation. Taking a flow scheme for monophasic synthesis
into consideration, more options for down-stream processing are possible. Here, distilla-
tion, extraction, and adsorption (often also referred to as solid-phase extraction, SPE)
are examples. Distillation-based down-stream processing in the monophasic approach is
challenging, as large amounts of water have to be evaporated, which is more energy in-
tensive than the evaporation of MTBE. Besides, after the removal of water, a mix of IL,
(buffer)salts, glucose, gluconic acid, 2-octanone, and 2-octanol remains in the still pot.
It is questionable if this mixture can be further processed by distillation. To make the
separation easier and distillation more convenient, an extraction step normally precedes
the distillation. In this case, the product quality is improved compared to a single dis-
tillation step. But when extracting diluted product solutions, large amounts of organic
solvent are required, and the aqueous phase is contaminated with the respective organic
13
1 Introduction and Motivation
Table 1.2: Physical properties of the main components used in this work (logPOW =
log of the partition coefficient in 1-octanol/water biphasic systems, as an
indicator for the lipophilicity of a substance. Values from MSDS, Carl-Roth,
Karlsruhe, Germany; Merck KGaA, Darmstadt, Germany; Sigma-Aldrich,
Steinheim, Germany)
substance boiling point melting point logPOW
MTBE 55◦C -109◦C 1.06
acetone 56◦C -95◦C -0.24
2-propanol 82◦C -90◦C 0.05
2-octanone 173◦C -16◦C 2.37
2-octanol 180◦C -38◦C 2.90
2-nonanone 188-190◦C -15◦C 3.14
2-nonanol 193-194◦C -35◦C -
2-decanone 211◦C 3.5◦C -
2-decanol 211◦C -6-(-4)◦C 3.93
solvent. For this reason, we opted for an adsorption or SPE step before distillation. SPE
has been developed to process diluted solutions60,187 and results in non-contaminated
aqueous solutions. Again, taking Table 1.2 into account, distillation to separate aliphatic
ketones from the corresponding alcohols might not always be successful as the boiling
ranges do overlap in some cases. Thus, to avoid challenging DSP tasks, conducting the
process at high levels of conversion is the method of choice in the case of overlapping
boiling ranges and/or similar hydrophobicities of substrate and product.
1.2 Motivation and aim
The aim of this work was to develop a process for the direct synthesis of poorly water-
soluble aliphatic (R)-2-alcohols from 2-octanol to 2-decanol since enantiopure chiral
aliphatic alcohols are in growing demand (see section 1.1.1). Additionally, the reduc-
tion of 2-octanone to 2-decanone to the corresponding enantiopure (R)-2-alcohols is a
reaction with a high added value (see section 1.1.2 Table 1.1). As the production of
the enantiopure target molecules is not possible using chemical catalysts (see section
1.1.2), biocatalysis was chosen for the synthesis. Here, alcohol dehydrogenase from Lac-
tobacillus brevis (LbADH, enzyme class EC 1.1.1.2, CAS 9031-72-5)133) was considered
ideal biocatalyst as the potential of this enzyme and its versatility under various process
conditions was made evident from the literature survey (see chapter 2). A three-stage
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work flow was necessary (see Figure 1.5). First, an appropriate biocatalyst had to be
identified. Based on a literature survey, the process options for the continuous synthesis
of the target molecules was identified. In the second step, the possible process options
were tested and rated according to their performance in the continuous synthesis. The
third step included the identification of possible bottlenecks and their reduction based
on in-depth stability investigations and model-aided process improvement.
The low solubility of the substrates and the products in aqueous solutions posed the
main challenge of the work presented here as the enzyme requires an aqueous surround-
ing (see section 1.1.4). This low solubility does not completely hinder the biocatalytic
synthesis as has been demonstrated previously,96 but makes continuous synthesis almost
impossible. Preliminary work has shown, that this can be overcome by using an ionic liq-
uid (IL) as a solubiliser94,95 or by employing a biphasic system(see section 1.1).124,192 As
the data from literature indicate the possible use of LbADH in biphasic and monophasic
systems, both alternatives were investigated (see chapter 3 and chapter 4).
As mentioned above, oxidoreductases like LbADH often require costly cofactors, such as
NADP(H) in this case. For in situ regeneration, several methods are available. Regener-
ation with glucose and glucose dehydrogenase from Bacillus spec. (GDH) is viable when
aqueous processes are planned (see chapter 4). Due to the insolubility of glucose in or-
ganic solvents, for biphasic synthesis regeneration with 2-propanol is more suitable (see
chapter 3). Thus, both synthesis modes, biphasic and monophasic, were judged based
on key figures such as catalyst and cofactor turnover number (TON), space-time yield
(STY), conversion of the ketone as well as practical constraints. The more promising
process mode was then further investigated. As the literature survey revealed a lack of
reliable cofactor stabilities, the latter were investigated under relevant conditions (see
chapter 5). Based on enzyme kinetics, cofactor and enzyme stability a process model
was developed with the aim of reducing the cost of the raw material while respecting
technical limitations to produce (R)-2-octanol as a model substrate (see chapter 6).
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Figure 1.5: Three-stage work flow for the implementation of a biocatalytic process with
hardly water-soluble substrates
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2 Alcohol Dehydrogenase from
Lactobacillus brevis: A Versatile
Robust Catalyst for Enantioselective
Transformations
Parts of this chapter have been published ina:
Susanne Leuchs and Lasse Greiner, Chemical & Biochemical Engineering Quarterly,
2011, 25, 267-281
Abstract
The alcohol dehydrogenase from Lactobacillus brevis (LbADH) is a versatile catalyst
for enantioselective reduction of ketones. Its substrate scope is wide with high regio-
and enantioselectivity. In this critical review we gather the information available on the
substrate scope as well as the applications reported. Quantitative information such as
productivity per catalyst, space-time yield (STY), cofactor utilisation, and stability are
derived to allow comparison and assessment of practical value.
aURL: http://pierre.fkit.hr/hdki/cabeq/pdf/25 2 2011/Cabeq 2011 02 13.pdf
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Figure 2.1: General reaction scheme for the LbADH -catalysed reduction of a ketone to
the corresponding R-alcohol and cofactor-regeneration, with R2 >R1
2.1 Introduction
The upcoming demand for enantiopure intermediates in the fine chemicals- and pharma-
industry makes biocatalysis more and more a profitable alternative the conventional
chemical catalysis/synthesis119,209. Also, as the environmental footprint of a process
is gaining increased attention, biocatalytic processes come to the focus of the chemical
industry. The generally mild reaction conditions (moderate pH, low T, aqueous solution,
no heavy metals) which characterise biocatalysis enhance this effect.
Over the years, hydrolases such as Lipase B from Candida antarctica (CALB) were dom-
inating industrial biocatalysis due to their stability and robustness even in the presence
of organic solvents and reactants.
The application of alcohol dehydrogenase from Lactobacillus brevis (LbADH) is rising as
mirrored in the number of publications (see Figure 2.2). The potential of this enzyme is
also reflected by the number of patents applied for.23,26,55,56,73,76,78,112,118,125,142,143,147,155,172,199,214
LbADH is a robust and versatile enzyme which catalyses the enantioselective reduc-
tion of ketones to the corresponding alcohols and requires NADPH (+H+) as reduction
equivalent (see Figure 2.1). Even in presence of non-conventional reaction media, such
as organic solvents, supercritical fluids (scF), or gaseous reactants LbADH remains ac-
tive. The excellent chemo- and enantioselectivity makes LbADH a valuable tool for the
synthesis of chiral building blocks. In most cases exclusively (R)-alcohols are formed
(typical enantiomeric excess (ee)>0.99, see below). The high activity of LbADH for a
broad range of substrates (from simple aromatic ketones and keto-esters to branched
acetophenone derivatives, see Figure 2.4)is one factor for the ongoing and growing in-
terest for this catalyst. Another factor for the rising interest is that LbADH is among
the few oxidoreductases with high solvent tolerance for both monophasic systems with
18
2.1 Introduction
Figure 2.2: Publications per year with LbADH since discovery in 1996
solvent addition as well as in biphasic media.
A number of reviews are available, such as Hummel 74 presenting different enzymes for
the synthesis of chiral compounds, Daußmann et al. 34 , Nakamura et al. 129for general
aspects of producing chiral alcohols, Eckstein et al. 41 , Hollmann et al. 69 , Wichmann and
Vasic´-Racˇki 205 for cofactor regeneration and Mu¨ller et al. 123 for a more detailed insight
into the asymmetric reduction of 3,5-dioxocarboxylates and propargylic ketones.
Here, we gathered the information available for the LbADH in view of its promising
activity and stability. To allow comparability, additional values following the guidelines
given in Gardossi et al. 49 were calculated from the information as derived by the au-
thors. To enable practical comparison not at least in view of optimisation potential
we focussed on space-time yield (STY) as productivity per unit volume of the reac-
tor, absolute productivity per catalyst amount used to derive the product, and cofactor
utilisation. Thereby, allowing a shorthand assessment of practical applicability. Occa-
sionally, this rigid definitions led to values given within this review differ from the ones
in the original articles. Sometimes, the necessary data for the calculations could not
be derived from the article alone, the corresponding authors were contacted to gather
further information. Where possible, PhD theses were consulted for additional informa-
tion. A table providing an additional overview can be found as electronic supporting
information (ESI).
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2.2 Enzyme technology
The LbADH was discovered by Hummel and coworkers during a screening in the class of
Lactobacillus and has close homology to the alcohol dehydrogenase from Lactobacillus
kefir (LkADH).154 Although, the enzymes are closely related in view of amino acid se-
quence with only 18 residues difference LbADH is found to be exceptionally more stable
than LkADH, thus a 10-fold higher yield could be achieved by the same purification pro-
tocol.74,154 Its recombinant expression in Escherichia coli (E. coli) is also highly efficient
and convenient purification protocols are available which are possible because of the high
robustness the enzyme shows throughout.73,154 The metabolic role is unknown154 which,
with the increasing significance of metagenomics and other screening strategies, will be
more and more common for industrially used enzymes.
The LbADH is classified as a short chain dehydrogenase/reductase (enzyme class EC
1.1.1.2, CAS 9031-72-5).133 It is denoted as R-selective. This is applicable when the
formal Cahn-Ingold-Prelog priorities (CIP) match the steric demand which is coinciden-
tally often but not necessarily the case.22,151 For the application of LbADH the most
prominent exception are α-halogen substituted ketones where the (S )-product is formed
but the intrinsic selectivity or side of hydride addition to the prochiral ketone does
not change as compared to the non-substituted homologue (see below).170 The term
R-selective is most often used to set the enzymes apart from the previously known ADH
as with the same substrate the opposite enantiomer is derived. The LbADH was among
the first commercially available dehydrogenases opening up the venue for these enan-
tiomers. It is patented by a non-profit organisation and thus commonly available at
reasonable terms as the commercial availability by enzyme suppliers underlines.73,182 It
is industrially applied for the production of ethyl-3R-hydroxy-butanoate on a ton per
year scale (see below).34,107,157
The enzyme is a homotetramer132,133 with molecular weight between 104-107kDa74,132
with monomers of 26kDa132,162 or 22.5kDa154 depending on the source.
The DNA and amino acid sequence was published.73,74 The high resolution crystal struc-
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ture for both, the apoenzyme and holoenzyme are also available (wild type: protein data
bank code 1NXQ133 and 1ZK4; mutant G37D: 1ZK4 1ZJY, 1ZJZ, 1ZK0, 1ZK1, 1ZK2,
1ZK3162). The high resolution crystal structure 1ZJY was used as homology model for
the computational study of the ADH from Lactobacillus kefir reduction of ethanal with
deuterated NADPH.102 An ample discussion of the implications of the active site can
be found in Schlieben et al. 162 . The stereospecificity can be explained by inspection
of the three dimensional model of the active site.133 Also, in a comparative study the
suitability for four diketones was investigated.101
The NADP+-dependence of LbADH is viewed as a drawback and reaction engineering
challenge, as compared to NAD+ the phosphorylated redox cofactor is more expensive
and less stable.25,216 Therefore, several approaches were taken.51,110,112,155,162 One strat-
egy was based on crystal structure and analysis of cofactor binding to allow the use of
NAD+. The site-directed mutagenesis to increase NAD+-affinity was tried first. How-
ever, the best mutant apparently still had 50-fold lower affinity compared to the wild
type and NADP+ affinity also decreased.162 Alternatively, mutations were introduced
leading to 4-fold higher activity with NADH compared to the wild type (vmax = 80
Umg(protein)−1) but the activity of the wild type with NADPH was still 4-fold higher
(vmax = 355 Umg(protein)
−1).110 Whether activity towards a substrate was affected as
well was not discussed. A LbADH-mutant was also used in an oxidative kinetic reso-
lution of phenylethanol with oxidative cofactor regeneration by a NADH oxidase from
Lactobacillus brevis.51 In Hortsch and Weuster-Botz 70 LbADH activity with NADH (and
Acetophenone) was used to monitor the growth of E. coli BL21 (DE3) T1r(pET24a-
adhl.brevis-fdhC.boidinii) in parallel cultivation.
Noteably, additives such as organic solvents (miscible and non miscible) or ionic liq-
uids are influencing selectivity, activity, and/or half-life.37,40,95,126,173 An aqueous two
phase system with the ionic liquid diethyl-methyl-polyethyleneglycol ammonium chlo-
ride (Ammoeng110TM) could be utilised for the extraction of LbADH. The system was
optimised by experimental design.37 The specific activity was found to be twofold higher
in the ionic liquid rich phase. Furthermore, the storage half-life at 30◦C was increased
10-fold from 14h to 142h by addition of 30% (w/w) ionic liquid. In biphasic systems of
aqueous buffer and organic solvents storage stability40,194 and operational stability126,192
were found to be unusually high with half-life in the range of several hundred hours.
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Figure 2.3: Diketones used as substrate by Kurina-Sanz et al. 101
2.3 Biotransformations
The application of LbADH in biotransformation was pioneered by Hummel and cowork-
ers as discussed in Hummel 74 . The bioorganic potential was exploited early-on by the
group of Mu¨ller123.
2.3.1 Substrate scope
Substrates which can be converted by LbADH are shown in Figure 2.4 and classified into
groups from 1 to 15. Generally, ketones are converted that have preferential short chain
substitution (methyl-, ethyl-) and are not too sterically demanding on the other residue.
Notable exceptions are cyclohexanone derivatives (12),44,74 2-hydroxy-phenyl-propanone
(11),87,88 and diketones (8, 9, 10, Figure 2.3).101 Interestingly, only 2,3-diketones are
reduced to the corresponding diols with high diastereoselectivity for 2,3-diketo-hexane
and -heptane to the syn-alcohols (2R,3S).101 This is in accordance with the reduction
of 1,2-hydroxy ketones such as 2-hydroxy-phenyl-propanone87,88 and hydroxy-propanone
(13).73,74 2,4-Diketones are regioselectively reduced only in 2-position (10).101
Acetophenone is widely used and also 4-nitro- and 4-ethyl-acetophenone, methyl-naphtyl-
ketone, as well as all monosubstituted chloro-acetophenones are accepted with varying
activity (11)18,19,73,74,204 as is 4-acetylpyridine77. Benzaldehyde and propiophenone are
accepted with low activity (11).73,74
Ketoesters are also widely used such as 2-oxo-ester (3),73,74 3-oxo-esters (4),18,33,46,73,74,131,166
4-oxo-esters (5),73, and 5-oxo-ester (6).73 When 3,5-dioxo-esters (7)38,48,80,210–213 are
transformed, the easiest accessible oxo-groups in view of steric hindrance are reduced.
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Figure 2.4: Overview of substrate motifs as converted by LbADH to the corresponding
R-ketones, possible residues can be found in chapter 8 Table 8.1
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A C-C triple bond in so called propargylic ketones is also accepted in substrates (14),169–172
as well as C-C double bonds in allylic ketones (15)177.
All aliphatic linear 2-oxo-alkanes from chain-lengths C3 up to C11 (1) are accepted as
substrates whereupon the achievable enantiomeric excesses increase with increasing chain
length. Butanone gives rise to varying enantioselectivity between≈ 0.32173 and>0.90192.
The reduction of 2-pentanone through 2-heptanone is reported without giving enantios-
electivity.43 For the reduction of 2-octanone and 2-nonanone, high enantiomeric excesses
are reported.19,41–43,165,173,192 Partly, solubilisers such as acetonitrile173,dioxane43, or ionic
liquids37,95 are used with low influence on the enantioselectivity.
In order to get a deeper insight in the substrate scope of LbADH, Naik et al. 128 investi-
gated different acetophenone derivatives (11) in view of their acceptability by LbADH
and Thermoanaerobacter sp. ADH (ADH-T). Out of thirteen substrates, only six sub-
strates were converted. Various effects like substrate size, substrate solubility, electron
withdrawing or donating groups, and electron charge distribution were considered to be
responsible for this specificity. It turned out, that the substrate size is not influencing
the enzymatic reaction, as all substrates were smaller than 310 A˚3, the volume of the
substrate cavity in the active center of LbADH. Further investigations showed, that
neither the substrate solubility nor the electron withdrawing or donating properties of
the p-substituent were rate determining, but the electronic charge distribution of the
substrate. Substrates with p-substituents exhibiting ionically demanding groups were
not converted. The authors suggest that these substrates enter the active center with
the side with higher electron density. Thus, the carbonyl function is far away from the
active center and cannot be reduced by LbADH.128
2.3.2 Applications
Whole cells of recombinant E. coli were applied for the reduction of methyl-3-keto-
butanoate (4) with 2-propanol as reducing agent.164,166 The authors developed a quan-
titative model for the process based on in vitro kinetics and metabolic cofactor con-
centration with more than 40 model parameters. The regeneration of the cofactor and
LbADH expression were identified as rate limiting. The limitation in view of cofactor
regeneration could apparently be circumvented by coexpression of a NAD+ dependent
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formate dehydrogenase (FDH) from Mycobacterium vaccae N10 along with LbADH46
with an approximately doubled productivity per cell mass (40 mmol gcww
−1 d−1) vs.
290 mmol gcdw
−1 d−1) (wcw: wet cell weight, cdw: dry cell weight).
Alginate immobilised whole cells were used for transformations of a variety of β-keto
esters (4). Immobilisation allowed up to 10 recycles without apparent loss in activity.131
The higher the cell loading in the immobilisates, the slower the apparent reaction rate
or the conversion obtained after a given time. Cell agglomeration and mass transport
limitations were discussed briefly by the authors. Recycling was improved as after 14
cycles conversion with free cells had dropped from more than 0.9 to 0.05 whereas with
the immobilised cells conversion better than 0.7 was obtained which is in line with cell
recovery. Continuous experiments in a packed bed plug flow reactor could be run for more
than 40h (13 residence times) at STY=25 gL−1h−1 for ethyl-(R)-3-hydroxybutyrate.
Both in the batchwise recycling as well as in the continuous reactions the immobilisation
conditions such as pH and ions used in the hardening, affected the stability of the catalyst
system.
A whole cell biotransformation with overexpressed LbADH and FDH from Mycobac-
terium vaccae N10 in E. coli for the reduction of 4-chloro-acetophenone (11), ethyl-4-
chloroacetoacetate (4), and 1-phenyl-2-chloroethanone (11) was performed in biphasic
systems with 9 and 10 ionic liquids, respectively.18,204 The authors proposed a selection
procedure for the ionic liquid based on testing of the membrane integrity and rating
criteria.18 In follow up work a FDH from Candida bodinii was used for the reduction
of 2-octanone (1) and 4-chloro-acetophenone (4).19 The number of ionic liquids was in-
creased to 21. As in the previous work a bis[(trifluormethyl)sulfonyl]amide (BTA) based
ionic liquid gave best yields and was chosen for a 200mL scale-up to a fed batch with
0.18kgL−1d−1.
The reduction of tert-butyl-6-chloro-3,5-dioxo-hexanoate (7) to tert-butyl-6-chloro-5R-
hydroxy-3-oxo-hexanoate was chosen for optimisation of reaction conditions as the best
candidate for statin synthesis among 12 substrates converted by LbADH .210,211,213,214
The chemical side reaction of this specific substrate, namely the elimination of HCl
giving a stable 5-membered furanone, was supressed by adjusting pH to 5.5 and keeping
the substrate concentration low via fed batch operation of the stirred loop reactor.48,212
Alternatively, a biphasic approach with methyl-tert-butylether (MTBE) as non-reactive
phase was described.48,194,211 At higher concentrations, this approach gave up to 10-
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fold higher turnover numbers of the cofactor NADP+. However, selectivity with the
competing chemical side reaction droped to 0.7 with increased substrate concentration.
For acetophenone (11) at low concentrations of 1 mmolL−1 a repetitive batch with at
least four recycles is described and the enzyme half-life is given as 480h.48,194
The influence of acetonitrile and 1,4-dioxane as cosolvents for the reduction of butanone
(1) on enantiomeric excess and half-life was investigated.173 Half life was generally re-
duced with increasing molar fraction of organic cosolvents from 400 h in buffer down to
1.6h with x = 0.10 acetonitrile. Enantioselectivity also depended on the molar fraction
of these cosolvents and is marginally increased with higher amounts from 0.37 in aqueous
buffer to 0.43 with x = 0.100 and x = 0.050 with acetonitrile and 0.40 at x = 0.100
1,4-dioxane.173
To convert hardly water-soluble ketones such as 2-octanone, 3-octanone, 2-nonanone
and 2-decanone (1), ionic liquids (IL) were used as solubiliser.95 For cofactor regenera-
tion glucose dehydrogenase (GDH) catalysed oxidation of glucose was chosen. From an
initial set of 10 water miscible IL AMMOENGTM101 was subsequently used. The ki-
netic characterisation revealed that AMMOENGTM101 is activating and stabilising the
LbADH. For all four ketones tested, product inhibition was much lower when 200g/L IL
is added when compared to the pure buffer. The half-life increased from 49 h to 158 h
in 200g/L IL/buffer-mixture. Optimised batches with cofactor regeneration via a glu-
cose dehydrogenase and glucose as co-substrate gave TONLbADH of 842,000, TONGDH
of 19,000 and TONNADP+ of 800.
The immobilisation of LbADH on a commercial amino-epoxy support was optimised
aiming for increased stability.62,63 Immobilisation yielded 0.15 of the activity and half-
life of about 20h at 30◦C similar to the one found in solution, in line with the observation
that the enzyme is readily desorbed in a 1mol L−1 sodium chloride solution. However,
treatment with glutardialdehyde gave half-life of more than 1000h with 0.4 activity before
treatment. Combination of mercaptoethanol and glutardialdehyde treatment yielded 0.2
of activity with a half-life of 500h. The process stability was demonstrated in a packed
bed plug flow reactor where the immobilised enzyme with combined treatment gave a
steady state conversion of 0.6 over more than 1500h (1h residence time) for the reduction
of acetophenone (11) via substrate coupled cofactor regeneration with 2-propanol.
An alternate method for immobilising enzymes or rather LbADH together with the co-
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Figure 2.5: 4-acetylpyridine which is used as substrate by Jeromin 77
factor is described by Jeromin 77,78 . Both, enzyme and cofactor were absorbed by a
superabsorbent polymer, namely Favor R©, and dried afterwards. The so prepared cata-
lyst was then used for the enantioselective reduction of acetophenone, 4-acetylpyridine
(11, Figure 2.5) and ethyl-3-oxobutanoate (4). Exclusively the R-enantiomer was formed
with almost quantitative conversion. The superabsorbed catalyst was easily separated
from the reaction mixture and reused four times in a repetitive batch mode. In total,
0.016 mmolproduct · U−1 (1 U = amount of enzyme which catalyses the conversion of 1
μmol of substrate per minute) were synthesised with TONNADP+ = 900.
For the application of whole cells in the continuous synthesis of methyl-(R)-3-hydroxy-
butanoate (4), different cofactor regeneration techniques were tested.164,165 Cells, over-
expressing LbADH were used in the substrate coupled approach with 2-propanol, or
regeneration enzymes like glucose dehydrogenase from Bacillus megaterium (GDH to-
gether with glucose facilitator GLF from Zymomonas mobilis) or formate dehydrogenase
(FDH) from Mycobacterium vaccae N10 were coexpressed (GDH/GLF,FDH in analogy
to Ernst et al. 46). The performance of the so produced cells was subsequently examined
in a stirred loop reactor (see Figure 2.6) with retention of the cells in a bypass. The
operational stability of both of the enzyme coupled approaches turned out to be rather
low with deactivation constants of 0.96 day−1 (FDH, half-life 17 h) and 0.219 day−1
(GDH, half-life 76 h). The deactivation constant using 2-propanol for cofactor regener-
ation was two orders of magnitude smaller (0.0059 day−1, half-life 2500 h) leading to a
stable process for 45 days with a maximum STY of 6 mol L−1d−1. Producing 2-butanol
(1) with the same setup gave a 3-fold higher deactivation of 0.016 day−1 (half-life >1000
h) with a maximum STY of 4 mol L−1d−1. For methyl-(R)-3-hydroxybutanoate the ee
was >0.99. For 2-butanol no data concerning ee is given.
In a two-phase system with MTBE as second phase, using isolated enzymes, the enzyme
coupled cofactor regeneration seemed to be favourable.41 For the reduction of 2-octanone
27
2 Alcohol Dehydrogenase from Lactobacillus brevis
Figure 2.6: Stirred loop reactor with filtration as used by Schroer et al. 165 ; P = pump,
M = filtration module
(1), cofactor regeneration with 2-propanol or with GDH/glucose were adopted. In this
case, the 2-propanol system was inferior to the GDH/glucose system due to equilibrium
constraints. So, a conversion of 75% was reached with the GDH/glucose system within
1 h, with 2-propanol as reducing agent, the same conversion was reached only after a
reaction time of almost 2 h. Also, the authors hint towards repetitive batch application
by replacing the organic phase.41
If cofactor regeneration is done via oxidation of 2-propanol, removal of acetone is al-
ways an issue regarding equilibrium constraints. In Eckstein et al. 42 2-octanone (1)
was used as substrate with isolated LbADH. To remove acetone, two two-phase ap-
proaches were tested, one with MTBE and one with [BMIM][CF3(SO2)2N] as second
phase. The partition coefficient for acetone in the IL/buffer system was higher (2.0)
than for 2-propanol (0.4) in contrast to the equal partition coefficients for both com-
ponents in the MTBE/buffer-system of with 1.1 /1.0, respectively. Thus, the selective
extraction of acetone in the IL/buffer-system led to a higher reaction rate than in the
MTBE/buffer-system. The conversion was not strongly affected in this case, which
was probably due to the 200-fold excess of 2-propanol.42 Another approach used the
same IL, [BMIM][CF3(SO2)2N], and MTBE as second phase for in situ acetone re-
moval.168 In this case, the conversion of 1-phenyl-2-propanone (2) was investigated. If
MTBE was used as a second phase, the yield was restricted to 24% , using the ionic
liquid [BMIM][CF3(SO2)2N] as a second phase, yields of 95% could be achieved. This
fact is due to the different partition behaviour of acetone in the buffer/MTBE and
buffer/[BMIM][CF3(SO2)2N] system. In the enantioselective reduction of 2,5-hexanedi-
one (5) to the corresponding diol, equilibrium constraints play a key role if the substrate
coupled approach is used because two equivalents of acetone are formed. Different non-
extractive acetone removal techniques like stripping and pervaporation were tested.164,168
Without acetone removal, the yield was limited to 55%. Pervaporation and stripping led
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to increased yields of 90 and 95% , respectively. Further stability investigations showed,
that pervaporation guarantees the highest catalyst stability when compared to stripping
and extraction with IL. These findings were later applied for the continuous synthesis of
the same target molecule, 2(R),5(R)-hexanediol.164,167 A continuous setup was built up
with in situ acetone removal by pervaporation, leading to a maximum space-time yield
of 1.4 mol L−1d−1 at a maximum yield of 77% .
In contrast to the above mentioned findings, in Mu¨ller et al. 124 results are reported
when reducing butanone (1) to (R)-2-butanol using 2-propanol as reducing agent. After
2 h reaction time, generally higher conversions and comparable ee were reached when
using a MTBE/buffer-system instead of a [PMIM][PF6]/buffer-system, although the IL
showed miscibility with acetone and no miscibility with the reducing agent 2-propanol.
An alternative approach was tested with a malate dehydrogenase (MDH) and L-malic
acid as reducing agent, but ee were lower. Hence, 2-propanol in a MTBE/buffer-system
was tested for the continuous production of (R)-2-butanol in a minimum volume (2
to 5 mL) biphasic reactor with aqueous buffer and MTBE.126,192 A space-time yield
of 200 mmol L−1d−1 with the ee starting from ≈ 95% dropping to ≈ 85% after 90 h
operation is reported.
The production of β-hydroxyesters (4) on an industrial scale was already established by
Wacker (Burghausen, Germany).33,34,107,142,157 In repetitive batch, methyl-3-oxobutano-
ate was reduced to the corresponding hydroxybutanoate, the cofactor regeneration was
achieved by substrate coupled regeneration with 2-propanol. The co-product acetone
was removed by reduced pressure and the target product was isolated from the reaction
mixture by continuous extraction with MTBE and subsequent distillation of the solvent.
The product-free enzyme-solution was then re-used leading to a TON for the cofactor
of 74,000 and a space-time yield of 92 gL−1d−1.
For the prediction of thermodynamic conversion and yield in various biphasic systems
LbADH was used as model catalyst for the reduction of acetophenone (11) with 2-
propanol. An analytical equation was derived to allow prediction of conversion and
yield from the equilibrium constant and the partition coefficients and the implications
for maximising them are discussed.44 The prediction is shown for 8 biphasic systems
including two ionic liquids. The lack of data in view of equilibrium constants and possible
means of deriving them from alternative sources are further discussed and evaluated.43
The approach with computational chemistry was developed further.145,146
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Freeze dried preparations of LbADH are active for conversion of gaseous reactants. By
optimisation of immobilisation conditions on coated glass beads, by addition of sucrose
half-life of 40 days under reaction conditions in a packed bed plug flow reactor were
possible.47 The effect of sucrose on the adsorption isotherms was investigated in detail
later showing that sucrose lowers water adsorption per protein as well as the adsorp-
tion of acetophenone (11) and isopropanol.36 Furthermore, the enzyme coated glass
beads tended to decrease in protein loading and sinter in the presence of water as shown
by scanning electron microscopy (SEM). In a study centered on yeast ADH (yADH)
influence of pressure during freeze drying was investigated and specific activity after
redissolution was found to be up 3-fold higher than of the initial LbADH preparation
at about 40kPa.188 The effect of pressure, water activity, cofactor to protein ratio, and
temperature on the reduction of acetophenone by an immobilised LbADH were investi-
gated. LbADH was applied as lyophilisate on glass beads in a packed bed reactor for
the reduction of acetophenone with STY of up to 1kgL−1d−1 at 60◦C calculated on basis
of the packed volume at half-life of 1 day .189 The authors point out that operational
half-life for gas phase reactions cannot be correlated with storage stability.
Dense propane can also be applied as non-reactive phase for LbADH catalysed transfor-
mations.186 Both, an aqueous/dense propane-biphasic system or a monophasic dense
propane system with LbADH -lyophilisate immobilised on glass beads were investi-
gated.186 For the synthesis of (R)-phenylethanol (11), using the biphasic system led
to 90% conversion of acetophenone whereas the reaction with immobilised LbADH gave
only 45% conversion. This was in contrast to deactivation investigations. At 30 bar
propane, in aqueous solution LbADH was less stable (t 1
2
= 0.2 h @ 35 ◦C) than a
corresponding freeze dried preparation (t 1
2
≈ 1h @ 34 ◦C).
Several multi-step one-pot syntheses including one step being catalysed by LbADH are
reported.14,21,50,150,177 Chiral allylic (15) alcohols were obtained in a two-step synthe-
sis by converting the product, an allylic ketone, of a Pd-catalysed Heck-reaction of
aryliodides with butenone by simply adding buffer, cofactor, 2-propanol and LbADH
to the transition-metal containing reaction mixture.177 High space-time yields of >1.0
mol L−1d−1 and yields between 20 and 80% were realised with this method.177 The
same method was used with 3-buten-2-ol being the substrate for the Heck-reaction-
step yielding aliphatic alcohols after the LbADH-catalysed reductin step in high ee and
yields between 77 and 92% .14 A similar approach to phenylethanol derivatives (11)
was published by the same group.21 Here, the first step was a Pd-catalysed coupling of
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aryliodides with acetic anhydride, which led to the corresponding acetophenone deriva-
tives. Hydrolysing excess acetic anhydride was achieved by heating the reaction mix-
ture with aqueous buffer. The enzymatic step was started by adding LbADH, NADP+
and 2-propanol. The products of a Suzuki-Miyaura cross-coupling were reduced in the
same manner to give chiral biaryl alcohols in high yields (73-91%).Prastaro et al. 150
Two diketo-acetophenone derivatives were converted in a three-step one-pot synthesis
to give hydroxy acids(11).50 In this case the regioselectivity of LbADH was utilised
to reduce a ketone in presence of an aldehyde, while the aldehyde was reduced by an
aldoketo reductase from E. coli (ECAKR). The oxidation of the primary alcohol was
then performed by a dihydrodiol dehydrogenase from Pseudomonas fluoroescens to give
the corresponding acid. Except LbADH, all enzymes were used as whole-cell catalysts
in E. coli. All three steps were carried out in one reaction mixture with the biocata-
lysts added stepwise after completion of the precedent step. The medium was always
containing NADP+ and 2-propanol for cofactor regeneration, though, no intermediate
workup had to be carried out. On a 250 mg-scale, (2S )-hydroxy(phenyl)ethanoic acid
(mandelic acid) was obtainaned with an overall yield of 90% and an ee of 99% and
3-[(1R)-1-hydroxyethyl]benzoic acid with an overall yield of 90% (ee = 99% ).
The high selectivity of LbADHtogether with its easy handling was also used to reduce p-
vinylacetophenone to (R)-p-vinylphenylethanol. The latter was then copolymerised (S )-
p-vinylphenylethanol and styrene in various ratios to yield chiral polymers which were
further processed with lipase B from Candida antarctica.39 A main drawback of polymers
is their relatively wide molecular weight distribution, and thus uncertainty about the
distribution of the chiral centers along the polymer backbone. To obtain products with
more precisely defined properties, the same group later published an approach for the
production of dendrimers containing chiral functionalised side groups.217 The substrate
in this case was 1-(4-ethynylphenyl)ethanone. While in Duxbury et al. 39 a reasonable
amount of 1 mmol NADP+ for 34.2 mmol substrate was used, in Yeniad et al. 217 3.2
mmol of the much more expensive NADPH was used to convert 6.9 mmol substrate.
Electrochemical cofactor regeneration methods were not possible due to the lack of sta-
bility of LbADH in presence of the redox mediator used, a rhodium bipyridin complex92
(Fig. refechemie) and due to the adsorption of the enzyme on the porous carbon felt and
subsequent deactivation.63,64 After deactivation of the enzyme, the ee decreased dramati-
cally due to the unselective direct reduction. Several approaches were tested to overcome
these limitations. Adding a second protein, such as bovine serum albumin (BSA) kept
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Figure 2.7: Reaction scheme for the reduction of acetophenone to (R)-phenylethanol
with electrochemical cofactor regeneration64,65.
the enzyme in solution and led to a TON of 74,000 for LbADH with an ee of >99.9 and
a productivity of 120 mmol L−1d−1 for (R)-phenylethanol (11).64 By means of immobil-
isation, a direct contact of LbADH with the carbon felt was avoided, thus a TONLbADH
of 21,000 with a productivity of 74 mmol L−1d−1 for (R)-phenylethanol (11) was possi-
ble.64 The ee dropped slightly to >98.0 due to the direct reduction in compartments of
the reactor where no enzyme was present.64 Using a two-phase system with MTBE as
second phase for the same substrate, acetophenone (11), the space-time yield dropped
to 25 mmol L−1d−1 with the conversion not exceeding 60%. These disadvantages may
be overcome by the facilitated downstream-procedure in this case.64 The spacial separa-
tion of LbADH immobilised on Sepabeads R© from the polymer enlarged electrochemical
mediator (Rhbpy) led to enhanced catalyst stability, so that electroenzymatic synthesis
was possible with a linear product formation rate for (R)-4-chloro-phenylethanol (11)
of 0.42 mmol L−1h−1 and a space-time yield of 10 mmol L−1d−1. One main drawback
of this approach was the low TON of 3 for the cofactor.63,65 The relatively complicate
configuration for electroenzymatic synthesis as compared to a simple substrate coupled
cofactor regeneration approach may be considered as another drawback.
Finally, the high stability and activity of LbADH was also used for simple cofactor regen-
eration in the hydroxylation of steroids to the corresponding 15β-hydroxy products.220
For the hydroxylation step, the soluble P450 monooxygenase, CYP106A2 from Bacillus
megaterium ATCC 13 368 was used. This enzyme requires an electron transfer part-
ner, in this case bovine adrenodoxin (Adx), which was coexpressed together with the
CYP106A2 in Escherichia coli. Adx acts as electron transfer agent from NADPH to
CYP106A2, the cofactor regeneration was carried out by LbADH using 2-propanol as
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Figure 2.8: Reaction scheme for the hydroxylation of steroids with monooxygenase
CYP106A2220.
reducing agent (see Figure 2.8). Growing and resting cells of E. coli were tested as well
as crude cell extract (CCE). Resting cells gave better conversion and less side products
when compared to growing cells. Because steroids are not actively transported through
the cell membrane, CCE was tested and showed higher activity, but also a higher amount
of side products compared to resting whole cells. After optimization a space-time yield
of up to 18.3 mmol L−1d−1 was achieved with CCE.
Another approach which uses LbADH for cofactor regeneration is the concurrent pro-
duction of two enantioenriched compounds.156 The main reaction here was the oxidative
kinetic racemic resolution of a ketone to the corresponding ester or sulfide oxidation to
the corresponding sulfoxide by two Baeyer-Villiger monooxygenases (BVMO). BVMO
need NADPH as redox equivalents with NADP+ as coupled product. The in situ re-
generation was done by the oxidation of an alcohol by LbADH or ADH from Ther-
moanaerobacter species (ADH-T). In this case the kinetic racemic resolution of a long-
chain alcohol (2-octanol, 2-undecanone, 2-hydroxy-6-methyl-hept-5-en (1)) was used for
LbADH -catalysed cofactor-regeneration. Only for high conversion high ee is possible
for the non-converted substrates. ee for the alcohols was between 27 and 99% depend-
ing on subtrates and enzyme combination. The authors do not comment on solubility
restrictions of the long chain alcohols.
In a similar approach, better results were obtained for the concurrent production of
two chiral alcohols via transfer-hydrogenation with LbADH, when the ketone to be
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reduced exhibits a Cl-atom in α-position to the keto-function.12 As hydride donors,
three phenylethanol derivatives (11)were used as well four other chiral 2-alcohols (two
from substrate class 1, and two from substrate class 2). The ketones were used in
a ratio of 1:2 to the chiral, racemic alcohols. High conversions were reached between
83 and 99% which is only accessible when using non halogenated hydride-donors in
high excess of typically 10 times, and leads to good to excellent ee (87 - 99% )for the
non-converted chiral hydride donor.. The same group later examined ketone-alcohol
equilibria with different catalysts and different ketones to be reduced.13 Generally, when
using 2 equivalents of 2-propanol, the conversion were > 99% when α-Cl-ketones were
reduced and much lower when reducing simple ketones like acetophenone for example
(49% conversion). The non-reactivity of the halohydrin product was identified to be
responsible for the high conversion. Modeling of the docking of 2-Cl-acetophenone, and
2-Cl-phenylethanol revealed, that there is no significant difference in the substrate and
product interaction with the active center of LbADH. Thus the oxidation of halohydrins
is not restricted by interactions with the enzyme. A possible intramolecular hydrogen
bond forming between OH and Cl was also excluded to be responsible for the non-
reactivity of the halohydrin products. This is credited to the fact that there are several
conformers which do not allow for such a hydrogen bond formation but are very close
in energy to the conformers which allow for OH-Cl hydrogen bond formation. In fact,
the difference in free Gibbs-energy for the ketone and alcohol was identified to be the
reason for the good conversion of α-Cl-ketones and α-nitrile-ketones.13
In a dynamic kinetic resolution the spontaneous racemisation of tert-butyl-4-methyl-3,5-
dioxo-hexanoate (7) was exploited to reduce the 4S,5R-alcohol80 with ee = 99.2% and
94% diastereomeric excess.80,213 The access to two other of the four possible diastereoiso-
mers by using other biocatalysts is also described.103
2.4 Conclusion
LbADH is a versatile and robust catalyst. Furthermore, the tolerance of organic sol-
vent/IL etc. as additives, as well as biphasic media, and gaseous dense reaction condi-
tions is outstanding for an oxidoreductase. The substrate scope is broad and high regio-
and stereospecifity can be obtained. Especially, the 2-keto motif has a high probability
to be converted with high selectivity and activity. Here, the tolerance of organic co-
34
2.4 Conclusion
Figure 2.9: Overview of the applications of LbADH with number of citations (the diam-
eter of the circles is proportional to the number of citations).
solvents and biphasic systems allow to compensate for water as the reaction medium.
LbADH is used as whole-cell catalyst in E. coli as well as isolated enzyme, soluble or
immobilised (see Figure 2.9). A priori, no choice for one of the regeneration methods
can be substantiated. When isolated enzymes are used, the ratio LbADH/regeneration
enzyme can be chosen independently. In whole-cell processes intracellular cofactor con-
centrations are mostly sufficient, but expression levels of the enzymes are rather difficult
to influence. This is especially an issue, if cofactor regeneration is done in an enzyme
coupled approach, so that two enzymes are coexpressed in one organism. Different ex-
periments have shown, that half-life of LbADH is strongly depending on the presence
of cofactor, magnesium, additives or organic cosolvents, pH and nature of the buffer,
ion strength, temperature, water activity, immobilisation, as well as non-miscible phases
and varies from single hours to more than 1000h. So, if stability is investigated, care
has to be taken to ensure that process conditions are covered by experiments, otherwise,
strong deviations from storage stability to process stability occur.
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3 Continuous Biphasic Enzymatic
Reduction of Aliphatic Ketones
Parts of this chapter have been published ina:
Susanne Leuchs, Thomas Nonnen, Dominique Dechambre Shukrallah Na’amnieh and
Lasse Greiner, Journal of Molecular Catalysis B: Enzymatic, 2013, 74, 52-59
Abstract
Biphasic reactions offer an attractive alternative for the utilisation of enzymes for con-
version of hardly water soluble substrates. Especially, the alcohol dehydrogenase from
Lactobacillus brevis was successfully used for the reductive synthesis of enantiopure sec-
ondary aliphatic alcohols. With the enzymatic catalyst and the cofactor effectively
retained in the reactive aqueous phase, the continuous operation was demonstrated by
continuous addition and withdrawal of the non-reactive phase. The four tested substrates
2-heptanone, 2-octanone, 2-nonanone, and 2-decanone showed that the space-time yield
and turnover numbers (TON) of the enzyme decrease as the availability of the sub-
strate decreases with increasing partition coefficients. Nevertheless, a TONLbADH of up
to 478 ·103 could be achieved. Remarkably, the cofactor utilisation turned out to be very
high and a TONNADP+ of more than 20 · 103 was easily achievable for both 2-heptanone
and 2-octanone by substrate coupled cofactor regeneration with excess of 2-propanol.
ahttp://www.sciencedirect.com/science/article/pii/S1381117712003013 - Reproduced by permission of
Elsevier B.V.,2013
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3.1 Introduction
The synthesis of enantiomerically pure alcohols is either carried out by kinetic resolu-
tion or by direct asymmetric synthesis. Kinetic resolution was almost exclusively carried
out by using hydrolases,185 for which prominent examples for robust and versatile en-
zymes can be found. The maximum yield for a kinetic resolution is 50%, which is
unfavourable both economically and ecologically. The asymmetric reduction of prochi-
ral ketones with alcohol dehydrogenases (ADH) offers an attractive alternative185 which
is more and more introduced in the fine-chemical and especially API-production.15,72,120
Chiral aliphatic alcohols are of special interest as they are widely applicable as building
blocks in the fine-chemical- and in the pharma-industry. For example, chiral aliphatic
alcohols can serve as cosurfactant in capillar electrophoresis for resolution of the enan-
tiomers of ephedrine-derivatives,224 as a building block for the synthesis of chiral liquid-
crystals with interesting optical properties,113 or as a derivative for polymeric aniline to
produce solid electrodes for the recognition of chiral compounds67. The direct enantios-
elective reduction of ketones to the corresponding alcohols represents a reaction with
high added value in the range of 100-fold. Classical chemical routes like hydrogenation
with modified noble metal-catalysts or Corey-Bakshi-Shibata reduction provide prod-
uct alcohols with high enantiomeric excess (ee) only from functionalised ketones.136,153
Enantiopure, aliphatic non-branched and non-functionalised chiral alcohols are hardly
accessible via non-enzymatic synthesis-routes. For 2-heptanol an ee of 51%114 and for
2-octanol an ee of 60%90, 52%114, 76%86, and 28%16 are reported. The main challenges
for the enzymatic asymmetric reduction lies in the dependency of the ADH on high-
priced nicotinamide cofactors (NAD(P)H) as redox mediator and the utilisation of both
cofactor and enzyme.
To recycle biocatalysts and cofactors, several methods are available such as immobil-
isation,179 retention by ultra- or nanofiltration membranes,100,109,174 entrapment ap-
proaches,32 or the use of biphasic systems.54,194 Immobilisation often implicates laborious
steps to derive an active catalyst for the specific reaction system. When an immobilisa-
tion protocol is available, the flexibility of the system is restricted. Membrane techniques
allow a straightforward use of the biocatalyst. If isolated/free enzymes are used, the re-
tention of cofactors remains an issue. By means of nanofiltration, a partial retention
of the cofactor is possible.174 However, substrates, products or auxiliary agents can be
in the same range of molecular weight as the cofactors and thus render nanofiltration
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impossible to selectively retain the cofactor. An alternative to immobilisation on solid
supports and membrane based retention is the application of aqueous-organic biphasic
systems. The enzyme and the cofactor are dissolved in the aqueous, reactive phase,
whereas the non-reactive phase acts as a substrate reservoir and extraction phase, re-
spectively.
An enzyme showing outstanding (enantio-)selectivity, activity and robustness is the al-
cohol dehydrogenase from Lactobacillus brevis (LbADH).104 The enzyme is depending
on NADPH as cofactor and compulsory needs Mg2+-ions to maintain its activity.133
LbADH is (R)-selective. It has been shown previously that LbADH is stable in the pres-
ence of organic solvents, especially in presence of methyl-tert-butyl-ether (MTBE).194
Although a slight increase in the reaction rate has been reported using an ionic liquid as
second phase,42 MTBE was preferred as second phase due to its lower viscosity, which
simplifies the dosage. Another reason is the low boiling point of 55◦C for MTBE which
allows for an easy down-stream processing as well as the lower price when compared
to most ionic liquids. In this report, we investigated the continuous exchange of the
MTBE non-reactive phase allowing high turnover numbers (molproduct/molcatalyst, TON)
for the cofactor and the enzyme as well as the integration of product separation into the
reaction.
The aim of this project was to use this approach to continuously synthesise long-chain
(R)-2-alcohols. A biphasic approach was chosen for the afore mentioned advantages
such as easy reuse of cofactor and enzyme as well as the facile product separation. As
the non-reactive organic phase, methyl-tert-butyl-ether (MTBE) was chosen as it has
already been proven that LbADH remains stable in presence of this solvent.194 The sys-
tem has already been tested with 2-butanone as model substrate and turned out to be
highly suitable for this purpose.124,192 However, short-chain ketones such as butanone are
water miscible, which is not the case for long-chain aliphatic ketones such as 2-octanone.
So, the continuous enantioselective reduction is a way to allow the conversion in water
as the reactive phase. To be able to conduct continuous synthesis, substrate coupled
cofactor-regeneration with 2-propanol is an appropriate choice as it can be continuously
added with the non-reactive phase and the coupled product acetone can be continuously
removed (see Figure 3.1). Most regeneration agents for an enzyme-coupled approach,
such as glucose or formate, are not soluble in organic media and can therefore not be
dosed conveniently. Also, coupled products would accumulate in the non-reactive phase
in the case of gluconic acid, the coupled product of the glucose-based cofactor regener-
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Figure 3.1: Biphasic reaction system for the enantioselective reduction of aliphatic ke-
tones
ation. Furthermore, both coupled products, gluconic acid as well as CO2 will strongly
influence the pH of the aqueous solution. In order to determine appropriate reaction
conditions, preliminary investigations on stability, kinetics, partitioning, equilibrium,
and interphase formation were conducted. Results from these experiments were later
transferred to the continuous syntheses of (R)-2-heptanol, (R)-2-octanol, (R)-2-nonanol,
and (R)-2-decanol.
3.2 Experimental
Reporting our experimental data, we followed the standards given by Gardossi et al.49 as
closely as possible. All ketones and alcohols were purchased from Sigma-Aldrich, Schnell-
dorf. All other chemicals came from Carl-Roth, Karlsruhe. N -methyl-N -trimethylsilyl-
trifluoracetamide (MSTFA) came from CS-Chromatographie-Service, Langerwehe. 2-
Propanol and acetone were of technical grade. Ultrapure water was obtained by reverse
osmosis and ultrafiltration in an ELGA purelab ultra-system and used throughout the
experiments
All reactions were carried out in potassium phosphate buffer with a concentration of
50 mmol L−1 , containing 2.5 mmol L−1 MgCl2 at pH=7.0. First, a buffer solution
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with a phosphate concentration of 500 mmol L−1 was prepared by dissolving the respec-
tive amounts of KH2PO4 and K2HPO4 in H2O. The desired buffer-solution was then
prepared by dissolving the respective amount of MgCl2 · 6H2O in H2O and adding the
respective volume of concentrated buffer-solution to give three quarters of the desired
final volume. For stock solutions of 2-octanone, 2-octanol, 2-propanol or acetone, the
respective amount was added. The pH was subsequently adjusted to the desired value
by adding dropwise KOH or H3PO4 and the solution was filled to the final volume.
For the kinetic measurements and determination of the protein content (see below), no
pretreatment was carried out. For the determination of partition coefficients and use in
the continuous synthesis, the buffer was saturated with MTBE by adding 10% of the
buffer volume. The buffer was then shaken and equilibrated for at least 24 h at room
temperature (23-26◦C).
The protein content of the LbADH-lyophilisate was determined according to the litera-
ture17 with a commercial kit (Carl Roth, Germany). Calibration was carried out with
bovine serum albumin. The protein-content of the enzyme preparation was 48%, all ac-
tivities and enzyme concentrations refer to the protein content of the enzyme preparation
(specific activity).
Samples of LbADH, NADPH and NADP+ were stored at 25◦C, 300 rpm in a ther-
momixer MKR13, HLC. For the LbADH, one sample was taken immediately after disso-
lution and in distinct time intervals, the activity was measured at 25◦C, c2−octanone= 1.8
mmol L−1 , cNADPH = 0.5 mmol L−1 . For the half-life of the cofactors, NADP+- and
NADPH-solutions were dissolved. Samples were withdrawn and mixed with substrate
solution (final concentrations: c2−octanone= 3.6 mmol L−1 and c2−octanol= 1.8 mmol L−1
). A concentrated LbADH-solution was added and the extinction at λ= 340 nm was
measured before and after adding the enzyme. From the difference in extinction, the
remaining amount of cofactor was deduced. For both, LbADH and the cofactors, a first
order degradation kinetic was assumed and the half-life was determined by fitting a first
order exponential function.59
If not stated otherwise, the kinetic measurements were carried out with non-MTBE-
saturated buffer at 25 ◦C in a UV/VIS-multiplate reader (Powerwave HT, BioTek). The
reaction volume was 180 μL and prepared in 96-well plates (greiner bio-one). 10 μL of
a buffer solution containing 10 mmol L−1 NADP(H) were added to give a final concen-
tration of 0.5 mmol L−1 . The reaction was started with 10 μL of a solution containing
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50 mg L−1 LbADH preparation (∼= 24 mg L−1 protein) to give a final concentration of
2.5 mg L−1 LbADH preparation (∼= 1.2 mg L−1 protein) in each well. Reaction progress
was observed by following the formation or degradation of NADPH at 340 nm. For the
oxidation of 2-octanol to 2-octanone and for inhibition experiments, (rac)-2-octanol was
used. The concentration of (R)-2-octanol was obtained by halving the total concentra-
tion. Kinetic measurements with 2-heptanone as substrate were carried out as described
for 2-octanone, but at 30◦C and in KPi-buffer with a concentration of 100 mmol L−1
and 1 mmol L−1 MgCl2.
For the determination of partition coefficients in ternary systems, samples of 2-octanone
and 2-octanol with concentrations between 20-100 mmol L−1 were prepared in water-
saturated MTBE. These samples were analysed via GC to verify the 2-octanone- and
2-octanol concentration and 5 mL of these samples were placed into screw capped
test tubes. 5 mL of MTBE-saturated buffer was added. The test tubes were closed,
vigourously shaken and stored at 25◦C in a water bath. The organic and the aqueous
phase were then separately analysed via GC.
For the determination of partition coefficients in multi-component systems, the aqueous
phase was prepared as described above. Concentrated solutions of 2-octanone, 2-octanol,
2-propanol and acetone were prepared in water-saturated MTBE and mixed together to
represent conversions of X2−octanone = 0, 20, 40, 60, 80, and 100% if the reaction had
started with a 2-octanone concentration of 100 mmol L−1 and a 2-propanol concentra-
tion of 1000 mmol L−1 in the organic phase. A sample of the mixtures in MTBE was
withdrawn and analysed via GC.
Monophasic batch experiments were carried out in a standard non-MTBE saturated
buffer solution. The different mixtures were prepared by weighing the respective amounts
of 2-octanone, 2-octanol, 2-propanol and acetone into a test tube with srew cap. 1000
μL of a MgCl2 · (H2O)6 solution with a concentration of 25 mmol L−1 were then added as
well as 1000 μL of the concentrated buffer-solution. Water and NADP+ stock-solution
were added to obtain a final concentration of 0.1 mmol L−1 NADP+. The reaction was
started with LbADH-solution, the final protein content was 12 mg L−1 protein. The
overall volume was 10 mL. The test tubes were shaken at 25 ◦C at 300 rpm. Samples
were withdrawn and analysed for conversion.
Biphasic batch experiments were carried out by preparing 2-octanone and 2-propanol
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stock-solutions in water-saturated MTBE. Defined volumes of both solutions and water-
saturated MTBE were put in a test tube with srew cap. The aqueous phase was prepared
with pre-MTBE saturated buffer concentrate and water as described for the monophasic
batches with a Mg2+ concentration of 9.7 mmol L−1 . A NADP+-solution was added
to obtain a final concentration of 0.1 mmol L−1 and the reaction was started by adding
LbADH-solution so that the protein content was 250 mg L−1. The overall aqueous
volume was 4 mL just as the volume of the organic phase. Samples were withdrawn in
defined time intervals from the organic phase.
Investigation of the interphase was conducted by mixing KPi-buffer with saturated
MTBE in combination with 2-propanol and LbADH lyophilisate. The samples were
stirred at ≈ 500 rpm and in all phases LbADH activity was determined.
For the continuous synthesis, a biphasic reactor was used as described previously.192 The
upper, MTBE phase was stirred by using a magnetic stirrer (Variomag Micro, Thermo
Scientific). The lower phase was stirred using a teflonated magnetic stirring bar. The
mobile MTBE-phase was prepared by dissolving the respective ketone and 2-propanol
in water saturated MTBE to give final concentrations of c2−ketone = 100 mmol L−1 and
c2−propanol = 1000 mmol L−1. The substrate solution was then stored with a slight
excess of water at 25◦C. The aqueous phase was prepared with MTBE-saturated KPi-
buffer. LbADH and NADP+ were dissolved in buffer and a defined volume was added
to obtain final conenctrations of 480 mg L−1 and 0.1 mmol L−1 respectively. Buffer
was added to a final volume of 5 mL aqueous phase. The capillaries and the pump
were flushed with substrate solution, and 5 mL of organic phase were placed above
the aqueous phase. Substrate solution was continuously pumped into and out of the
reactor by two countercurrent working syringe pairs in a syringe pump (MDSP3f, MMT
Micromechatronic, Siegen/Germany). The operating temperature of the reactor was 25
◦C. A flow cell (V = 107 μL was integrated in the product stream and samples were
taken automatically by an autosampler and analysed by GC.
The analysis of the organic phase was carried out by taking a 200 μL sample, mixing it
with 400 μL of a solution of 20 mmol L−1 1-octanol in ethanol and analysing the mixture
by GC. For analysis of the product stream in the continuous synthesis, 0.5 μL sample
and 1 μL of a solution of 20 mmol L−1 1-octanol in ethanol were taken from a flow cell
with an autosampler and immediately injected into a GC for analysis. In the case of
the 2-heptanone and 2-nonanone experiment, the internal standard was 1-octanol and 1-
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nonanol respectively in the same concentrations as for the 2-octanone experiments. For
the analysis of the monophasic batches, 200 μL sample were mixed with 400 μL of a 20
mmol L−1 ethanolic solution of 1-octanol. The mixture was immediately extracted with
n-heptane by vigourous agitating on a vortex-shaker. After the phase-separation, the
n-heptane phase was separated from the aqueous phase to prevent further conversion.
To get reliable data for the concentrations in the aqueous phase for the partitioning
experiments, a concentration by extraction had to be carried out. 800 μL of the aqueous
phase were mixed with 200 μL of a 1 mmol L−1 solution of 1-octanol in water. The whole
mixture was extracted with 200 μL of n-heptane and subsequently analysed via GC.
All samples were measured on Trace GC Ultra or Focus GC (both Thermo Scientific,
Dreieich/Germany) on a CP-ChirasilDex CB column (Varian; l=25 m, ID=0.25 mm,
film=0.25 μm) as described previously.94 ee was determined after derivatisation with
N -MSTFA as described previously.94
3.3 Results and discussion
3.3.1 Stability and kinetics
A key requirement for a successful continuous process is the stability of the involved
catalysts (respectively enzymes) and cofactors. Thus, the stability of LbADH, NADP+
and NADPH were examined independently by storing samples of each compound in pure
buffer as well as in MTBE-saturated buffer with and without addition of 2-propanol,
and acetone. The half-life of LbADH was between 9 and 14 days, for NADPH between
0.56 and 0.65 days, and for NADP+ between 155 and 370 days (see chapter 8 Figure 8.A
for detailed information). Therefore, the stability of the oxidized cofactor NADP+ is not
a limiting factor for the synthesis. With ≈ 10 days, the half-life of LbADH is lower, but
this value is still sufficient for a continuous setup. Due to the short half-life for NADPH
this is limiting for the continuous approach.
Kinetic measurements are an important tool to characterise an enzyme. In order to ob-
tain a deeper insight, initial reaction rates were determined for all four reactions, M, M’,
R and R’ (see Table 3.1) with 2-octanone as substrate. For every reaction, the reactant
concentrations as well as the effect of the MTBE content were varied (see chapter 8 Fig-
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Table 3.1: Reactions characterised by initial rate measurements
S1 S2 P1 P2 P1’
M: 2-octanone + NADPH → (R)-2-octanol + NADP+ 2-propanol
M’: (R)-2-octanol + NADP+ → 2-octanone + NADPH acetone
R: 2-propanol + NADP+ → acetone + NADPH 2-octanol
R’: acetone + NADPH → 2-propanol + NADP+ 2-octanone
ure 8.B). Investigating of the effect of the respective co-substrate on a specific reaction
(effect of acetone on M for example) was not reasonable. As only the concentration of
the reduced cofactor NADPH can be determined spectrophotometrically, it is not possi-
ble to distinguish between the conversion of 2-octanone and acetone in this special case.
An extended Michaelis-Menten based model
v =vmax[S][S2][
KM1
(
1 +
[P]
KP1
)(
1 +
[P’1]
KP ′1
)
+ [S1]
(
1 +
[S1]
KS1
)]−1
[
KM2
(
1 +
[P2]
KP2
)
+ [S2]
]−1
(3.1)
with limiting rate vmax, substrates S, products P, inhibitor P’, Michaelis-Menten con-
stants KM1 and KM2, as well as inhibition constants KP1, and KP2 were then used
to describe the measured initial rates. The parameters were estimated by a non linear
fitting to the experimental data (Origin 8G, OriginLab Corp.). The parameter values
are given in Table 3.2 and plots of the respective models are shown in chapter 8 Fig-
ure 8.B, 8.2(a)-8.2(e). MTBE concentration showed no significant influence and was not
considered in the model (see chapter 8 8.2(f)).
Apparently, the reduction of 2-octanone M is fast compared to its reverse-reaction M’.
The vmax is more than threefold higher for M than for M’ (see Table 3.2). Furthermore,
the reductive cofactor regeneration R is slower than the cofactor oxidation R’, with a
fourfold lower vmax for the latter. The respective KM -values reflect this trend in the
same manner. Unfortunately, product- and co-product-inhibition, reflected by the pa-
rameters KP1 and KP ′1 were highly pronounced especially for the two reactions M and
R which are important for producing the desired substance, (R)-2-octanol. This means,
that the main reaction M is inhibited by high concentrations of (R)-2-octanol as well as
by high concentrations of 2-propanol. In view of the high excess of 2-propanol needed
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Table 3.2: Parameter values of Equation 3.1 for 2-octanone/2-octanol (dashes indicate
that the corresponding inhibition was not found to be significant)
M M’ R R’
vmax / U mg
−1 51.0 ±1.7 15.4 ±0.4 4.8 ±0.1 21.6 ±0.6
KM1 / mmol L−1 0.056±0.005 0.511±0.042 3.417±0.511 0.064±0.009
KP1 / mmol L−1 0.031±0.004 – 0.035±0.006 0.010±n.a.
KP ′1 / mmol L−1 0.96±0.11 5.5 ±0.4 0.004±0.0006 –
KS1 / mmol L−1 – – – 374±30
KM2 / mmol L−1 0.160±0.018 0.036±0.002 0.067±0.007 0.032±0.006
KP2 / mmol L−1 0.088±0.011 0.012±0.001 0.155±0.042 –
Table 3.3: Parameter values of Equation 3.1 for 2-heptanone/2-heptanol at 30◦C (dashes
indicate that the corresponding inhibition was not found to be significant)
M M’
vmax / U mg
−1 41.8 ±1.4 14.6 ±0.139
KM1 / mmol L−1 0.134 ±0.02 0.315 ±0.013
KP1 / mmol L−1 0.223 ±0.03 0.026 ±0.001
KP ′1 / mmol L−1 38.36 ±4.88 –
KM2 / mmol L−1 0.21 ±0.012 0.053 ±0.002
to obtain a reasonable conversion (see below), and the partition coefficient which leads
to a 2-propanol concentration of 420 mmol L−1 in the aqueous phase, these inhibitions
are disadvantageous. The same is true for the inhibition by the corresponding product-
cofactor, represented by KP2. Nevertheless, these inhibitions are intrinsic properties of
the enzyme and their adjustment is not within the scope of our research. We focussed
on the elaboration of a process within the imposed boundaries.
For comparison, 2-heptanone was also tested as a substrate (see Table 3.3). In turn,
2-heptanone is less well accepted as 2-octanone by LbADH which is mirrored by the
lower value of vmax and from the higher Michaelis-Menten constant KM1. For both 2-
heptanone and 2-octanone oxidation M’ no inhibition by the corresponding ketone was
observed. Initial rate experiments for 2-nonanone/2-nonanol proved to be futile as the
solubility limit95 of less than 1mmol L−1 led to inconclusive results.
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Figure 3.2: Kinetic measurements with LbADH , variation of the respective substrate;
full squares: reduction of 2-octanone (reaction M); full circles: oxidation of
2-octanol (reaction M’); open triangles: oxidation of 2-propanol (reaction
R); open diamonds: reduction of acetone (reaction R’); solid lines: models
for C8-reaction; dashed lines: models for C3-reactions; all reactions carried
out at 25◦C with concentrations if not stated otherwise: cKPi= 50 mmol L
−1,
cMgCl2= 2.5 mmol L
−1, pH = 7.0, cNADP(H)= 0.5 mmol L−1 , c2-octanone= 2.63
mmol L−1 or c2-octanol= 1.32 mmol L−1 , cLbADH= 1.2 mg L−1
3.3.2 Partitioning
The partition properties of 2-octanone and 2-octanol were determined in ternary systems
(C8-component, MTBE and KPi-buffer) and for multiple systems with concentrations
chosen to represent extents of conversion (X2−octanone) in the system consistent of 2-
octanone, 2-octanol, 2-propanol, acetone, MTBE, and aqueous KPi-buffer (see chapter 8
Figure 8.C 8.3(a) and 8.3(b)).
In a two phase-system the partitioning of a substance i is described by the Nernst parti-
tion law, where Pi is the partitioning coefficient of i. corg,i represents the concentration of
i in the upper organic phase, caq,i is the concentration of i in the lower aqueous phase:
Pi =
corg,i
caq,i
(3.2)
In the ternary system, the average partitioning coefficient P for 2-octanone is 330±24 and
350±29 for 2-octanol. Both are concentration independent. In the multiple component
system, the partitioning coefficient for 2-octanone is unchanged with 330±49 compared
to the ternary systems. The observed partitioning coefficient for 2-octanol in this system
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of 400±40 is higher than in the ternary system (see chapter 8 Figure 8.C). A slight
increase of P as a function of X2-octanone up to 40% conversion could be observed in the
multiple component system with P2-octanol > P2-octanone.
Partitioning of 2-propanol and acetone was investigated in ternary systems with MTBE
and KPi-buffer (see chapter 8 Figure 8.D). For both acetone and 2-propanol, P is
concentration independent with Pacetone = 1.47 ± 0.06 and P2-propanol = 1.38 ± 0.04.
Hence, a selective extraction of acetone is not possible. With a starting concentration
of 1 mol L−1 2-propanol in the organic phase, the equilibrium concentration is 0.42 mol
L−1 in the aqueous phase. At this concentration range, the reaction rate of LbADH is
pseudo-zero order, thus the biphasic system will not influence the cofactor regeneration
rate (see Figure 3.2 and chapter 8 Figure 8.B).
An aqueous 2-octanone concentration of 0.3 mmol L−1 results for a concentration of
100 mmol L−1 in the MTBE-phase at a volume ratio of one. The kinetic investigations
revealed a sufficient LbADH activity for 2-octanone concentrations of 0.3 mmol L−1
on (Figure 3.2). Nonetheless, a twofold decrease in the reaction rate for 2-octanone
reduction M is expected.
3.3.3 Batch experiments and prediction of equilibrium conversions
It has been shown previously that the equilibrium conversionXeq in a monophasic system
is depending on the initial ratio of the starting materials.44,52,145 In a biphasic system,
factors like the phase volume ratio and the partitioning coefficient further determine
Xeq. If the phase volume ratio is one and the partition coefficients of the two corre-
sponding ketones and alcohols are similar, the equilibrium is determined by the initial
ratio of R0 =
c0(2−propanol)
c0(2−octanone) . With the equilibrium constant K, the Xeq can be calculated
according to
Xeq = K
1 +R0 −
√
(R0 − 1)2 + 4R0K
2(K − 1) (3.3)
for the reduction of 2-octanone. For the oxidation of (R)-2-octanol the equilibrium
conversion X ′eq is calculated according to
X ′eq =
1 +R′0 −
√
(R′0 − 1)2 + 4R′0K
2(1−K) (3.4)
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with R′0 =
c0(acetone)
c0(2−octanol) .
To determine R0, andK, batch syntheses were carried out in one- and two-phase systems
with various R0. The reduction of 2-octanone and the oxidation of (R)-2-octanol were
investigated. In Figure 3.3 the obtained Xeq vs. R0 and X
′
eq vs. R
′
0, respectively, are
shown. K could be determined to be 0.38 which is in the range of previously reported
values (K = 0.425 for acetophenone/2-propanol and K = 0.536 for 2-heptanone/2-
propanol)40,43. The fact that both the equilibrium conversion of monophasic and biphasic
batches are described with the same model underlines the validity of the findings that
the partitioning coefficients P of 2-propanol and acetone can be considered equal which
also accounts for 2-octanone and 2-octanol.
The initial turnover frequencies (TOF / s−1) for LbADH for monophasic and biphasic
batches were determined as a function of R0 (see Figure 3.4). As expected from the
initial rate measurements, the rates for the biphasic experiments are lower than those
for the monophasic experiments. The lower reaction rate in the biphasic system even
at high R0 is in line with the lower 2-octanone concentration in the aqueous phase
due to the partitioning. Noteworthy, the initial TOFLbADH in the monophasic system
correlates linearly with R0. A pseudo-zero order in R0 is observed in the biphasic cases
due to the partitioning. Although, high 2-propanol concentrations will increase the
equilibrium conversion, they do not necessarily increase the reaction rate. Additionally,
the concentration of the long-chain ketone in the aqueous reactive phase is unaffected
by 2-propanol concentration.
In the course of the biphasic batch-wise syntheses, the formation of a third, emulsion-like
phase or crud between the organic and the aqueous phase has been observed. When these
phases were separated, the emulsion-like phase spontaneously split up into two phases:
The lower phase was clear, the upper phase was emulsion-like. Further investigations
revealed that the emulsion-phase is only formed when LbADH is present in the aqueous
phase. On first view, emulsion-forming seems to be advantageous due to the enhanced
mass transfer. However, for the continuous synthesis a good phase separation is required
otherwise, parts of the aqueous, reactive phase can be carried out of the reactor. This
leads to leaching of the catalyst. For this reason, we determined the enzyme activity
in all three phases. The highest volumetric activity was found in the aqueous phase,
less in the interphase and no activity was detectable in the organic phase (see chapter 8
Figure 8.E). 2-Propanol did not influence the phase behavior, but reduced the volumetric
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Figure 3.3: Measured and calculated Xeq resp X
′
eq as a function of R0 respectively R
′
0,
with K = 0,38 full triangles: monophasic reduction; open triangles: biphasic
reduction; squares: monophasic oxidation; full line: model for the reduction;
dotted line: model for the oxidation; conditions: see Experimental
Figure 3.4: Initial turnover frequencies (TOF) for the monophasic (full triangles) and
biphasic (open triangles) reduction reactions; conditions: see Experimental
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activity as already indicated by the kinetic measurements. These results show that
emulsion forming needs monitoring to prevent loss of the aqueous phase.
3.3.4 Continuous syntheses
The continuous synthesis offers advantages over batchwise synthesis such as better cat-
alyst utilisation, constant product quality and easy automatisation.181 As reactor, the
biphasic mini-reactor as described previously192 was chosen. This can be considered
as a continuous stirred tank reactor (CSTR). For information gathering, a CSTR of-
fers more detailed information on the catalyst system long term activity and stability
than a plug flow reactor (PFR). A biphasic approach with pure substrate as second
phase was considered96 but turned out to be challenging if carried out continuously
due to the aforementioned difficulties with the co-substrate dosage and removal. Only
the substrate coupled approach with 2-propanol would be feasible. Then, a mixture of
2-propanol and 2-octanone could be dosed into the reactor. Due to the miscibility of
2-propanol with water, the initial phase ratio would change and removal of acetone and
remaining 2-propanol is no longer guaranteed. Thus, an approach where the 2-ketone
and 2-propanol are dissolved in MTBE was preferred. Both, the organic MTBE-phase
and the aqueous buffer-phase, were pre-saturated prior to use in the continuous synthesis
in order to prevent loss of the aqueous phase due to solubility in MTBE. Initial LbADH
concentration was 480 mg L−1 (= 2.4 mg lyophilised enzyme preparation) and NADP+
concentration was 0.1mmol L−1 if not stated otherwise. The outlet concentrations were
monitored by using a flow cell via online gas chromatography.
2-octanone was chosen as substrate for comparison with previous studies, in which either
a solubiliser was used in both batch and continuous synthesis in a single phase,40,94,95
or biphasic approaches with pure substrate as second phase96 and a biphasic approach
with ionic liquid or MTBE as non-reactive phase in a batch.40,42 The reaction conditions
were chosen based on the results of the kinetic investigations and batch-experiments.
All continuous syntheses were carried out at R0 = 10 with a ketone concentration of
100 mmol L−1 and 2-propanol concentration of 1.00 mol L−1 .
The influence of stirring speed in the aqueous phase and cofactor concentration were
determined. Apparently, increasing the stirring speed to more than 400 rpm led to no
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further increase in the conversion. It also turned out that an initial stirring speed of
200 rpm was beneficial for the long time enzyme performance. So, the aqueous phase for
all subsequent experiments was stirred at 200 rpm for 2 h (except for the 2-decanone-
experiment, here the initial stirring time was 20 h) and increased to 500 rpm afterwards.
As increasing the cofactor concentration from 0.1 mmol L−1 to 0.2 mmol L−1 augmented
the conversion from 25% only to 30% (data not shown), the lower concentration was fixed
in view of a better cofactor utilisation.
Conversion as a function of time of a typical experiment with 2-octanone as substrate is
shown in Figure 3.5. With the initial reaction conditions, a conversion of 31% could be
observed with an apparent deactivation of 0.1% h−1. After 170 h on stream, the initial
enzyme concentration of 480 mg L−1 (= 2.4 mg lyophilised enzyme preparation per 5 mL
aqueous phase) was increased to 1,480 mg L−1 (= 7.4 mg lyophilised enzyme preparation
per 5 mL aqueous phase) which led to a doubling of the conversion from 26% to 48%. A
doubling of the residence time from 4 to 8 h showed less effect on the conversion (from
48% to 56%) but led to a decrease in the space-time yield (STY) from 142 mmol L−1
d−1 to 82 mmol L−1 d−1. After readjusting the residence time to 4 h, the conversion
dropped to 42%, which, assuming a constant deactivation rate, is in accordance with
the steady-state before increasing the flow rate of the non-reactive phase. An overall
turn-over number (TON) of 186·103 for the LbADH has been achieved. For the cofactor
TONNADP+ was 26·103, which is exceptionally high for an in vitro application.223 The
conversion in the continuous synthesis is with 56% at its best not reaching the estimated
equilibrium conversion of 81% . In this experiment emulsification was observed to a very
low extent, so that continuous decantation was operable.
Although the kinetic model is in line with the measured initial reaction rates, it was not
possible to predict the course of the biphasic batch-reaction or the continuous syntheses.
Reasons for this may lie in the complex reaction system. Partitioning of the substrates
and products is not included in the model and may be not ideal. The prediction of
a continuous experiment starting from initial reaction rates is not straightforward, es-
pecially if a biphasic experiment is described with data from monophasic initial rate
experiments. Conducting biphasic initial reaction rate experiments might be helpful,
but not straightforward to carry out.
To show the potential and limitations of the approach, we extended the experiments to
homologous alkanone substrates with higher and lower solubility in water. Subsequently,
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2-heptanone, 2-nonanone, and 2-decanone were employed under the same reaction condi-
tions as for 2-octanone (see Figure 3.5 and Table 3.4). Kinetic data for 2-heptanone hint
towards lower reaction rates when compared to 2-octanone experiments (see Table 3.2).
However, in the continuous synthesis, with 2-heptanone as substrate, a conversion of
49% could be realised. Under the same reaction conditions with 2-octanone as sub-
strate, a conversion of only 31% could be achieved. At a reaction time of 140 h, the
residence time was decreased from 4 h to 3 h which led to a decrease in conversion to
29% . After increasing the residence time again to 4 h, the conversion regained 45%. In
total, a TONLbADH of 478·103 and a TONNADP+ of 22·103 were achieved. It is noteworthy
that the conversion with 2-heptanone as substrate is higher than for 2-octanone, even
though the kinetics with a lower vmax,2-heptanone hint to a lower rate for 2-heptanone.
Here, the higher availability of 2-heptanone seems to play the key role for the higher
reaction rate and thus a higher conversion. Still, the equilibrium conversion of 85%
with K = 0.53640,43 was not reached either. In this experiment, emulsification was not
significant.
In contrast to the high conversion reached with 2-heptanone as substrate, the maximum
conversion achieved was 24% with 2-nonanone as a substrate - under comparable reaction
conditions. Due to the formation of an interphase making decantation of the organic
phase impossible, the experiment was stopped after 72 h. Still, an overall TONLbADH of
6.4·104 and a TONNADP+ of 3.0·103 were reached. Similar results were achieved with 2-
decanone as a substrate. The maximum conversion was 22% although the residence time
was 8 h instead of 4 h for 2-nonanone. Again, the formation of an extended interphase
caused the end of this experiment. Slightly higher TON were achieved when compared
to the 2-nonanone experiment (TONLbADH = 8.2·104; TONNADP+ = 3.8·103).
Comparing the biphasic experiments with 2-octanone and 2-heptanone, the effective
reaction rate is much higher in the case of 2-heptanone. The lower rate for the longer-
chain ketones in the continuous biphasic system is most probably due to their lower
solubility in water. A similar trend for a biphasic batch reaction has also been observed40.
This is in contrast to the monophasic acetonitrile-buffer approach40 where almost the
same initial reaction rates were observed for the reduction of 2-heptanone, 2-octanone
and 2-nonanone. Furthermore, a similar trend for apparent reaction rates in monophasic
batch reactions with an ionic liquid as solubiliser was observed for the homologous series
2-octanone, 2-nonanone and 2-decanone.95
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(a) 2-heptanone (b) 2-octanone
(c) 2-nonanone (d) 2-decanone
Figure 3.5: Conversion as a function of time for the continuous syntheses of (R)-2-
alcohols in the biphasic reactor, solid lines indicate the limiting conversion
Xeq and dashed vertical lines indicate change of reaction parameters (all:
c2-ketoneMTBE= 100 mmol L
−1; c2-propanolMTBE= 1000 mmol L
−1 ; V˙= 1.25 mL
h−1; τ= 4 h; cNADP+= 0.1 mmol L
−1 ; cLbADH= 480 mg L−1; 2-heptanol: t =
140 h, τ=3 h; t = 180 h, τ=4h; 2-octanol: t = 172 h, LbADH concentration
1,480 mg L−1; t = 245 h, τ=8 h; t = 266 h, τ=4 h); 2-decanone: τ = 8 h)
Table 3.4: Overview of the key performance indicators of the biphasic continuous syn-
theses
Substrate ttotal X2−ketone STYa TONNADP+ b TONLbADH b
/ h /% a / mmol L−1 d−1 / 103 / 103
2-heptanone 180 49 147 22 478
2-octanone 320 31 94 26 186
2-nonanone 72 24 73 3.0 64
2-decanone 90 22 54 3.8 82
a Values in steady state with initial reaction conditions
b Values based on the accumulated amount of product produced
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3.4 Conclusion
Our investigations demonstrate that the proposed reaction and reactor system are suit-
able for the continuous synthesis of enantiopure (R)-2-alcohols with at least a minimum
solubility in aqueous solutions ((R)-2-heptanol and (R)-2-octanol). Longer chain al-
cohols are also accessible via the same approach, but, the STY, apparent rate, and
the conversion drop drastically when the solubility decreases in the series 2-heptanone,
2-octanone, 2-nonanone, and 2-decanone as substrate. Thus, a major limitation of the
system is the effective aqueous concentration of the respective substrate.
One major advantage of the biphasic continuous synthesis is the cofactor utilisation. In
monophasic continuous systems with retention of the enzyme(s) via ultrafiltration, the
TONNADP+ is always directly coupled to the substrate solubility.
94,95 A TONNADP+ of
26,000 is an extremely good value. An overview for LbADH catalysis is given in literature
Leuchs and Greiner 104 . In academia typically values between 365 and 20,000169,170 are
obtained, whereas in an industrial process conducted by Wacker, Germany, TONNADP+
is given with 74,00033,34.
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4 Enantioselective Reduction of
Sparingly Water-Soluble Ketones:
Continuous Process and Recycle of
the Aqueous Buffer System
Parts of this chapter have been published ina:
Susanne Leuchs, Shukrallah Na’amnieh and Lasse Greiner, Green Chemistry, 2013, 15,
167-176
Abstract
Low solubility of starting material and products in water and low enzyme utilisation are
the two main obstacles for the production of enantiopure long-chain alcohols with alcohol
dehydrogenases. A combination of techniques was used to overcome these limitations.
A previously identified ionic liquid was used as detergent to increase the low solubility
for the starting materials as well as for the products. The low enzyme utilisation was
increased by using ultrafiltration in an enzyme membrane reactor. Based on kinetic
characterisation and stability data of the alcohol dehydrogenase from Lactobacillus brevis
and glucose dehydrogenase from Bacillus sp. used for ketone reduction and cofactor
regeneration, respectively, a continuous process was realised. In a configuration of a
aSusanne Leuchs, Shukrallah Na’amnieh and Lasse Greiner, Green Chemistry, 2013, 15, 167-176, URL:
http://pubs.rsc.org/en/content/articlelanding/2013/gc/c2gc36558h - Reproduced by permission of
The Royal Society of Chemistry (RSC)
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cascade of two enzyme membrane reactors the process could be demonstrated for more
than 1000 hours with turnover numbers of more than 106 and space-time yield of up
to 34 g L−1d−1 with 99.9% enantioselectivity. Furthermore, downstream processing via
adsorption of the alcohols was included, allowing 90% recycle of the aqueous buffer.
Thus, the E-factor (amount of waste stream per product) was reduced to 13.
4.1 Introduction
In view of the growing demand for enantiopure substances, especially in the pharma
industry,58 asymmetric reduction with soluble precious metal catalysts and other means
like the reduction after Corey Bakshi and Shibata (CBS-reduction) has been investigated
extensively with great success.30,31,135–137,153 However, those catalysts lack enantioselec-
tivity for the reduction of long-chain aliphatic ketones.86,90 The use of oxidoreductases is
a straightforward way to produce enantiomerically pure substances starting from prochi-
ral ketones and is applied more and more for the synthesis of active pharmaceutical
ingredients (API).15 An oxidoreductase with outstanding selectivity and activity to-
wards long-chain aliphatic ketones is the alcohol dehydrogenase from Lactobacillus brevis
(LbADH).104 The need of oxidoreductases for expensive cofactors is generally regarded
as their main drawback. Nowadays, a number of high standard oxidoreductases for the
in situ regeneration of cofactors are available. Therefore, cofactor costs are significantly
reduced.58 However, the cofactor contribution to the overall cost of a process depends on
several aspects and has to be assessed individually for every case. The cofactor turnover
number (TON, molproduct/ molcofactor) is directly coupled to the amount of substrate
which can be dissolved as well as on the overall conversion. To overcome this limitation,
the advantages of using ionic liquids (IL) as a solubiliser for hardly water-soluble sub-
strates has been proven recently. Especially, NR+4 Cl
–-IL were beneficial for the TON of
the cofactor as well as for the space-time yield (STY) and the reaction rate.94,95
Biocatalysis is generally regarded as safer, greener and more sustainable than conven-
tional chemical catalysis.203 This is often credited with the fact that water is used as a
solvent. It is true that the environmental impact of water at an ambient temperature
is low, but high salt loadings can be imposed by process needs. In addition, extrac-
tion is typically included for down-stream processing in order to avoid energy intensive
evaporation of water. Low product concentrations in the aqueous phase leads to the
58
4.2 Experimental
extraction step often being ineffective.203 A method which is suitable for concentrating
substances from aqueous diluted solutions is adsorption, also called solid-phase extrac-
tion (SPE).60? This method is easy to handle, easy to automate, and the formation
of emulsions is avoided. In addition, the aqueous solution is not contaminated with
organic solvents, which simplifies its disposal and allows for water recycling, even when
solvent-sensitive biocatalysts are used.
4.2 Experimental
Reporting our experimental data, we followed the standards given by Gardossi et al.49
as closely as possible.
4.2.1 Chemicals
All ketones and alcohols were purchased from Sigma-Aldrich, Schnelldorf, Germany.
N -methyl-N -trimethylsilyl-trifluoracetamid (MSTFA) came from CS-Chromatographie-
Service, Langerwehe, Germany. All other chemicals were obtained from Carl-Roth,
Karlsruhe, Germany. Ethanol and n-heptane were of technical grade. Ultrapure water
was obtained by reverse osmosis and ultrafiltration in an ELGA purelab ultra-system
and used if not stated otherwise. Enzymes were provided by X-Zyme GmbH/Johnson
Matthey Catalysts. The ionic liquid TEGO IL K5 was from Evonik Industries (purity
according to the material safety data sheet (MSDS): 100%, Methyl Chloride≥ 0.03%).
4.2.2 Preparation of reaction media
All initial rate measurements were carried out in a solution containing N-(2-acetamido)-
iminodiacetic acid (ADA) as buffer with a concentration of 100 mmol L−1 , containing
10 mmol L−1 MgCl2 at pH=7.0 at 25
◦C with addition of 0, 100, or 200 g L−1 TEGO
IL K5. All continuous experiments were carried out in ADA-buffer with a concentra-
tion of 150 mmol L−1 , containing 20 mmol L−1 MgCl2 at pH=7.5 in the substrate
solution at 25 ◦C with addition of 100 g L−1 TEGO IL K5. The reaction media for
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the continuous syntheses were prepared using a 500 mmol L−1 ADA-buffer solution.
The respective volume was charged, MgCl2 · 6H2O, the respective amounts of IL and
glucose were added. After the dissolution of all solid substances, pH was adjusted
with concentrated NaOH-solution. The respective 2-ketone was then dissolved and fi-
nally, the solution was brought to the final volume with water. This solution could
be stored, cofactor was dissolved only prior to the use in the continuous synthesis in
order to prevent degradation. Reaction media for kinetic measurements and stability
tests were prepared in the same manner but only dissolving one of the substances glu-
cose, gluconic-acid-δ-lactone (GDL), 2-ketone or 2-alcohol. For the stability tests of
the enzymes in different buffers, the solutions were prepared accordingly, the buffers
tested are the following: N-(2-acetamido)-2-aminoethanesulfonic acid (ACES); N-(2-
acetamido)iminodiacetic acid (ADA); N,N-bis-(2-hydroxyethyl)-2-amino-ethane sulfonic
acid (BES); 2-[4-(2hydroxyethyl)-1-piperazinyl]-ethanesulfonic acid (HEPES), potassium
phosphate buffer (KPi) and piperazine-N,N-bis(2-ethane-sulfonic acid) (PIPES)
4.2.3 Determination of protein content
Prior to the use of LbADH and GDH, the protein-content of the enzyme preparation was
determined using the method proposed by Bradford 17 with a commercial kit from Carl-
Roth, Karlsruhe, Germany. The protein content of LbADH was 44 weight-%, protein
content of GDH used with 2-octanone and 2-decanone was 14.1 weight-%, and for the
2-nonanone experiment and for kinetic measurements with all 2-ketones 35.1%. The
kinetics for both GDH-lots could be described with a single set of kinetic parameters.
4.2.4 Enzyme stability
Stability was determined by storing the enzymes in the respective substrate solution
in a thermomixer MKR13, HLC at 300 rpm at 25 ◦C at pH 7.0 if not stated otherwise.
Samples of 10 μL were withdrawn and the residual activity was measured via fluorescence
spectrometry (excitation at 340 nm, reading at 460 nm, BioTek Synergy MxHT ) at
25 ◦C. For the determination of the stability in different buffer solutions, the activity
was determined by adding 180 μL of a solution containing 100 mmol L−1 KPi-buffer, 1
mmol L−1 MgCl2 and 6 mmol L
−1 of 2-octanone for LbADH resp. 750 mmol L−1 glucose
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for GDH, pH of the buffer solution was 7.0. The reaction was started with a 1 mmol
L−1 cofactor solution in the same buffer to a final cofactor concentration of 0.05 mmol
L−1. To determinate the activity in all other stability tests, 2-octanone and glucose were
dissolved in a 100 mmol L−1ADA-buffer-solution containing 10 mmol L−1MgCl2. For
both, LbADH and GDH, a first order degradation kinetics was assumed and half-life
was determined assuming first order exponential decay.59
4.2.5 Activity and kinetics
Kinetic measurements were carried out in a Biotek Powerwave HT multiplate fluores-
cence spectrometer in black 96-well-plates (nunc immuno modules). All kinetic mea-
surements were conducted at a final pH of 7.0 in an ADA-buffer (100 mmol · L−1 with
MgCl2, 2.5 mmol · L−1. The total reaction volume was 200 μL. Substrate, product,
co-substrate, co-product, cofactor, and product-cofactor concentration variations were
prepared in a total volume of 180 μL by dilution of stock solutions. 10 μL of a 1 mmol
L−1 cofactor-solution was added to give a final concentration of 0.05 mmol L−1 , the
reaction was started with 10 μL of the respective enzyme-solution. The final concentra-
tion of LbADH was 1.25 mg L−1 (∼= 0.55 mg L−1 protein), the final concentration of
GDH was 10 mg L−1 (∼= 3.51 mg L−1 protein). Dilution rows were prepared using stock
solutions of glucose 1500 mmol L−1, gluconic acid δ-lactone 1000 mmol L−1. 2-octanone,
2-octanol, 2-nonanone and 2-nonanol stock solutions were 6, 60 or 120 mmol L−1 in a
buffer containing 0 (only for 2-octanone), 100 or 200 g L−1 ionic liquid. 3-octanone
and 3-octanol stock solution was 40 and 80 mmol L−1 , 2-decanone and 2-decanol stock
solution was 30 and 60 mmol L−1 in buffer containing 100 and 200 g L−1 ionic liquid.
4.2.6 Continuous experiments
Prior to the continuous experiments, the reactor setup (V= 0.015 L) was flushed with
ethanol and water. A 10,000 Dalton (Da) cut-off polyethersulfone membrane from Sar-
torius Stedim (ø= 63 mm) was soaked in water for at least 1 h and then carefully placed
into the reactor avoiding air inclusions. The reactor was flushed with ADA buffer so-
lution (100 mmol L−1 ADA, 10 mmol L−1 MgCl2, pH=7.0). The enzymes were then
flushed into the reactor before the reaction was started by pumping the respective sub-
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strate solution into the reactor. All continuous experiments were started with fresh
substrate solution, recycled substrate solution was used after 72 h of stable conversion.
Conversion was determined after the first and second reactor by automatically taking
samples of 0.5 μL with an autosampler (see below) from a flow cell and directly injecting
the sample together with 1 μL of an internal standard (respective 1-alcohol, 20 mmol
L−1 in ethanol) into the gas chromatograph (GC) for analysis. The product solution
was processed using solid phase extraction. The 2-ketone and 2-alcohol content was
determined via GC. If less than 0.5 mmol L−1 was detected, the solution was used for
recycling by mixing it with fresh solution (cglucose = 750 mmol L
−1), pH was adjusted
to the initial value of 7.5, fresh ketone was dissolved as well as 0.1 mmol L−1 cofactor,
and, the solution was then reused for synthesis. For the continuous syntheses the fol-
lowing standard reaction conditions were used :cADA-buffer = 150 mmol L
−1, cMgCl2 = 20
mmol L−1, cglucose = 200 mmol L−1, cTEGO IL K5 = 100 g L−1, c2-ketone = 60 (or 30 for
2-decanone) mmol L−1, cNADP+ = 0.1 mmol L
−1, pH=7.5, τ = 2.75 h =⇒ V˙ = 4 mL
h−1.
4.2.7 Solid phase extraction
The break through curve as well as the down-stream processing in the continuous syn-
thesis was carried out using a stainless steel column 8 mm inner diameter (ID) and 250
mm length filled with 4.4 g of HR-P material (Macherey-Nagel, Du¨ren, Germany). For
the break through curves, 500 mL of ADA-buffer solution (100 mmol L−1, cMgCl2 = 10
mmol L−1, c2-ketone = 30 mmol L−1, c2-alcohol = 30 mmol L−1, pH= 7.0 ) were prepared
and pumped through the column. Fractions of ≈ 10-15 mL were collected. The volume
of each fraction was determined and concentrations of the 2-ketone and 2-alcohol were
determined using GC.
4.2.8 Gas chromatography
The concentration of the respective ketones and alcohols was determined using an in-
ternal standard (20 mmol L−1 of the respective 1-alcohol in ethanol) by mixing 300
μL sample with 600 μL standard and subsequent analysis via GC. For the continuous
syntheses, 0.5 μL samples were automatically withdrawn with an autosampler TriPlus,
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Thermo Scientific, Dreieich, Germany from a flow cell (V= 150 μL, workshop of the
institute) in the product stream, mixed with 1 μL of standard solution and injected
into a Focus or Trace GC from Thermo Scientific, Dreieich, Germany. Aqueous sam-
ples were analysed via GC (Chirasil-Dex, length 25m, inner diameter 0.25mm, Varian
GC Capillary Columns, carrier gas: H2, 0.4 bar). Octanol: 100
◦C (2min), 5◦C·min−1
to 120◦C (6.5 min), 40◦C·min−1 to 180◦C(1min), 2-octanone (4.8 min), 2-octanol (6.6
min), internal standard 1-octanol (8.7 min). Nonanol: 110◦C (1min), 2◦C·min−1 to
120◦C (1 min), 40◦C·min−1 to180◦C(2min), 2-nonanone (7.6 min), 2-nonanol (8.7 min),
internal standard 1-nonanol (9.8 min). Decanol: 120◦C (2min), 3◦C·min−1 to 150◦C (1
min), 40◦C·min−1 to180◦C(2min), 2-decanone (5.01 min), 2-decanol (6.61 min), internal
standard 1-decanol (8.4 min).
To determine enantiomeric excess (ee), samples of the n-heptane phase (250 μL) were
mixed with N -MSTFA (50 μL), heated to 80◦C for 30 min and analysed by GC.94
Octanol: 80◦C (4 min), 1◦C·min−1 to 100◦C (10 min), 40◦C·min−1 to 180◦C (1 min),
(R)-2-octanol (22.8 min),(S )-2-octanol (23.1 min). Nonanol: 75◦C (60 min), 40◦C·min−1
to 180◦C (1 min), (R)-2-nonanol (62.9 min),(S )-2-nonanol (63.1 min). Decanol: 80◦C
(120 min), 40◦C·min−1 to 180◦C (2 min), (R)-2-decanol (122.4 min),(S )-2-decanol (122.5
min).
4.2.9 Modelling
Parameter estimation for the initial rate experiments was performed with Origin 8G,
the modelling of continuously operated enzyme-membrane reactor-experiments using a
set of ordinary differential equations was done with Berkeley Madonna.
4.3 Results and discussion
The enantioselective reduction of aliphatic ketones in biphasic systems showed good
results for substrates with a sufficient solubility in aqueous solutions. However, with
increasing chain length and decreasing solubility or increasing partitioning, respectively,
the conversion and the space-time yield (STY) dropped dramatically.106 A monophasic
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solubiliser-aided approach seemed to be more suitable for the conversion of substrates
with very low aqueous solubility.94 The aim of our study was to asses continuous pro-
cess conditions for the enantioselective reduction of hardly water-soluble ketones with
integrated product separation and the reuse of the substrate solution after product-
removal by SPE. For the ketone reduction, the (R)-selective alcohol dehydrogenase
from Lactobacillus brevis (LbADH) was used.104 This enzyme needs NADPH as re-
duction equivalent (see Figure 6.2). For cofactor-regeneration, several approaches are
available, in connection with the LbADH especially the substrate-coupled approach
with 2-propanol is often preferred.104 We decided to use an enzyme-coupled approach
with the glucose dehydrogenase from Bacillus spec. (GDH) and glucose because of the
lower price of one redox equivalent of glucose compared to one redox equivalent of 2-
propanol.198 Another motivation is the unfavorable equilibrium of the system. A high
excess of 2-propanol is normally necessary when using a substrate-coupled approach.106
The excess R0 = c0,2-propanol/ c0,2-ketone which is necessary to reach a conversion of 95%
was calculated.43,44,52 At a substrate concentration (2-ketone) of 60 mmol L−1, 50fold
excess would be necessary, meaning that in order to reach a conversion of 95% 3 mol
L−1 2-propanol are minimally required. As the calculated conversion is an equilibrium
conversion, within reasonable reaction times only lower conversion would be accessible.
Therefore, with increased solubility, substrate coupled cofactor regeneration became less
attractive.
The intended process is a complex system with various parameters. A fully informed
decision on reaction conditions (concentrations, pH, flow rate, temperature) is desir-
able, but not always accessible in view of time and labour. To reduce the complexity of
the system, technical and economic constraints should be considered from the beginning.
Preliminary investigations concerning activity/initial rate experiments and stability were
carried out to find adequate reaction conditions for the synthesis in an enzyme-membrane
reactor (EMR). Down-stream processing (DSP) using solid phase extraction (or adsorp-
tion SPE) has also been investigated as well as the possibility of reusing the aqueous
buffer solution for ecologic and economic reasons.
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Figure 4.1: Reaction system for the enantioselective reduction of aliphatic ketones
Figure 4.2: Half-life of LbADH and GDH in presence of different buffer salts, black:
GDH; grey: LbADH; pH=7.0; T = 25 ◦C; 300 rpm; cbuffer = 100 mmol L−1
; cMgCl2 = 2.5 mmol L
−1
4.3.1 Enzyme characterisation
Stability of the catalyst under process conditions is key requirement for the use in contin-
uous synthesis. It has been shown previously that both catalysts, LbADH and GDH, are
stable in potassium phosphate buffer (KPi-buffer).
94 KPi buffer was chosen as starting
point for further investigations. Storage stability was determined for KPi-buffer, TEGO
IL K5, MgCl2, and pH. High buffer concentrations (above 500 mmol L
−1) are beneficial
for the stability of GDH, but decrease the stability of LbADH (see chapter 8 Figure 8.F ).
High concentrations of TEGO IL K5 increase the half-life of LbADH and GDH whereas
low concentrations (≤ 200 g L−1) decrease the half-life of GDH (see chapter 8 Figure 8.G
). The half-life of both enzymes was determined at different pH between 5.5 and 8.5 in
KPi-buffer (see chapter 8 Figure 8.H). For both enzymes, the half-life decreases sharply
at pH≥7.5. The best stability was found for both enzymes between pH 6.5 and 7.0.
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Both, LbADH as well as GDH-stability benefit from high MgCl2 concentrations (see
chapter 8 Figure 8.I). However, high MgCl2 concentration in combination with KPi-
buffer will lead to oversaturation. Working with oversaturated solutions in batch is
possible but not advisable. In continuous application, precipitations and blocking of
the capillaries as well as the micropumps especially at pH≥7.0 may occur. Thus, a non-
phosphate based buffer had to be found. Different buffers were chosen according to their
pKa
11 and the enzyme’s half-life was determined in a solution of 100 mmol L−1 in the
respective buffer with 2.5 mmol L−1 of MgCl2 (see Figure 4.2). The buffers tested were:
ACES, ADA, BES, HEPES, PIPES. GDH was most stable in ACES-, ADA-, and PIPES-
buffers, the half-life of LbADH was ≥ 1000 h in HEPES–buffer, and sufficiently high in
ADA-buffer. ADA-buffer was chosen for all further experiments due to its compatibility
with both enzymes and reasonable price. Furthermore, a switch to ADA-buffer imposed
no issues regarding down-stream processing. Furthermore, the activity and stability of
LbADH and GDH were investigated at different temperatures (see chapter 8 Figure 8.J,
8.K, and 8.L).
From the stability tests, standard reaction conditions were set for all kinetic experi-
ments: cADA-buffer= 100 mmol L
−1; cMgCl2 = 10 mmol L
−1; pH=7.0. The substrate,
product and cofactor concentrations were chosen according to the conditions intended
for the continuous experiments. The main reaction (M) of LbADH, its back reaction (B)
and the cofactor-regeneration reaction with GDH (R) were investigated independently
for all substrates at IL concentrations of 0, 100, and 200 g L−1 (see Figure 4.3). The
respective interaction matrix is given in table Table 4.1.159 It turned out that inhibition
of the LbADH-catalysed reaction by glucose or GDL was relevant. Uncompetetive inhi-
bition was identified (data not shown) and was assumed to be applicable for all LbADH
catalysed experiments. The parameters of a modified Michaelis-Menten model
v = vmax · [S1]
KM1 · (1 + [P1]
KP1
) + [S1] · (1 + [S1]
KS1
) · (1 + [Gluc]
KIuGluc
)
. . .
(1 + [GDL]
KIuGDL
)
· [S2]
KM2(1 + [P2]
KP2
) + [S2]
were then estimated using OriginLab 8G. The resulting parameters are listed in chap-
ter 8, Table 8.3 and 8.4. A residual plot of the predicted reaction rates versus the
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Table 4.1: Interaction matrix159
Reaction M B R
Enzyme LbADH LbADH GDH
Ketone S1 P1 –
Alcohol P1 S1 –
NADPH S2 P2 P2
NADP+ P2 S1 S2
Glucose I1 I1 S1
GDL I2 I2 P1
M = main reaction (reduction of 2-octanone to (R)-2-octanol); B = back reaction
(oxidation of (R)-2-octanol to 2-octanone); R = cofactor-regeneration
measured initial reaction rates indicates the quality of the estimated parameters and
measurements (see Figure 4.4). Substrate surplus inhibition and inhibition by glucose
and GDL were included in the model used for parameter estimation. Due to numerical
constraints, all constants were limited to 10 mol L−1 . Comparing the parameter sets
for different experimental sets some trends are apparent. For example, vmax is strongly
depending on the position of the keto-group. This is especially the case for the main
reaction M at an IL concentration of 100 g L−1. In this case, vmax is the same within
the error margin for the ketone reduction of 2-octanone, 2-nonanone, and 2-decanone.
However, for the reduction of 3-octanone, vmax is substantially lower. Furthermore, the
Michaelis-constant for the substrate, KM1 is strongly influenced by the presence of the
IL. The higher the IL-content, the higher is KM1, the lower the enzyme’s affinity for the
substrate. Although, the apparent vmax for the LbADH-reaction indicates an activation
at 100 g L−1 compared to 0 and 200 g L−1 IL, the measured activities are nearly the
same in 0 and 100 g L−1 and are only slightly reduced when using a buffer-solution con-
taining 200 g L−1 (see Figure 4.3). Furthermore, inhibition is reduced so that at higher
concentrations the rates are comparable. Initial rate experiments were also carried out
with two different lots of GDH. It turned out, that both lots are covered by the same
set for the kinetic constants.
4.3.2 Down-stream processing
Among a selection of commercial solid-phase-materials, HR-P from Macherey-Nagel was
identified as the best alternative.94 Thus, a packed bed with 4.4 g of HR-P was applied
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Figure 4.3: LbADH-activities for the 2-octanone-reduction at 0 (open squares), 100 (grey
diamonds), and 200 (black triangles) g L−1 TEGO IL K5; cADA-buffer= 100
mmol −1; cMgCl2 = 10 mmol L
−1; pH=7.0; T = 25 ◦C
Figure 4.4: Normalised residual plot of all kinetic measurements, scaling with the maxi-
mum measured activity for LbADH and GDH separately; LbADH: grey dots
(2626 data points); GDH: black dots (319 data points); black line: prediction
= measurement
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for DSP in the continuous synthesis of (R)-2-octanol. Prior to the use of the column
for DSP in the continuous synthesis, its performance was tested using a model solution
containing 100 g L−1 IL and 30 mmol L−1 of 2-octanone and 30 mmol L−1 2-octanol.
The solution was pumped through the column. Fractions of the solution were collected
and analysed via GC (see Figure 4.5). 155 mL of the model solution could be pumped
through the column to give a complete 2-octanone/ol-free solution. At this point, the
column was loaded with 0.55 g 2-octanone and 0.60 g 2-octanol (1.15 g in total). 2-
octanol was the first compound to break through the column, followed by 2-octanone.
Interestingly, the 2-octanol concentration in the outlet exceeded the inlet concentration
(50 mmol L−1 vs. 30 mmol L−1) before 2-octanone broke through. The maximum loading
of the column of 1.66 g material (1.12 g 2-octanone + 0.52 g 2-octanol) was reached at
a volume of 363 mL. To verify these results and to show the flexibility of the setup,
the same experiment was carried out with a model solution containing 2-nonanone and
2-nonanol, each at 30 mmol L−1 (seeFigure 4.5). The results were comparable to those
obtained with 2-octanone/2-octanol. Approximately 140 mL of the model solution could
be passed through the reactor to get a complete 2-nonanone/2-nonanol-free solution
(concentrations ≤ 0.5 mmol L−1) . At this point, the loading of the column was 0.65
g of each compound and 1.30 g in total. The first substance to break through was
again the alcohol. The total loading in the end of the experiment was 2 g. This slight
selectivity for the ketone which was observed when an IL-buffer-mixture was used may
be used for separation techniques like simulated-moving-bed (SMB).176 This technology
is established and routinely applied in large-scale applications.
The results from these experiments are important for down-stream processing of the
continuous experiments to prevent accumulation of organic compounds (2-ketones and
2-alcohols). Remaining 2-alcohol in the feed-solution may lead to falsified results when
determining the conversion, whereas by feeding too much 2-ketone, the solubility limit
might be exceeded. To avoid these problems and to make use of the whole capacity of
the column, the product solution was fractionated behind the column. Only fractions
with a 2-ketone- and 2-alcohol concentration ≤ 0.5 mmol L−1 were used for the feed-
stream. By using this technique, more than 80 cycles of loading and regenerating with
solutions containing 2-octanone/ol, 2-nonanone/ol, or 2-decanone/ol were possible with
an average loading of 0.90 g per cycle and an alcohol-recovery of 63% . Although the
loading per cycle fluctuated, an overall decrease in the capacity was not observed and
the SPE-material was well suited for this purpose. Future focus should be laid on the
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(a) 2-octanone (b) 2-nonanone
Figure 4.5: Break through curve for a packed bed with 4.4 g of HR-P material, so-
lutions: cADA-buffer= 100 mmol L
−1; cMgCl2 = 10 mmol L
−1; pH=7.0;
c2-octanone(2-nonanone) = 30 mmol L
−1; c2-octanol (2-nonanol) = 30 mmol L−1; circles
= ketones; squares = alcohols horizontal lines indicate inlet concentrations
recovery of 2-octanol. An option for the recovery of 2-ketone and 2-alcohol is the elution
with super-critical carbon dioxide (scCO2).
94 This way, the purity of the product may
be increased as IL are mostly insoluble in scCO2. However, using scCO2 for product
elution is technically more challenging (pressure of ≈ 80 bar at ≈ 40 ◦C79) than using
an organic solvent. A final decision has to be taken according to the technical effort and
achievable product purities for both cases.
4.3.3 Continuous syntheses
For the continuous syntheses of enantiopure alcohols, a cascade of two enzyme-membrane
reactors (EMR) was realised (see Figure 4.6). The EMR is a long-known, well-established
and industrially proven technology.97,98,100,206,207 Hyperbolic kinetics, like in the present
case, always conduct the operation window to lower conversions to make use of the
higher reaction rate and to get as much information as possible concerning the process-
stability. This is also true for the product inhibition which was measured in the initial
rate experiments. Thus, a reactor-cascade allows information to be gained and use to
be made of the high reaction rate in the first reactor. The reaction is then brought
to completion in the second reactor to simplify DSP. A more detailed discussion and
evaluation of the advantages of a cascade of two EMR compared to a single EMR and a
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Figure 4.6: Flow scheme of the cascade of two EMR with integrated down-stream pro-
cessing (S: Substrate solution, B: base, P: product by reextraction, W: 10%
waste, EMR: enzyme membrane reactor, SP: syringe pump equipped with
two pairs of syringes running synchronously, F: flow cells for automated sam-
pling for gas chromatography, SPE: solid phase extraction/adsorption
batch-setup can be found in Kragl et al. 99 . Down-stream processing was done via SPE in
a stainless steel column as described above. The product and substrate-free solution was
then brought to the initial pH. As the EMR can be considered as a continuously stirred
tank reactor (CSTR), the reaction conditions in the reactor are uniform on the space-
and time-scale (assuming a stable catalyst). Thus, using a pH-stat in the reactor can be
avoided as the pH can be adjusted by the initial pH in the substrate-solution. Using a pH-
stat in a closed reactor is rather challenging. Good stirring has to be guaranteed together
with a relatively low base concentration to prevent degradation of the biocatalysts.
Dilution of the solution in the reactor further complicates the control and regulation of
the process. Thus, adjusting the pH after the solution leaves the reactor, helps to reduce
the complexity of the whole system. A part of the aqueous stream was then replaced by
a solution with high glucose- and cofactor concentration in order to compensate for the
reacted glucose and degraded cofactor. Finally, the ketone was added and the solution
was then applied again for synthesis. From the breakthrough curves, it was known, that
≈ 160 mL of product solution can be passed through the column resulting in a ketone-
and alcohol-free solution (both concentrations ≤ 0.5 mmol L−1). This solution has to be
treated prior to its reuse in the continuous synthesis. In contrast to the LbADH-process
presented in Liese et al. 107 , the coupled product GDL cannot easily be removed by
stripping or other physical methods. Thus, in order to avoid accumulation of GDL and
depletion of glucose (which is solid in contrast to 2-propanol see107), the solution has
to be partly replaced. The replacement ratio depends on the concentration of ketone in
the feed. By numerical simulations, taking solubility constraints and practical handling
of highly concentrated replacement solutions into account, it turned out that replacing
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Figure 4.7: Simulation of concentration of glucose (black) and GDL (grey) in substrate
(thick line) and product (thin line) solution when a substrate solution with
c0glucose= 200 mmol L
−1; and c0ketone = 60 mmol L−1 is used when 90% of the
solution is recycled and the replacing solution has a concentration of cglucose
= 750 mmol L−1 (assuming quantitative conversion)
10% of the product solution with glucose concentration of cglucose = 750 mmol L
−1, a
stable concentration of 600 mmol L−1 GDL in the product-solution and a concentration
of cglucose = 210 mmol L
−1 in the feed solution are obtained assuming quantitative
conversion (see Figure 4.7). Using lower ketone concentrations of 30 mmol L−1 (for
2-decanone), allows for a higher recycling rate of 95% with a glucose concentration of
cglucose = 180 mmol L
−1 in the substrate solution (data not shown).
The amount of GDL, and thus gluconic acid, is directly coupled to the amount of 2-
ketone which is converted (see Figure 6.2). Previous experiments showed, that both
enzymes are unstable at pH≥7.0. As the EMR is a CSTR, the conditions in the reactor
are equal to those at the outlet. When the substrate solution is at pH=7.5, the effective
pH in the reactor is between 6.7 and 7.0 (for conversion ≥ 50%). Applying this method
unfortunately also implicates a self-accelerating enzyme deactivation, as higher pH at
lower conversion/activity results in faster deactivation.
The continuous synthesis with 2-octanone was first carried out in one EMR. After 24 h
of synthesis, a conversion of 76% was achieved. After 140 h of stable operation with a
slight decrease of 0.8 ·10−3 h−1 conversion, a second reactor was added to give a cascade
of two EMR, leading to nearly full conversion in the outlet of the second reactor (see
Figure 4.8). The results of all continuous experiments are summarized in Table 4.2. In
order to compensate for the degraded enzyme, 1 mg GDH (0.14 mg protein) was dosed
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into the first reactor after 643 and 1083 h runtime and 0.5 mg LbADH were added (0.22
mg protein) at a runtime of 1174 h. Both times, dosing GDH led to a slight increase
in conversion. However, the highest improvement was achieved dosing supplemental
LbADH into the reactor. A continuous dosage of the enzyme was not used as the overall
stability of the reaction system was of interest. In total, a stable operation for 1250 h was
possible. Until the dosage of LbADH at 1174 h a turnover number TONLbADH of 45.6 ·
10 6 and TONGDH of 7.7 · 10 6 were reached for the first reactor (see Table 4.2). The
data of the kinetic experiments were then used to predict the conversion in this setup,
assuming a half-life of 1000 h for both enzymes. The results are shown in Figure 4.8.
The overall trend is well represented as well as the enzyme dosage steps.
In order to show the potential and to reveal possible limitations of the approach, 2-
nonanone and 2-decanone were also tested as substrates. The solubility of 2-nonanone is
similar to that of 2-octanone, so that a substrate solution with a ketone concentration of
60 mmol L−1 was used with analogous reaction conditions, only with slightly decreased
GDH concentration, of 213 mg L−1 instead of 280 mg L−1. The solubility of 2-decanone
is much lower, a substrate solution with a ketone concentration of 30 mmol L−1 was
used, taking the same GDH concentration as for the experiment with 2-octanone. In
this case, a recycling rate of 95% of the aqueous solution could be realised (see above).
The results of all continuous experiments are summarised in Table 4.2. Due to the much
shorter total runtime for the 2-nonanone and 2-decanone experiments, the TON for
both enzymes are reduced compared to the 2-octanone experiment. Other key figures
are comparable, at least for 2-octanone and 2-nonanone. The STY, as an indicator for
the reaction rate, is comparable with 291 mmol L−1 d−1 for 2-octanone and 313 mmol
L−1 d−1 for 2-nonanone. This also holds for the corresponding conversion-levels with
respectively 75.8 and 81.7% after 24 h runtime. The STY for the experiment with 2-
decanone is lower with 187 mmol L−1 d−1. This is due to the lower concentrated substrate
solution. For the experiments with 2-nonanone and 2-decanone, predictions, based on
the respective kinetic measurements, are also available and are shown in Figure 4.9 and
Figure 4.10 together with the experimental data. A deviation between measured and
predicted conversion is again obvious, especially for the experiment with 2-nonanone,
but the general trend is well represented.
The conversion for all substrates are similar in contrast to Leuchs et al. 106 , where a
decrease in conversion was observed when 2-heptanone (X = 49%), 2-octanone (X =
31%), or 2-nonanone (X = 24%) were used as substrates.
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Figure 4.8: Conversion X as a function of time for continuous synthesis of (R)-2-octanol
with standard reaction conditions and a 2-octanone concentration of 60 mmol
L−1; c0, LbADH = 67 mg L−1 each reactor; c0,GDH = 280 mg L−1 each reactor;
t = 643, 1083 h 1 mg GDH in reactor 1; t = 1174 h 0.5 mg LbADH in reactor
1; dots: measured data; solid lines = prediction; grey = reactor 1; black =
reactor 2
Figure 4.9: Conversion X as a function of time for continuous synthesis of (R)-2-nonanol
with standard reaction conditions and a 2-nonanone concentration of 60
mmol L−1; c0, LbADH = 67 mg L−1 each reactor; c0,GDH = 213 mg L−1 each
reactor; dots: measured data; solid lines = prediction; grey = reactor 1;
black = reactor 2
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Figure 4.10: Conversion X as a function of time for continuous synthesis of (R)-2-decanol
with standard reaction conditions and a 2-decanone concentration of 30
mmol L−1; c0, LbADH = 67 mg L−1 each reactor; c0,GDH = 280 mg L−1 each
reactor; dots: measured data; solid lines = prediction; grey = reactor 1;
black = reactor 2
Table 4.2: Key indicators for the continuous reactions (X: Conversion; R: reactor)
substrate t / h R Xa TONbLbADH
/ · 10 6
TONbGDH /· 10 6
TONc
NADP+
STYa / mmol
L−1 d−1
ee E-factorad
(/g L−1 d−1)
2-octanone 1174 1 75.8 45.6 7.7 411 291 (37.9)
2 96.9 12.8 2.9 539 124 (16.1) ≥ 99.9 132 (13.2)
2-nonanone 90 1 81.7 4.3 0.34 459 313 (45.1)
2 98.9 1.0 0.19 553 65 (9.4) ≥ 99.9 116 (11.7)
2-decanone 300 1 97.3 8.0 1.8 275 187 (29.6)
2 99.7 0.4 0.08 289 4.4 (0.7) ≥ 99.9 214 (10.7)
aafter 24 h runtime bat the end of reaction cper pass through the reactor d(with recycling)
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Figure 4.11: Simulation results based on initial rate experiments in cADA = 100 mmol
L−1 ; cMgCl2 = 10 mmol L
−1 ; pH=7.5 filled symbols: reactor 1; open
symbols: reactor 2; conversion X2-ketone: circles STY: diamonds
The comparison of experimental data with predictions based on initial rate experiments
(see Figure 4.8, 4.9, and 4.10) shows the potential of this approach. Cost and labour
intensive experiments can be reduced by a significant amount if modeling and practical
work complement. As a first example, a comparison of the predicted STY and the
conversion after 48 h runtime for all substrates at a ketone concentration of 30 mmol
L−1 based on the preliminary experiments is shown in Figure 4.11. For all substrates,
near quantitative conversion is reached after the second reactor. After the first reactor,
the conversion increases from 3-octanone to 2-decanone. The same trend was observed
for the STY in the first reactor. Apparently, the opposite is true for the STY in the
second reactor. As the conversion in the first reactor increases with increasing chain-
length of the substrate, the achievable conversion in the second reactor decreases (see
Figure 4.11). Thus, the faster the reaction, the lower the STY in the second reactor. As
NADP+ is not retained in the reactor therefore the maximum TONNADP+ is given by
the ratio of initial substrate and cofactor concentration and conversion. When using the
same cofactor concentration with different substrates, the conversion and STY is only
marginally affected and so is the TONNADP+ .
In view of STY and catalyst productivity, especially the synthesis of (R)-2-octanol is
clearly in the range of a fine chemical. The range of required productivity in the fine
chemical field for an isolated enzyme is indicated with 670 − 1700 kgproduct/kgenzyme.191
In the experiment with 2-octanone, we reach ≈ 55·103 kgproduct/kgenzyme, which is within
the range typically obtained for a bulk chemical. In view of STY, a minimum value of
76
4.4 Conclusion
0.1 g L−1 h −1 (2.4 g L−1 d −1) is given for a competitive synthesis.203 In the 2-octanone
experiment, we reach a value of 38 g L−1 d −1. Even though the process has not been
optimized yet, it is already competitive for the production of a fine chemical in view of
enzyme productivity. An industrial process with LbADH, the production of (R)-ethyl-
3-hydroxybutyrate, is conducted at a STY of 92 g L−1 d −1.107 This value is probably
achievable with our setup with the aid of further process optimisation, in particular
higher enzyme concentrations in combination with a higher volumetric flow rate should
lead to an improved STY.
Furthermore, by using the recycling concept for the aqueous-solution, it was possible to
reduce the E-factor (kgwaste/ kgproduct)
181 by a considerable amount. A typical value for
a fine chemical is 5-50. Taking the case of the (R)-2-octanol synthesis without recycling,
the E-factor is 132, including water. With recycling the E-factor can be reduced by a
factor of 10 to 13.2. For the 2-decanone experiment even an improvement by a factor of
20 was reached due to the higher recycling rate. This is clearly in the range suggested
for sustainable production.181 Generally, water is regarded to be a green solvent, but
care has to be taken in detailed analysis.61,203 The environmental impact of pure water
is nil. (as long as it is not too hot), problems occur when polluted water, e.g. high salt
content, has to be treated prior to its release in the environment. The general statement
that IL are green solvents, has also been disproved.152,222 The toxicity of IL with a high
structure similarity to TEGO IL K5 on zebrafish has been found to be high with LD50 in
the range of a few mg L−1.152 Also, TEGO IL K5 is considered a water pollutant that is
potentially harmful to the environment. Here, the recycling of the aqueous buffer with
IL is mandatory for low environmental impact.
4.4 Conclusion
The process presented here is well suited for the continuous synthesis of enantiopure
aliphatic alcohols. We proved that substrates with a low solubility in water can be
converted with high reaction rates using an ionic liquid as solubiliser. Especially for
LbADH , the turnover numbers are extremely high with more than 40 · 106. Using a
cascade of two EMR allows for a fast reaction, and thus a high STY in the first reactor,
and completion of the reaction in the second reactor to reduce complexity and cost of the
separation step. The SPE-recycling-concept used is well suited for this type of reaction
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Table 4.3: Comparison of key synthesis figures for the continuous production of (R)-2-
octanol in a biphasic (chapter 3) and monophasic (chapter 4) setup
Biphasic Monophasic
Runtime / h 72 - 320 350 – 1150
Conversion /% 22 - 49 51 – 97
STY/ mmol·L−1d−1 54 - 147 124 – 291
TONLbADH / 10
3 82 - 478 1620 – 45600
TONNADP+/ 10
3 3.8 - 26 0.411 – 0.918
Deactivation /% h−1 0.1 (2-octanone) 0.003 – 0.013
and allows for an overall reduced environmental impact of the process. Comparing the
monophasic approach (chapter 4) and the biphasic approach (chapter 3) advantages and
drawbacks of both setups are reflected by the respective key values (see Table 4.3). The
total runtime, conversion, STY, and TONLbADH are much better for the monophasic
system. In particular, the TONLbADH is remarkable with more than 45 Mio. in the
synthesis of (R)-2-octanol. For the biphasic system, due to the fact, that the cofactor is
retained together with the enzyme in the reaction system, TONNADP+ is extraordinary
high, but the overall stability of the system reflected by the deactivation is reduced in the
biphasic system compared to the monophasic setup. Thus, both synthesis modes have its
own advantages, but taking the values given in Table 4.3 into account, the monophasic
setup is more promising in view of the development of an industrial viable process.
In order to obtain higher TONNADP+ in this approach, the stability of NADPH under
process-relevant conditions (chapter 5) and the overall improvement of the recyclability
of the cofactor ( chapter 6) are subject for further investigations.
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Abstract
Together with industrial biocatalysis as a whole, the redox mediators or cofactors NAD
and NADP are gaining importance. With the increasing number of effective regeneration
systems, their application for in vitro systems for pharmaceuticals and fine chemicals
production is expanding and the use of oxidoreductases in industry can be considered
a feasible option. However, both cofactors are price intensive and especially NADP
may still dominate costs even if used in substochiometric amounts as a redox mediator.
Furthermore, their activity apparently deteriorates under reaction conditions. Despite
their discovery already decades ago and their technical relevance today, there is a lack
of recent quantitative studies covering cofactor degradation and stabilisation.
Here, we present a survey of the discussed mechanisms and interactions of importance as
well as quantitative data used as the basis for optimisation of enantioselective ketone re-
duction. The proposed mechanisms are laid out and discussed rendering the electrophilic
attack on the C5-C6-bond of the nicotine amide moiety as the main degradation pathway
for the most relevant reduced forms NADH and NADPH. The experimental approach
is laid out and the stability was experimentally quantified in view of process conditions.
Mostly, the results are in line with qualitative trends. In contrast to literature data, a
non linear dependency on initial NADPH concentration was observed. Also, stability
varied over several orders of magnitude with relatively small shifts in conditions which
advocates an experimental validation for the process at hand.
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5.1 Introduction
The redox cofactors nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine
dinucleotide phosphate (NADP) are ubiquitous in vivo and in vitro as redox mediators.
Their technical importance has grown over the last decades as more and more redox bio-
transformations have been developed as an asset to highly selective reductions and oxi-
dations catalysed by enzymes dependent on them (Enzyme class 1, oxidoreductases).
Even though NAD+ and NADH are nowadays marketed as a food supplement91 and
relatively cheap, NADP+ remains expensive even after a price drop41. This is more often
than not considered to be prohibitive for economically viable processes. Furthermore,
particularly the reduced cofactors possess restricted stability under reaction conditions.
Therefore, understanding of the degradation is needed as well as quantitative data under
relevant conditions is needed to asses and run efficient processes with the appealing
enzymes dependent on them.
The important role of NAD and NADP was discovered in the 1930s.196,201 As the struc-
ture was unknown at first the names changed several times. Most common names for
NAD are Co-Zymase, Coenzyme I, and diphospho pyridine nucleotide (DPN). For the
NADP, (Warburg’s) Co-Ferment, triphospho pyridine nucleotide (TPN)201, and Coen-
zyme II are the most common synonyms.
Already in the first contribution by Warburg and Christian200, the half-life under acidic
and alkaline conditions was investigated, but as it is not clear which species was isolated
from 250 L horse blood, the results have no quantitative connection to current investiga-
tions. More detailed investigations on the nature of the new substance followed shortly
after. Warburg et al.202 found the sum formula for which only hydrogen content was
later corrected and typically the tetra sodium salt is given with Na4C21H26N7P3O17. It
was also discovered, that NAD(H) and NADP(H) are different substances but of very
similar structure. The absorption maximum at 260 nm for NAD and NADP was dis-
covered as well as the absorption maximum at 340 (345 nm) for the reduced cofactors
NADH and NADPH. Irreversible reduction with platinum/H2 was described as well as
reversible reduction/oxidation with an enzyme (probably old yellow enzyme = NADPH
dehydrogenase). The nicotinic acid amide moiety was also identified to be the place for
reversible oxidation/reduction.202
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5.2 Factors and mechanism for the degradation of
NAD(P)H
5.2.1 Factors influencing the degradation of NAD(P)H
In early studies factors influencing the stability of the cofactors were identified such as
temperature,216 pH,4,89,216 ionic strength,216 presence of oxygen,89 light,111 and buffer
salts like phosphate and acetate216 (Table 5.1). The reduced forms and the oxidised forms
show different stability which is particularly depending on storage conditions. A major
factor of influence is the pH. While high pH increase the half-lives of NADH and NADPH,
NAD+ and NADP+ show the opposite trend. As also the nature of buffer, ion strength,
and temperature influence degradation, the comparison and quantification of the studies
proves difficult. Also, pKA-values are unavailable to support deprotonation of NAD
+ as
the starting point of degradation.108 At pH-values relevant for biotransformation (4-8)
NAD+/NADP+ are more stable than NADH/NADPH. Low molecular ions were found to
have deteriorative effects such as sulfite, phosphate, arsenate, thioglykol, pyrophosphate,
citrate, sulfate, Ag(I), Au(III), and Pd(II).184 So far, some ionic liquids have been shown
to stabilise NADPH.93
Stability as a function of ion strength cannot be generalised as often specific interac-
tions with anions dominate stability. Especially, phosphate108,215,216, and acetate215,216
destroy NADH and NADPH very fast. Both reduced forms are also affected by sodium-
oxalate, -sulfate, -maleate,108 carbonate, and glucose-6-phosphate,215 as well as sulfite,
arsenate, thioglykol, pyrophhosphate, and citrate.184 For some buffers a first order de-
pendence degradation was found. Whereas, a hyperbolic dependence could be observed
for others and was well studied for pyridininium based buffers.83 Magnesium cations
specifically interact with NAD and NADP to further stabilise the most stable conforma-
tion in aqueous solution as a NMR study showed. Also, the interaction differs from NAD
to NADP.115 Ag(I), Au(III), and Pd(II) form adducts of π-complexes. Both, Cu(II), and
Li(I) cations catalyse the primary acid product formation.184 When frozen samples of
NAD+ and NADP+ are investigated, shock freezing is the method of choice using e.g.
liquid nitrogen to avoid non-uniform composition of the solid phase. Otherwise, deteri-
oration may be accelerated by the increasing concentration from partly frozen solutions.
Storing at -4◦C was shown to be less deteriorative then storage at -20 ◦C.108 The ana-
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Table 5.1: Influence factors investigated; (only model substances)
NAD+ NADH NADP+ NADPH
pH ([H+]) 25,108,127,215 25,108,215,216 25,215 25,108,215,216
T 108,127 216 108 184,216,218
PO4
108 215,216 215,216
CH3COO
– 215,216 215,216
Ionic strength 216 216
c0,NADPH
216
Light 111
NaCl/ NaOxalate/NaMaleate 108
Na2SO4
108 (184) (184)
IL 93 93
Glucose-6-phosphate 215 215
Mg+2
115 115
CO2–3
215 215
Pyridine buffers 83
Ag+/Au3+/ Pd2+/Cu2+/Li+ (184) (184)
SO2–3 /Arsenate/Citrate/Thioglykol/P2O
4–
7 (
184) (184)
lytical expression for optimal pH was derived in view of cofactor stability. However, the
dependency of stability on the NAD+/NADH or NADP+/NADPH ratio is neglected.215
It has been shown, that the temperature has an effect on the stability of nicotinamide
cofactors,108,127,184,216,218 and it is assumed, that light decreases cofactor stability.111 This
leads to the general recommendation to keep them in a cool and dark place. With more
and more enzymes from (hyper-) thermophilic organisms such as hydrogenases117 and
light driven enzyme catalysis, this may not always be desirable.
The structure of the NAD(H) was published in 1936160 and verified in 1937193 without
assigning absolute configuration of stereocenters. The existence of the two stereoisomers,
α- and β-NADH, was detected in 195585. By carrying out optical rotation measurements,
the opposite stereo configuration of both isomers was detected. By enzymatic assays,
the incapacity of α-NADH to donate hydride in physiologic reactions was identified.85
The mechanism for the transformation of α-NAD to β-NAD allows only for the transfor-
mation of α-NADH to β-NADH. A conversion of α-NAD+ to β-NAD+ is not possible.208
The structure of nicotinamide cofactors was also investigated by NMR-studies in solu-
tion. The authors suggest a folding of the B-side of the dihydropyridine ring against the
adenine moiety and a minor change in conformation for the oxidised cofactors.141
82
5.2 Factors and mechanism for the degradation of NAD(P)H
5.2.2 Degradation mechanism of NAD(P)H
As the overall degradation is dominated by NADH or NADPH degradation under rele-
vant conditions, a survey of the state of the art in the literature is presented revealing,
that neither a full understanding of the mechanism is yet obtained, nor that quantitative
rate data is available for process simulation and development.
A common phenomenon observed during the degradation of NAD(P)H is the disappear-
ance of 340 nm peak in the UV/VIS spectrum respectively in the fluorescence signal
together with the formation of a peak with λmax = 280 -290 nm. The latter subse-
quently slowly disappears.7,20,57,57,84,200 Based on literature from 1934200 till 201068 four
degradation mechanism for nicotinamide cofactors have been compiled and are briefly
discussed:
1. Electrophilic attack of H+ at N-1 of the nicotinamide-ring followed by ring-opening
between C-6 and N-1 (with formation of an aldehyde) (Figure 5.1)7,20
2. Hydration across C-5/C-6 double bind with addition of H+ at C-5 probably and
OH− or other nucleophil at C-68,27,84,89,184 (Figure 5.2)
3. Electrophilic attack of H+ to C-6, followed by addition of OH− to C-6 and forma-
tion of another ring between ribose and nicotinamide10,83,138,139
4. Internal rearrangement at ribose subunit together with oxidation followed by ring-
opening of the ribose68
One of the first degradation mechanism can be found in ref20, an electrophilic attack
of H+ at the ring-nitrogen (N-1) of the pyridine-ring was suggested, followed by ring-
opening between N-1 and C-6 by addition of water (Figure 5.1). The resulting enol is
in a tautomeric equilibrium with the corresponding aldehyde. Another group suggested,
that the resulting compound is further split at the N-ribose bond which would lead
to a primary amine.20 They justified their suggestion by a positive Hinsberg test for
a primary amine,66 which may have resulted from the primary amine at the adenine
moiety. The formation of an aldehyde has later been disproved by others7,89 as these
groups did not detect an aldehyde in their NMR-studies. In ref7 another degradation
product which is close to the dismissed aldehyde20 was suggested, rendering it as not
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Figure 5.1: Degradation mechanism 1 for NAD(P)H as proposed in ref7,20 resulting in
an aldehyde
very likely.
Another mechanism was postulated in which water is added to the C-5/C-6 double bond
(Figure 5.2).8,27,84,89,121,184 In ref8 the acid induced degradation of NAD(P)H model com-
pounds was investigated and similar spectral behavior as for the original cofactors was
found. Thus, the other moieties are not overly involved in primary degradation, as some
studies suggest (see below). Second order kinetics with rate = k[H+][reactant] were
postulated and are reasonable in view of the proposed mechanism. If the concentration
of the H+-donor is several orders of magnitude higher than that of the dihydropyridine
compound, pH during the reaction remains almost constant and pseudo-first order ki-
netics can be applied.27 It was also possible to cristallise the degradation product of
the model compound 1-benzyl-3-acetyl-1,4-dihydropyridine and two distinct products
were found.8 One product with the empirical formula 1 molecule water per 1 molecule
dihydro compound (product 1). The other product contained 2 molecules dihydro com-
pound per molecule water (product 2). Product 1 was obtained in higher amounts when
lower concentrations of the starting material was used, product 2 was formed when
higher concentrated solutions were prepared. Product N1 was assigned the structure
demonstrated in Figure 5.2 based on infrared measurements and the determination of
the melting point of the crystalline product. In ref184 proton and anion affinity of the
different locations in the dihydro pyridine moiety are discussed as it is not evident if
the protons adds first followed by addition of the hydroxyl anion or vice versa. For this
reason, both possibilities are discussed. For the proton, the affinity is ranked as follows:
O > Nring > C-5 > C-3 > Namide. Proton attachment to N and O-atoms is reversible
whereas it is not reversible for the attachment to C-5 and C-3 if it is followed by the
addition of OH− to the neighboring C-atom. The highest anion affinity is accorded
to C-2 but as the proton addition at C-3 is unfavoured, the water addition across the
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Figure 5.2: Water addition for the 2nd degradation mechanism for NAD(P)H as pro-
posed in ref8,27,84,89,184
C-5/C-6 double bond is stated to be most likely. This group correlates the cleavage of
the C-5/C-6 double bond directly to the disappearance of the 340 nm absorption band.
The resulting monohydrated product is accorded to the 280/290 nm band. A successive
hydration step across the C-2/C-3 double bond is correlated with the disappearance of
the 280/290 nm band. In ref84 it is proposed that low pH implicates the protonation
of a second group other than C-5. They also exclude the possibility that other anions
than OH− are added to C-6 and observed the relative change of absorption at 287 and
350 nm +Δ287 nm/-Δ350 nm ≈ 3. By the aid of NMR-studies, they confirmed the addition
of water across the C-5/C-6 double bound with OH− added at C-6. They also observed
addition of methanol across C-5/C-6 analogous to water. By investigating isotope ef-
fects with deuteriated and tritiated water, the protonation-step was identified to be
rate-limiting, as well as direct reaction with non-dissociated acetic acid was excluded.
The reversibility of the protonation step was assumed and proven by adding NaOH
shortly after exposition of the model dihydropyridine to acid induced degradation con-
ditions. Dihydropyridine which has been exposed to acid degradation conditions for a
longer time, could not reversibly be transformed back to the starting material. Another
group discovered, that α- and β-NAD(P)H give the same product after acid treatment
and for this reason located the place of action on the dihydropyridine ring,121 thus H2O
addition across C-5/C-6 double bond is supported27 It was also suggested, that water
addition across C-5/C-6 double bond takes place, but with the hydroxyl at C-5 instead
of C-6 based on a test with 2,4-dinitrophenylhydrazine.175 The third path includes a
primary epimerisation of β-NAD(P)H to α-NAD(P)H and protonation at C-5 as for the
water addition mechanism (see Figure 5.3).138 This step is then followed by internal cy-
clisation with the ribose C-2’-OH yielding a five membered ring. This group, as well as
another139 based its suggestion upon NMR-studies. The mechanism was also supported
in Bernofsky 10 .
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Figure 5.3: Water addition followed by intermolecular cyclisation (3rd degradation mech-
anism) as proposed in ref10,138,139
Figure 5.4: Oxidation and ring-opening of the ribose subunit degradation mechanism 4
for NAD(P)H as proposed in ref68
The degradation of reduced nicotinamide cofactors in solution and as solid was inves-
tigated and named as thermal degradation.68 In this context, the word thermal degra-
dation is slightly misguiding, especially for the degradation in solution. HPLC-MS was
used to determine the constitution of the degradation products. According to this study,
besides the main degradation product NAD(P)+, in an internal rearrangement/oxidation
step, the ribose ring is opened yielding an aldehyde. A pH for the applied solution is not
given, but generally, water contains a sufficient amount of H+-ions to induce or catalyse
the so called acid-degradation as described above. Also according to this mechanism
again the formation of an aldehyde is stated which has already been disproved in the
1960s.7,89
Comparing all four mechanism, some appear to be more probable than others. Both
mechanism which include ring openings, (mechanism 1 and 4) were disproved by the
absence of aldehyde protons in NMR studies.7,89 Mechanism which do involve the ribose
moiety in the degradation like 3 and 4 can also be questioned, as several studies in-
vestigated the degradation of nicotinamide model substrates with aliphatic or aromatic
groups at N-1 found the same degradation pattern in UV/VIS-measurements as de-
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scribed for native cofactors.8,57,89,175,184 Among the results found in literature, the water
addition across C-5/C-6 double bond seems to be the most probable for the primary
reaction. This is also in line with the observation that electrophiles such as acetate
and phosphate lead to accelerated degradation with comparable UV/VIS patterns. As
described above, the disappearance of the second nicotinamide double bond might be
correlated with the disappearance of the 280 nm chromophore as second step. Other
mechanism for cofactor degradation as for example the cleavage of NAD+ to adenosine
monophosphate (AMP)/ adenosine diphosphate (ADP) and nicotinic acid amide by hot
alkaline solution are not of practical relevance, as these conditions are not extensively
used in biocatalytic processes (except maybe for down-stream processing).161
The oxidation of NAD(P)H to NAD(P)+ apparently takes place, but NAD(P)+ is not the
main degradation product.4,68 Only, up to 20%4 of the degradation product is oxidised
cofactor NAD(P)+. In applications with integrated cofactor regeneration, this degrada-
tion path is less important, as NAD(P)+ can be recycled in situ, only the hydride donor
is lost in this case.
Also, anomerisation takes place with the reduced cofactors, which is unfavorable in
case of the anomerisation of β-NAD(P)H to α-NAD(P)H as the latter is biologically
inactive.10 Dimerisation of NADPH has also been reported.8 At low initial NADPH
concentrations the main product is still the water adduct, only at higher initial NADPH
concentrations, the dimer is formed to a higher extent.
A common phenomenon is the higher stability of NADH compared to NADPH. The only
explanation for this is an intramolecular catalysis of the phosphate group in NADPH.215
A prove for this statement could not be found. When Mg2+ is present, the altered inter-
action of NADPH compared to NADH115 may also be a reason for different stabilities,
which may be also applicable to other cations.
5.2.3 Further reactions of NAD(P)H
NAD(P) can undergo several reactions with diverse agents which mostly give enzymat-
ically inactive forms. Early investigations (19364) found, that NAD+ can be reduced
with dithionite (Na2S2O4) (other names: hydrosulfite, hyposulphite) Only, if carried out
at pH = 7.6 the product is enzymatically active. If the reduction is done at high pH (
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0.1 N alkaline solution) an inactive molecule results. The same was observed when nico-
tinic acid-amide-iodinemethylate was used as substrate. The water addition across the
C-5/C-6 double bond is generally acid catalysed (see above), but can also be catalysed
by glyceraldehyde-3-phosphate dehydrogenase which was verified by NMR for β-NADH
as substrate. The resulting product contained 65% A-side hydroxyl and 35% B-side
hydroxyl.140 Thus, the product of this reaction (often named as NADH-X) is identical
to the acid catalysis product of other groups,8,27,84,89,184 while in ref140 mechanism 3, the
formation of another ring between the nicotinamide and the ribose moiety is depicted
as the primary acid product. Again, this mechanism is not very probable as discussed
above. Nevertheless, it is certain, that the product resulting from a glyceraldehyde-3-
phosphate dehydrogenase catalysed reaction of NADH (NADH-X) is not identical with
the primary acid product.24,116 While NADH-X can be back-converted with an enzyme
called nucleotide pyrophosphatase, this is not the case for the primary acid product of
NADH.116
5.2.4 Motivation
With all the -partly conflicting- reports available concerning the degradation mechanism
and factors influencing the half-life of nicotinamide cofactors, it still remains to quantify
degradation to allow process optimisation. Especially, NADP may considerably con-
tribute to the cost of the chemicals needed for a certain process. For this reason, a
detailed knowledge of the NADP behavior is essential for economic process optimisa-
tion. Although, a number of studies investigated NAD(P) half-life, a quantitative value,
representing exactly the desired conditions (buffer, salt concentration, temperature etc.)
resulting from other boundaries is hard to find.
5.3 Experimental
5.3.1 Chemicals
All buffer-salts, cofactors, and NaOH were from Carl-Roth GmbH + Co. KG, Karlsruhe.
KOH was from Merck KGaA, Darmstadt. Ultrapure water was obtained by reverse
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osmosis and ultrafiltration in an ELGA purelab ultra-system and used throughout the
experiments.
5.3.2 Preparation of reaction media
For the preparation of a buffer solution, the respective amounts of the buffer salt, MgCl2,
and other additives (Ionic Liquid) were dissolved in water (roughly 75% of the desired
final volume). pH was adjusted by titration with NaOH (KOH for potassium phosphate-
buffer (KPi-buffer)). The solution was then brought to the desired volume adding water.
The cofactors solutions were prepared prior to the respective experiments by dissolving
the respective amount to get a 10 mmol ·L −1 stock solution of the desired cofactor. The
half-life of NADPH was determined using a UV/VIS-multiplate reader (Powerwave HT,
BioTek, absorbance mode only) or a UV/VIS-multiplate fluorescence reader (Synergy
Mx, BioTek, excitation and emission mode possible). For both devices, dilution series of
NADPH were prepared in the respective multiplates (clear from greiner bio-one, Frick-
enhausen Germany for UV/VIS absorbance, polystyrene black Nunc, Thermo Scientific,
Langenselbold Germany for fluorescence). To avoid evaporation, the plates were sealed
using highly transparent adhesive films for qPCR, Sarstedt AG & Co., Nu¨mbrecht Ger-
many. The plates were then stored at 25, 30, or 35◦C in the respective multiplate reader
and absorption or fluorescence were measured over time. For the measurements at 5◦C,
the plates were measured at 25◦C and immediately cooled to 5◦C. The measurement was
carried out by placing the plates into the respective multiplate reader without warming
the plates to 25◦C. In order to get an idea of how fast the plates are thermally equi-
librated in these readers, plates, containing solutions of 15◦C temperature were placed
in such a reader at 30 ◦C and the temperature in the solution was measured using Ni-
Cr/Ni thermoelements with a diameter of 0.5 mm. In the first 5 minutes, no significant
increase in temperature was observed. After 35 minutes, a total increase of 10◦C (from
15 to 25◦C) was measured. Thus, taking the plates out of the fridge and measuring the
fluorescence within 5 minutes does not increase the temperature by more than 5◦C. For
the calculation of half-life, first order degradation kinetics were assumed.59 The experi-
mental data from the multiplate reader (fluorescence or absorbance) were directly used
to calculate half-lives. In order to account for the background absorbance or fluorescence
of the solution a term was included taking the absorbance/fluorescence at the end of
the experiment at the lowest concentration as baseline. Parameter estimation was done
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using MatLab 2009a R© from Mathworks R© . For the determination of the half-life as a
function of the light intensity, a fluorescence probe from Hellma R©, Jena/Mu¨llheim Ger-
many, coupled to a LED-light source with a wavelength λ = 365 nm was used. Read-out
and data processing was performed using a custom made setup from tec5, Oberursel/Ts
using a CCD UV-NIR 200-980 nm detector from Carl-Zeiss, Oberkochen Germany, and
Software from tec5. Calculation of NADPH half-life was done using Origin R© 8G from
OriginLab R©.
5.4 Results and discussion
When oxidoreductases are used or considered for industrial biocatalysis, their depen-
dency on costly nicotinamide cofactors is often regarded as the main drawback. How-
ever, today a number of viable cofactor regeneration methods are available (see for ex-
ample41,205,223) and oxidoreductases are also used for industrial biocatalysis.107,185 Our
research interest is the enantioselective reduction of aliphatic 2-ketones to the corre-
sponding (R)-2-alcohols105 by using an alcohol dehydrogenase from Lactobacillus bre-
vis(see104). A method to recycle the cofactor in the aqueous solution after product
removal to obtain a higher turnover number and thus lower cofactor costs per prod-
uct unit was developed. Nevertheless, due to degradation, not all of the cofactor could
be recycled. Thus, data concerning the cofactor stability was needed. But, as pre-
sented above, quantitative results derived from the literature concerning stability and
the degradation mechanism are contradictory and pushed our decision to produce own
results respecting process conditions which are relevant for an economically viable pro-
cess. Moreover, most of the data found in literature are more than 20 years old and
were determined for relatively high concentrations. First of all, factors influencing the
cofactor stability were identified from literature:
1. pH
2. Light
3. Temperature
4. Presence and Concentration of Salts (including ionic liquids and buffers)
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Figure 5.5: Stability of NADPH and NADP+ at different pH; triangles: NADPH, circles:
NADP+ ; cNADPH= 0.1 mmol·L−1, cNADP+= 0.1 mmol·L−1,cADA-buffer = 150
mmol·L−1, cMgCl2 = 20 mmol·L−1, cTEGO IL K5 = 100 g·L−1, T = 25◦C
The half-lives of NADPH and NADP+ were investigated trying to represent process
conditions as close as possible. It turned out, as expected, that NADP+ is at each
pH investigated at least one order of magnitude more stable than NADPH from almost
1000fold to 10 fold for pH = 6 to pH = 7.5. This is not to surprising as H+ concentration
is also increased 30fold.(Figure 5.5). For this reason, a further analysis of NADP+-half-
life was skipped and the focus was brought to the stability of NADPH.
5.4.1 Hydrogen ion concentration (pH)
As described above, from the literature25,108,215,216 a dependency of the cofactor half-life
on the H+ concentration exists. In order to get quantitative data, we investigated the
NADPH half-life in a pH-range which is interesting for our system at various cofactor
concentrations (Figure 5.6). As expected, the stability/the half-life of NADPH increases
with increasing pH. Interestingly, the half-life seems to be dependent on the initial
cofactor concentration at pH ≥ 7.5. Normally, a (pseudo)-first order exponential decay
is assumed for cofactor degradation. Our data do not support this over the full pH and
concentration range and the measurements in literature do not cover the concentration
range below 0.05 mmol·L−1. This is of relevance as in cofactor regeneration, steady-state
concentrations of NADPH are deliberately low.
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Figure 5.6: Half-life of NADPH as a function of pH and initial concentration; squares:
pH 6.0, circles: pH 6.5, triangles: pH 7.0, diamonds: pH 7.5, stars: pH 8.0;
cADA-buffer = 100 mmol·L−1, cMgCl2 = 20 mmol·L−1, T = 25◦C
5.4.2 Light intensity
In former studies, NAD(P)H-solutions were kept in the dark to avoid exposure to light
without prompting a reason for that.111 In order to find out if this is truly advocated,
the half-life of NADPH as a function of the LED-unit intensity between 5 and 100%
of the maximum output was tested (Figure 5.7). Values for the half-life between 44 h
for 5% intensity and 19.5/21.8 h for 100% intensity clearly indicate a dependency on
the light radiation at 365 nm. The half-life at 5% intensity is with 44 h comparable
to the 50 h measured in a fluorescence multiplate reader under comparable conditions
(Figure 5.6). The difference of 6 h may be due to geometrical differences and the
intensity of the UV/VIS flash lamp used. Thus, a general dependency of the half-
life on the light intensity can be observed, but, quantification is difficult and pending.
This is also underlined by the finding that the half-life in the fluorescence spectrometer
is much higher than the one measured in the UV/VIS spectrometer under irradiation
(Figure 5.8). We refer this effect to a different geometry in the devices. The amount
of light which is absorbed by the solution is probably higher in the UV/VIS-absorption
setup than in the fluorescence setup. In the absorption unit, reflection is carefully avoided
by the geometry, in the fluorescence unit, reflection plays probably a more important role
as irradiation is not perpendicular to the solution surface. The different half-lives cannot
be caused by the light source, as in the fluorescence device and absorption device, the
same lamp is integrated, with the difference, that in fluorescence, the maximum power
of the lamp is even higher than in the absorption unit.
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Figure 5.7: Stability of NADPH as a function of the relative irradiation intensity pH 7.0;
cNADPH = 0.05 mmol·L−1, cADA-buffer = 100 mmol·L−1, cMgCl2 = 20 mmol·L−1,
T = 25◦C
Figure 5.8: Stability of NADPH in a UV/VIS and Fluorescence-Multiplate Reader,
pH 7.0; squares: UV/VIS, circles: fluorescence, cADA-buffer = 100 mmol·L−1,
cMgCl2 = 20 mmol·L−1
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Figure 5.9: Stability of NADPH as a function of temperature without (and with IL),
pH 7.0; circles: without IL, triangles: with 100 g·L−1 IL; cNADPH = 0.05
mmol·L−1, cADA-buffer = 100 (150) mmol·L−1, cMgCl2 = 20 mmol·L−1
5.4.3 Temperature
The stability of NADPH was investigated with and without addition of IL at different
temperatures (Figure 5.9). As expected, the half-life of NADPH drops at higher tem-
peratures and is higher at low temperatures. A general influence of the IL (TEGO IL
K5) cannot be deduced (see below). The half-life of NADPH was also determined in the
pH range from 6.0 - 7.5 with and without 100 g·L−1 IL as a function of initial NADPH
concentration at various temperatures (see chapter 8 Figure 8.N - 8.S). A common trend
which was observed for nearly all experiments is, that the half-life is increasing with
increasing initial cofactor concentration at high pH (pH 7.0 and 7.5), at low pH (pH 6.0
and 6.5), the half-life is more or less independent on the initial concentration. Thus,
the assumption of a first order degradation mechanism only holds for low pH, and is
apparently different at high pH.
5.4.4 Presence and concentration of salts
The negative effect of phosphate and acetate on the stability of NADPH has been re-
ported by others.216 Taking their results into account, the unexpensive and widely used
phosphate buffer is not the best choice in view of cofactor stability. For this reason,
six alternate buffers were chosen according to their pKA being in the vicinity of 7.0.
The buffers tested were ACES, ADA, BES, HEPES, KPi (as a reference), and PIPES.
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Figure 5.10: Stability of NADPH in presence of different buffer-salts at pH 7.0; squares:
ACES, circles: ADA, triangles: BES, hexagons: HEPES, stars: KPi, di-
amonds: PIPES; call-buffers = 100 mmol·L−1, cMgCl2 = 20 mmol·L−1, T =
25◦C
Indeed, the use of KPi-buffer resulted in the lowest half-lives measured. Better for the
NADPH stability were ADA, ACES, HEPES, PIPES, and BES in ascending order. The
low stability of NADPH in ADA-buffer might be caused by the acetate moieties in this
molecule. Although, ADA-buffer is not the best buffer for NADPH stability, all further
experiments were carried out in this one, as a compromise for relatively low price and
beneficial for enzyme stability.105
As mentioned above, a stabilisation effect by Mg2+-ions was found which is in line
with the stabilisation of NADPH reported.115 Therefore, the half-life of NADPH was
investigated at MgCl2 concentrations between 1.5 and 190 mmol·L−1. In the range
between 1.5 and 95 mmol·L−1 no stabilisation effect by MgCl2 was observed, but at 190
mmol·L−1 MgCl2, a strong increase in half-life from ≈ 20 h to ≈ 120 h was measured.
This was confirmed at higher temperatures (see chapter 8). Generally, an influence
of the ionic strength on the NADPH half-life was reported216, especially the buffer
concentration. Own experiments concerning the stability of NADPH as a function of
ADA-buffer concentration were carried out at 25◦C (Figure 5.12) as well as at 5, 30,
and 35◦C (see chapter 8 ). Surprisingly, a hyperbolic increase of half-life with the ADA
concentration was observed. This is in accordance with the aforementioned study, where
linear, as well as hyperbolic increase of NADPH half-life was observed.216 The presence
of other salts like ionic liquids can also affect the stability of NADPH.93 In contrast
to the findings reported in literature93, in our study strong stabilising effects of the IL
were only observed when high concentrations were applied. Furthermore, at 35 ◦C, no
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Figure 5.11: Stability of NADPH in presence of different MgCl2 concentrations at pH
7.0; cADA-buffer = 100 mmol·L−1, pH = 7.0, circles: T = 5◦C, squares: T =
25◦C, triangels: T = 30◦C, diamonds: T = 35 ◦C
Figure 5.12: Stability of NADPH in presence of different ADA-buffer concentrations at
pH 7.0; cMgCl2 = 20 mmol·L−1, pH = 7.0, circles: T = 5◦C, squares: T =
25◦C, triangels: T = 30◦C, diamonds: T = 35 ◦C
96
5.5 Summary
Figure 5.13: Stability of NADPH in presence of different TEGO IL K5 concentrations
at pH 7.0; cADA-buffer = 100 mmol·L−1, cMgCl2 = 20 mmol·L−1, pH = 7.0,
circles: T = 5◦C, squares: T = 25◦C, triangels: T = 30◦C, diamonds: T =
35 ◦C
stabilising effect of the IL was observed. The applied IL is a surfactant/tenside. The
behavior of such substances in combination with others is complex and might be the
reason for the observed inconclusive results.
5.5 Summary
The present paper contains a brief literature survey concerning NAD(P)H-stability and
degradation mechanism. Four main degradation mechanism were identified, but from
the available data, a decision in favour of one or the other mechanism is hard to take.
Probably, a combination of all of the mechanism takes places depending on the condi-
tions, but electrophilic attack on the C-5/C-6 double bond appears to be the dominant
pathway. Also, quantitative data for process conditions is unavailable. For this rea-
son, own stability measurements were carried out in order to create quantitative data
for the process evaluation for the enantioselective enzymatic reduction of long-chain,
aliphatic ketones.105 For this, NADPH was identified as the most contributing partner
and was focussed on. The measurements prove findings from literature, for example de-
teriorative influence of phosphate, (acetate), elevated temperatures, UV-radiation, and
H+-ions. Whereas, Mg+2 -ions, low temperatures, OH
–-ions, and the IL TEGO IL K5 do
increase half-life. Unprecedented, higher stability of NADPH at higher initial NADPH
concentrations was observed. All in all, the complexity of our findings, in combination
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with data derived from literature, enforce our recommendation to measure half-lives for
the conditions which will be applied in the intended process as quantitative literature
data is sparse and possibly not applicable.
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6 Calculation and Cost Optimisation
of the Biocatalytic Enantioselective
Reduction
Parts of this chapter have been published ina:
Susanne Leuchs, Joana Lima Ramos, Naweed Al-Haque, Pa¨r Tu¨fvesson, John M.
Woodley and Lasse Greiner, Organic Process Research & Development, 2013,
doi:10.1021/op400117t
Abstract
Previously, it could be demonstrated, that the monophasic, enzymatic reduction of
aliphatic 2-ketones into the corresponding (R)-2-alcohols is an adequate an viable method
as carried out in a cascade of two enzyme-membrane reactors (chapter 4). In the present
work, the process metrics of the ketone reduction were calculated. A cost analysis re-
vealed, that the enzyme costs are negligible, but the cost for nicotinamide cofactor
NADP+ is dominating the overall cost of the chemical raw material followed by the ionic
liquid (TEGO IL K5) used as solubiliser and the buffer. The overall costs of chemicals
were 148 e/kgproduct. To assess the environmental impact of the process, the E-factor
(kgwaste/kgproduct) 132 and the process mass intensity 133 (PMI, kgsubstrate/kgproduct) were
calculated. A process model based on initial rate experiments was elaborated and used
aReproduced in part with permission from S. Leuchs, J. Lima Ramos, N. Al-Haque, P. Tu¨fvesson, J.
M. Woodley and L. Greiner, Organic Process Research & Development, 2013, 17, 1027-1035, URL:
http://pubs.acs.org/doi/abs/10.1021/op400117t Copyright 2013 American Chemical Society
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to improve the process under cost and environmental aspects. Applying several mea-
sures to enhance the cofactor utilisation, the cost base could be reduced by 65% and the
E-factor (PMI) to 17 (18).
6.1 Introduction
Today, biocatalysis is not restricted to lab-scale use and fundamental academic research
but has made its way to mainstream industrial production.158 Prominent examples of
large-scale biocatalytic processes yielding low-cost products are for example the pro-
duction of acrylamide, L-aspartate, and high fructose corn syrup to name a few.107,158
Nevertheless, the unique enantio-, regio-, and stereoselectivity of most enzymes makes
biocatalysis most suitable for the pharmaceutical, and fine chemical industries.149,185
While hydrolases dominate process biocatalysis, several oxidoreductases have also made
it to the production level,107,157,185 mainly because reductive cofactor regeneration can
be routinely performed.25,41,205 Most of the biocatalytically produced substances possess
at least one chiral centre in which the stereo centre originates from the biogenic starting
material or alternatively is created during the biocatalytic conversion .185
In view of limited patent lifetime, especially in pharmaceutical development, time to
market is an important issue. Typically, at the beginning sub-kg quantities are sufficient
to allow for primary assessment of the product. However, in order to make the most of
the patent lifetime, soon multi-kg amounts of the respective product are required.149
Catalysts in general, and enzymes in particular respond to changes in reaction conditions
very sensitively. Since at a minimum a reaction comprises the enzymes, oxidising and
reducing agent and their respective products. This alone imposes a multivariate non-
linear optimisation problem for productivity and stability. From a practical perspective,
other substances, e.g. cofactor in all forms, buffer, solubilisers, and other additives, as
well as temperature, pH will further add to the overall complexity. In order to assess
the best conditions for production, easily hundreds of experiments can be necessary to
cover the whole range of all parameters, which rapidly exceeds experimental capacity
and time. In such cases, process modeling can help to reduce the experimental effort
and to quickly assess process alternatives or improvement strategies. In doing so, it is
important to carefully define the aim of the process development. For example, this can
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Figure 6.1: Proposed work flow for optimisation
be based on space-time yield (STY), enzyme productivity, a decrease in environmental
impact (in order to make the calculation quick and easy the E-factor defined by Shel-
don178,180can be used for a primary environmental assessment), conversion, reduced cost
for raw material, reduction of side product formation, or ease of down-stream process-
ing. According to the literature, we listed key values to be obtained for an economically
viable industrial process. However, these values are guidelines that depending on the
desired product.(Table 6.1) Defining maximum conversion as the modeling goal, will al-
ways lead to higher residence times and catalyst concentrations. This will normally not
lead to a more economic process. Thus, in this case, a conversion range should be used.
Most probably, all aspects end up leading to lower overall production costs, which may
be the result of reduced cost of the raw materials or a reduction in the waste produced
and thus lower costs for waste water treatment and waste disposal (see also158). For this
reason a scheme to improve and develop a process based on pre-existing knowledge was
derived and has been applied throughout the present paper(Figure 6.1).
In this work we focused on the enantioselective reduction of aliphatic ketones into their
corresponding alcohols using oxidoreductases, since there is no chemical alternative
available that yields similar enantiomeric excess (ee).16,86,90,114 Long-chain enantiop-
ure aliphatic alcohols are an interesting raw material in the pharmaceutical industry.
They have also been used for the production of liquid crystals with interesting optical
properties.113
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Table 6.1: Key values to be obtained for an economically viable (bio-)catalytic industrial
process
Bulk Fine-chemical Pharma
Product amount (t/a)178 104-106 102-104 10-103
Typical cost191 /(e /kg) 1(-5) > 15 > 100
E-Factor178 (kgwaste/kgproduct) <1-5 5-50 25-100
STY185 /g·L−1·h−1 > 0.1 > 0.001
cProduct
185 / g·L−1 > 1 > 0.1
Catalyst productivity/ (kgproduct/kgenzyme)
191 5000-20000 670-1700 100-250
6.2 Experimental
All continuous and initial rate experiments as well as stability tests were carried out as
described by Leuchs et al.105 The parameter estimation, process modelling and process
improvements were performed using MATLAB R©R2009a from Mathworks R©.
6.3 Results and discussion
6.3.1 Process/Pre-existing Knowledge
Alcohol dehydrogenase from Lactobacillus brevis (LbADH, EC 1.1.1.2) exhibits out-
standing enantioselectivity, robustness, and flexibility in a wide variety of reaction condi-
tions.104 The substrate scope of this enzyme is broad and its ability to convert long-chain
aliphatic ketones into the desired (R)-2-alcohols has been proven in many batch syn-
theses,95,96 as well as in monophasic,95,105 and biphasic96,106,124 continuous experiments.
Water-solubility restrictions in single-phase approaches can be overcome by applying an
ionic liquid (IL) as a solubiliser94,95,105. Kinetics94,106 and stability tests94,105 reveal the
applicability of LbADH in many processes. Among these possibilities, the monophasic
continuous synthesis with an ionic liquid as solubiliser105 was chosen for further assess-
ment and development.
LbADH requires NADPH as a cofactor or redox equivalent, respectively.104,133 For in
situ cofactor regeneration, an enzyme-coupled approach with glucose dehydrogenase
from Bacillus spec. (GDH, EC 1.1.1.47) was chosen (Figure 6.2). To enhance the sol-
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Figure 6.2: Reaction scheme for the synthesis of aliphatic, enantiopure alcohols
Figure 6.3: Flowscheme of the process to be improved according to Leuchs et al. 105
(chapter 4). S = substrate solution, SP = syringe pump, P = product, B =
NaOH-solution, W = waste, EMR = enzyme-membrane reactor, F = flow
cell, SPE = solid-phase extraction
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Table 6.2: Base case conditions for the continuous synthesis of (R)-2-octanol
Substance Concentration
ADA-buffer 150 mmol L−1
MgCl 20 mmol L−1
TEGO IL K5 100 g · L−1
2-Octanone 60 mmol L−1
Glucose 200 mmol L−1
LbADH 66.7 mg · L−1
GDH 280 mg · L−1
NADP+ 0.1 mmol L−1
Other conditions
pHinlet 7.5
V˙ 4 mL h−1
τ 3.75 h
T 25 ◦C
ubility of the aliphatic compounds (2-ketones and 2-alcohols) a solubiliser was used, in
this case the ionic liquid (IL) TEGO IL K5.95,105 A cascade of two enzyme-membrane re-
actors (EMRs) was employed for the synthesis of enantiopure (R)-2-alcohols (2-octanol,
2-nonanol, 2-decanol) (Figure 6.3). In the outlets of reactor 1 and 2 flow cells were inte-
grated for automatic online-GC-measurements. Due to the stoichiometric formation of
gluconic acid and the resulting decrease in pH, the pH had to be adjusted to recycle the
aqueous stream. This was achieved by dosing NaOH solution with the aid of a pH-stat
immediately after reactor 2. The product and remaining substrate were removed by
passing the solution through a stainless steel column filled with solid-phase-extraction
(SPE) material, HR-P (Macherey-Nagel). The product was eluted from the column by
washing with n-heptane which was selected because of its lower toxicity compared to
n-hexane.6 90% of the aqueous stream were recycled after recharging with 2-octanone,
glucose (via fresh solution), and NADP+. Previous work led to the choice of the re-
action conditions, such as the best buffer, pH, type and concentration of the salt, and
type and concentration of the solubiliser.105 All these conditions elicited a very stable
and promising process with more than 1000 h of continuous operation and very low
deactivation. Thus, this process was chosen for further development with 2-octanone
as the model substrate representing the class of poorly water-soluble aliphatic ketones.
The continuous synthesis of (R)-2-octanol was taken as the base case; its conditions are
detailed in Table 6.2.105 All alternatives were compared to the results obtained for these
conditions.
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6.3.2 Process evaluation
Economic assessment
In order to identify possible bottlenecks in the base process,105 a cost analysis was carried
out, taking into account the costs of all the chemicals (substrates, buffer, enzymes, and
cofactor) (Figure 6.4). The substances which dominated cost were the ionic liquid TEGO
IL K5 accounting for 20.4% of the entire expenditure, the cofactor NADP+ (36.7%) , and
the ADA-buffer (26.3%) . The overall cost was 149 e/kgproduct. In contrast to many
other biocatalytic processes, the cost analysis revealed, that the enzyme costs were
relatively small. Their contribution to the overall cost was less than 1% . For a fine
chemical, enzyme or catalyst costs can be, depending on the case, up to 5% of the selling
costs.191 Thus, the enzyme productivity is not subject to possible improvements.
Environmental assessment
In general, a process should not only be judged by its costs, but also by its impact on the
environment. An easy method to get a first idea about a process’s environmental impact
is the E-factor (kgwaste/kgproduct) introduced by Sheldon.
178,180,181 In contrast to a full
assessment of the environmental impact of a process, the E-factor only considers the mass
of waste. The American Chemical Society Green Chemistry Institute Pharmaceutical
Roundtable favours another measure, the process mass intensity (PMI).81 To allow for
a comparison with other processes, we calculated both, the E-factor and PMI of the
respective experiments. The E-factor for the base case was 132 (including water) and
the PMI 133. Amongst others,178,180 benchmarks for the E-factor were given. For a
bulk chemical it should not exceed 5, for fine chemicals a value between 5 and 50 is
reasonable and for a pharmaceutical, values up to 100 are standard. Thus, even for
a fine chemical, an E-factor of 132 and thus, a PMI of 133 are to high and should
be decreased. Sheldon 180 suggested not to include water into the calculation of the E-
factor because exceptionally high E-factors may be obtained with biocatalytic processes.
Whether water can be left out or should be included is certainly depending on the
process considered and on the available separation techniques. As we only assessed
and compared improvements in a single process scheme, including water or not did not
change the results qualitatively. However, as the solubiliser is considered toxic to aquatic
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organisms, water was included into the E-factors given throughout.
Bottleneck analysis
In order to reduce cost, the E-factor and the consumption and release of the IL, which is
possibly harmful to the environment,152 recycling of 90% of the aqueous product stream
was carried out. The effect of this recycling step on the amount of waste produced and
chemicals consumed to produce 1 kg of product was enourmous. The E-factor could be
reduced from 132 to 27, while the PMI was reduced from 133 to 28. More benefits of
this step are demonstrated in Figure 6.4.
The overall cost was reduced by 36.5% to 95 e/kgproduct. Due to the recycling, the
contribution of the ADA buffer was lowered to 8.8% and of the IL to 7.0%. Although
the absolute contribution of the cofactor was not changed, its contribution to the overall
cost was increased to 63.5% due to the fact, that the IL and the buffer were recycled and
not the cofactor. Less costly than NADP(H) is NAD(H),1 and the preference of LbADH
for NADP(H) is regarded as its major drawback. So far, attempts to change the cofactor
preference to NAD(H) have not been successful and the resulting enzyme variants are not
commercially available.110,162 Instead of relying on time-consuming molecular biology to
change the cofactor preference of the enzyme, we decided to use chemical engineering
tools to ameliorate the productivity of the cofactor. In that way, we also wanted to
demonstrate, that an enzyme’s preference for NADP(H) instead of NAD(H) is not a
general knock-out criterion. Thus, the cofactor-consumption per kg product was further
optimised.
6.3.3 Model-aided process optimisation
When optimising a process, modeling can help to reduce experimental effort by avoiding
time-consuming experiments and and thus, save money and resources. Based on initial
rate experiments and few batch experiments, a process model was developed (see also
Leuchs et al. 105). The quality of the model was tested by comparing experimental
results with a prediction using the estimated parameters (Figure 6.5 and 8.3). Given,
that the model was based on initial rates and contained no further correction factors,52
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Figure 6.4: Cost distribution for the base case as presented in Leuchs et al. 105 base case:
without recycling of the aqueous phase; recycling: with recycling of the
aqueous phase; improved: improved synthesis with reduced cofactor concen-
tration
the predictions were very good. Upper and lower bounds were determined by numerical
inspection of all 131072 possible combinations of errors, yielding the confidence interval
for the batch and the continuous synthesis shown in Figure 6.5. In the batch experiment,
a deviation between the experimental data and the model-based predictions was observed
at higher conversions, which was most likely caused by a pH shift that was not included
in the model. The beginning of the experiment was well predicted. In the continuous
synthesis, the conversion and the overall trend were well represented. Thus, the model
could be used to obtain reliable predictions and for further process optimisation.
The main aim of the optimisation procedure was to enhance the cofactor utilisation.
In order to enhance the amount of product per amount of cofactor consumed, basically
two strategies are promising. The first one is to increase the ratio substrate/cofactor,
because the stoichiometry limits the maximum possible turnover number for the cofactor
(TONNADP+). The second strategy is to recycle the cofactor together with the aqueous
stream.
The substrate/cofactor ratio can be increased by increasing the substrate concentration
or by decreasing the cofactor concentration. As 2-octanone is a poorly water-soluble
substrate, its concentration cannot be further increased without increasing IL concen-
tration beyond a practical viscosity limit. Therefore, the cofactor concentration has to be
reduced. As the reduction reaction rate strongly depends on the cofactor concentration,
a decrease of the latter may lead to a reduced reaction rate. In order to estimate the
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Figure 6.5: Effect of confidence intervals on the conversion (grey lines) in comparison
to the predicted conversion using the estimated parameters (black lines) and
measured conversion (black dots) in batch (left) and continuous synthesis
(right, see also105). V˙= 4 mL/h; c2−octanone = 60 mmol L−1 cLbADH= 50
mgL−1 ;cGDH= 250 mgL−1 (batch); cGDH= 250 mgL−1 (conti) ;ttotal= 10 h
(batch); ttotal= 1000 h (conti); cNADP+= 0.05 mmol L
−1(batch); cNADP+= 0.1
mmol L−1 (conti)
effect of a decreased cofactor concentration, the process model was consulted to predict
the conversion in reactor 1 and 2 as a function of the cofactor inlet concentration (Fig-
ure 6.6). The calculations indicated, that reducing the cofactor concentration from 100
μmol · L−1 to 50 μmol · L−1 affected the conversion in both reactors only marginally.
In view of recycling, it is known that nicotinamide cofactors possess only restricted
stability in aqueous solutions, at which the phosphorylated cofactors (NADP(H)) are less
stable than the non-phosphorylated ones (NAD(H)) and the reduced ones (NAD(P)H)
are less stable than the oxidised ones (NAD(P)+) under typical, near neutral pH.25,68
Other parameters strongly influencing the stability of cofactors are pH and temperature.
While decreasing the temperature will increase stability, a lower pH will increase the
stability of the reduced cofactors and a higher pH will enhance the stability of the
oxidised cofactors.152 In order to quantify these trends, we investigated the half-lives of
the oxidised and reduced cofactors under conditions, that were relevant for the process
(Figure 6.7). The half-life of the oxidised cofactor NADP+ was longer than 1000 h in
the pH range of 6.0 to 7.5. Thus the stability of NADP+ was not limiting in this case.
The stability of NADPH varies from less than 10 h at pH 6.0 to almost 150 h at pH
7.5. Hence, in order to ameliorate the cofactor-stability and thereby its recyclability,
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Figure 6.6: Estimated mean conversion in reactor 1 and reactor 2 as a function of the
cofactor concentration in the feed stream. V˙= 4 mL/h; c2−octanone = 60 mmol
L−1; cLbADH= 50 mgL−1; cGDH= 250 mgL−1; ttotal= 1000 h
Figure 6.7: Half life of NADP+ (circles) and NADPH (squares) as a function of pH, T
= 25 ◦C cADA = 150 mmol L−1 cMgCl2 = 20 mmol L
−1 pH = 6.0 - 7.5; Values
for NADP+ partly extrapolated, measuring time was 1950 h
the pH has to be increased to the inlet pH of 7.5 immediately after the product stream
leaves the reactor. The huge difference in the stability of NADPH and NADP+ can be
utilised as well to improve recyclability. By varying the LbADH/GDH ratio in reactor
2, the steady-state ratio of NADP+/NADPH can be shifted to higher NADP+ and lower
NADPH concentrations. Thus the overall stability of the cofactor is increased and allows
for a decreased NADP(H) replacement in the recycled solution.
The effects of varying LbADH to GDH ratios on the NADP+/NADPH ratio and the con-
version in reactor 2 were predicted using the aforementioned process model (Figure 6.8).
A low LbADH/GDH ratio in reactor 1 in combination with a high LbADH/GDH ratio in
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Figure 6.8: Estimated NADP+/NADPH-fraction in reactor 2 (left) and mean conversion
in reactor 2 (right) as a function of the LbADH/(LbADH + GDH) -fraction
in reactor 1 and 2. V˙= 4 mL/h; c2−octanone = 60 mmol L−1 cLbADH= 10-280
mgL−1; cGDH= 300-cLbADH mgL−1; ttotal= 1000 h; cNADP+ = 0.05 mmol L
−1
; black star: conditions base case; white star: conditions improved synthesis
reactor 2 turned out to be beneficial for the NADP+/NADPH ratio in reactor 2, allowing
for high recyclability, as well as for the conversion in reactor 2, which is mandatory to
conduct a reasonable synthesis and facilitate down-stream processing. Unfortunately,
the regime with high conversion (Figure 6.8 right) did not overlap with the regime of a
high NADP+/NADPH fraction (Figure 6.8 left).
Considering the results from modeling and the investigations on cofactor stability, an-
other experiment was designed aiming for a higher cofactor utilisation. Measures to
improve cofactor productivity included a lower cofactor inlet concentration of 50 μmol
· L−1 instead of 100 μmol · L−1, and changing enzyme concentrations from 66 mg/L
LbADH and 280 mg/L GDH in both reactors to 50 mg/L LbADH and 250 mg/L GDH
in reactor 1 and 250 mg/L LbADH and 100 mg/L GDH in reactor 2. To make use of the
higher NADPH stability at elevated pH values, pH was adjusted directly after reactor
2 instead of fixing it after the adsorption unit. The pH-stat unit was kept at 5 ◦C and
the experimental setup was optimised to reduce void volume in order to reduce cofactor
residence time in the recycling loop.
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Figure 6.9: Improved continuous production of (R)-2-octanol; conditions:V˙= 4 mL/h;
c2−octanone = 60 mmol L−1 cLbADH= 50 mgL−1 (R1) ; cGDH= 250 mgL−1
(R1); cLbADH= 250 mgL
−1 (R2) ; cGDH= 100 mgL−1 (R2); ttotal= 350 h;
cNADP+= 0.05 mmol L
−1
6.3.4 Evaluation of the improved process
A continuous experiment was conducted, applying the conditions elaborated in the previ-
ous section. The enzyme ratio in the second reactor and the cofactor inlet concentration
were changed (Figure 6.9). The conversion was stable for more than 350 h. Compared to
the base case synthesis and recycling, a further reduction of the E-factor to 17 (PMI=18)
was achieved. Although the runtime of the new experiment was shorter, the TON for
both enzymes were still in the range of several million and the enzyme contribution to
the overall cost was within the abovementioned range of 5%191. The cofactor turnover
number per pass through the cascade was improved from 539 to 918. In addition to this
improvement, roughly 25% of the cofactor could be recycled. This was also reflected by
the much lower overall cost of 52 e/ kg for the improved synthesis (- 65% compared to
base case) (Figure 6.4). The costs per kg product in our case exceed 15 e/kgproduct given
in Tufvesson et al. 191 as a minimum selling price for a fine chemical. However, as the
costs of the substrates 2-octanone and glucose already lie in the same range (Figure 6.10
right), 15 e/kgproduct is not achievable in this case. Typically, enantiopure alcohols
achieve higher prices judging from related examples.
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6.3.5 Future perspectives
The overall system for the continuous synthesis of enantiomeric pure alcohols has a high
level of complexity and leads to a multi-parameter optimisation problem. In order to
guide the process towards an economically viable one, a sensitivity analysis was carried
out.35 In the study of Degenring et al. 35 conversion and enantiomeric ratio were the
evaluation targets. In the present investigation, that the enantioselectivity of the enzyme
was not an issue. No matter the conversion or other circumstances, the measured ee
was always ≥ 99.5% for long-chain aliphatic alcohols, which was in line with previous
findings.94–96,105,106
The cost analysis revealed, that cofactor utilisation was the bottleneck of this process.
Thus the target key figures were: XR2, gNADP+consumed/g2-octanol, and STY, as well as the
overall cost. Modifications of the process that needed to be addressed were improved
enzyme stability or activity, different enzyme and cofactor concentrations, as well as
higher flow rates and higher solubility of the substrates. These modifications fit into
three groups: Group 1 involved changes on a reaction engineering basis, such as increased
flow rate, increased enzyme concentrations or elevated cofactor concentration. Group
2 consisted of changes on a molecular biology basis like, improved enzyme activity or
stability, while group 3 contained changes that would require a reconsideration of the
process itself. An increased substrate concentration fell in group 3 due to the restricted
solubility of the substrate. A higher IL concentration will improve substrate solubility,
but at the same time, the viscosity of the solution increases (data not shown) which leads
to practical limitations in the ultrafiltration step. Moreover, a higher IL concentration
also renders the down-stream processing more challenging due to different partition
behavior (higher solubility in the aqueous IL-containing phase). Thus, another solubiliser
should be considered when a higher substrate concentration is required. The effect
of improving or increasing all these parameters by a factor of 2 is demonstrated in
Figure 6.10 (left). Only one parameter was considered at a time to avoid excessive
extrapolation of the model.
When judging the effects of all the modifications, processes should be favored that
increase the conversion in reactor 2, increase STY and lower the ratio of gNADP+consumed/
g2-octanolproduced compared to the base case. This could be achieved by increasing the
enzyme concentration, the enzyme Vmax and the enzymes’ half-life. Among these, the
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enzyme half-life has the least effect on the target key figures. The effects of the increased
Vmax and increased enzyme concentration are the same.
Assuming the same price for the native enzymes and the improved enzymes, nearly no
difference were observed in the overall cost. Thus, to improve the process a higher en-
zyme concentration is advisable, whereas expensive, time-consuming, and economically
risky molecular biological improvements are not warranted in this case.
A higher cofactor concentration increased the conversion and STY slightly, particularly
elevating the amount of cofactor needed per kg of product. Hence, increasing the cofactor
concentration is not advisable, since better results are obtained with reduced cofactor
concentrations.
Doubling the flow or the substrate concentration generates the same results when consid-
ering the three target key figures (XR2, gNADP+consumed/g2-octanolproduced, and STY). The
cost analysis confirmed that a higher flow rate made the product more expensive due to
the lower cofactor utilisation. Therefore, a higher flow rate is only advisable if the en-
zyme concentration is adjusted at the same time to maintain a high level of conversion.
The effect of applying a higher flow rate together with higher enzyme concentrations
on STY (average R1 and R2) and conversion (after R2) is predicted using the process
model (Figure 6.11).
Before these conditions can be used for a larger scale synthesis, some research should fo-
cus on the filtration step. We used polyethersulfone (PES) membranes which, normally
allow for higher flow rates compared to a regenerated cellulose membrane. Ionic sur-
factants like TEGO IL K5 can interact with such PES-membranes (see manufacturers’
data sheet) which can lead to an accelerated fouling of the membrane. Experimentally,
at a constant flow of 8 mL/h a constant increase in the reactor pressure was observed,
rendering continuous operation impossible. Hence, to increase the synthesis further in
view of STY, some effort has to be put into the improvement of the filtration step.
All the cost analyses and modeling did not include down-stream processing. Thus,
solvent consumption during product elution was not included in the calculations. As
the performance of the adsorber depends on the solubility of the substrates/products
in the aqueous solution, comparing syntheses with the same IL concentrations will not
falsify the results. However, preliminary results showed, that the n-heptane/ethanol
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Figure 6.10: Left: Cost analysis based on 250 mL substrate solution without recycling,
afterwards 90 % recycling for the base case, the recycling case and the im-
proved synthesis as well as for selected hypothetic improvements; grey line
= stoichiometric minimum /ekgproduct based on substrate costs; conditions
here: cLbADH = 50 mg · L−1 ; cGDH = 250 mg · L−1 ; V˙ = 4 mL/h; cNADP+ =
0.1 mmol L−1 ; c2-octanone = 60 mmol L−1 ; cTEGO IL K5 = 100 g · L−1 ; cADA
= 100 mmol L−1 ; cMgCL2 = 20 mmol L
−1 ; pH= 7.0; Right: Sensitivity
analysis of the process (mean values based on the prediction of a 1000 h ex-
periment) Improvements and aggravations compared to the base case. black
bars= Conversion in reactor 2; grey bars = gNADP+consumed/g2-octanolproduced;
white bars= STYtotal
Figure 6.11: Space-time yield (average R1 and R2, left) and conversion (after R2, right)
as a function of total enzyme concentration and flow rate (mean values
based on the prediction of a 1000 h experiment); Conditions: cLbADH,R1 =
50 mg · L−1; cGDH, R1 = 250 mg · L−1; cLbADH,R2 = 250 mg · L−1; cGDH, R2 =
100 mg · L−1 and multiples of the enzyme concentrations; V˙ = 4 - 20 mL/h;
cNADP+ = 0.01 - 0.1 mmol L
−1; c2-octanone = 60 mmol L−1; cTEGO IL K5 =
100 g · L−1; cADA = 100 mmol L−1; cMgCl2 = 20 mmol L−1; pH= 7.0
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mixture could be reused after distillation for eluting the substrates/products from the
column. When solvents are recycled by distillation, generally a loss of 10% can be
assumed.180 Thus, even though n-heptane is a relatively eco-toxic solvent, its release to
the environment can largely be avoided.
Apart from the changes in the existing process, a totally new synthesis route could be
considered, for example, the biphasic synthesis as described in Leuchs et al. 106 . Methyl-
tert-butyl-ether (MTBE) is very suitable for biphasic synthesis in combination with
LbADH.194 In this context, it is mandatory to use 2-propanol for cofactor regeneration
in continuous synthesis due to the low solubility of glucose in MTBE.
Sheldon 180 178 proposed the use of atom efficiency for a quick assessment of the environ-
mental impact of an alternative process when compared to an existing benchmark pro-
cess. In contrast to the E-factor, which includes conversion, by- and coupled-products,
the atom efficiency can easily be calculated even before the process is tried at the
laboratory-scale. Atom efficiency is the molar mass of the desired product divided
by the sum of the molar masses of all products. It is based on stoichiometry only.
The overall reaction equation for the existing monophasic approach is: CH3COC6H13 +
C6H12O6 −→ CH3COHC6H13+C6H10O6, the overall reaction equation for the alternative
biphasic approach is: CH3COC6H13+CH3COHCH3 −→ CH3COHC6H13+CH3COCH3.
Assuming high turnover numbers of the catalysts (enzymes) and cofactors in both cases,
the atom efficiency is 42% for the monophasic approach and 69% for the biphasic ap-
proach.
At first glance, the biphasic approach seems to be favorable, but it is known, that for
this kind of transfer-hydrogenation, thermodynamics play an important role.43,44,106,145
With a ratio of 1:1 2-octanone:2-propanol, a conversion of 38% is expected.106 With a
3.3-fold excess, as used in the present study, a conversion of 68% is expected when using
2-propanol as the hydride donor compared to full conversion when using glucose/GDH
as hydride donor. Another reason for choosing glucose as the redox equivalent and not
2-propanol is the lower price of glucose.198 In view of atom economy and efficiency, the
selective addition of a hydrogen molecule per molecule substrate would be the most effi-
cient method.190 Such syntheses have been investigated for some time and in particular
the asymmetric hydrogenation using ligand modified noble metal catalysts is very suc-
cessful.135–137 A major drawback of this synthesis route is the low enantioselectivity when
it comes to the reduction of aliphatic non-functionalised ketones.136 The use of suitable
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hydrogenases for cofactor regeneration is a biocatalytically favourable alternative.53
6.4 Conclusion
The continuous synthesis of (R)-2-octanol could be improved to decrease the chemical
cost basis by 65% . Modelling and simulation allows the optimisation of this complex
process. Further targets of optimisation can be revealed by careful extrapolation and
sensitivity analysis. We demonstrated, that an enzyme’s affinity to NADP(H) instead of
NAD(H) is not a knock-out criterion for an industrial process. This is important given
the fact, that molecular biological methods that change an enzymes’ affinity to NAD(H)
instead of NAD(P)H are not always applicable as for the LbADH as the enzyme of
choice. Improvements by reaction engineering may be more cost and time effective.
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Table 6.3: Kinetic constants for LbADH and GDH measured with fluorescence spec-
troscopy at 25 ◦C cLbADH = 1.25 mg L−1; cGDH = 5 mg L−1 cADA-buffer= 100
mmol L−1; cMgCl2 = 10 mmol L
−1; cTEGO IL K5 = 100 g L−1; pH = 7.0
Constant Enzyme Value Confidence Interval
Vmax, forw LbADH 17.50 0.13
KM2-octanone LbADH 0.206 0.017
KP2-octanol LbADH 0.03704 0.00065
KMNADPH LbADH 0.208 0.040
KP
NADP+
LbADH 0.212 0.028
KS2-octanone LbADH 163 10
Vmax, back LbADH 9.96 0.18
KM2-octanol LbADH 0.0332 0.0014
KP2-octanone LbADH 0.835 0.049
KM
NADP+
LbADH 0.0122 0.0021
KPNADPH LbADH 0.359 0.030
KS2-octanol LbADH 6065 4040
Vmax, forw GDH 5,82 0,053
KMGlucose GDH 2,73 0,23
KPGDL GDH 0,0258 0,00067
KM
NADP+
GDH 0,028 0,0033
KPNADPH GDH 3780 279
KSGlucose GDH 62260 111000000
Table 6.4: Comparison between the base case (including recycling) and the improved
synthesis
base case improved
Reactor 1 2 1 2
X2-octanone /% * 75.8 96.9 50.5 83.5
TONLbADH / 10
6 a 45.6 12.8 12.3 1.62
TONGDH / 10
6 a 7.7 2.9 0.945 3.12
TON
NADP+
(per pass)/ - + 411 539 588 918
STY / mmol L−1 d−1 (gL−1 d−1 )* 291 (37) 124 (16) 194 (25) 124 (16)
ee > 99% > 99%
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7.1 Summary
The results of this work demonstrate that a variety of approaches can be successfully
utilised for the enantioselective reduction of poorly water-soluble ketones with enzymes
as biocatalysts. The work suggests an approach which is generally applicable for batch
processes and explicitly designed for continuous reactions (Figure 7.1):
• Identification of a suitable and robust catalyst by surveying the literature (see
chapter 2) and targeted experimentation.94–96
• Both biphasic (see chapter 3) and monophasic (see chapter 4) reaction conditions
were successfully demonstrated and compared.
• Accordingly, efficient down-stream protocols were established.
• The reaction system was analysed for cost and consequently optimised (see chap-
ter 5 and 6).
The literature survey revealed that LbADH is a versatile and stable catalyst. Its out-
standing robustness in the presence of organic solvents, IL, biphasic systems, and gas-
phase conditions is extraordinary for an oxidoreductase. The high stability of this en-
zyme up to 1500 h62 and its (enantio-)selectivity except for very short ketones make it
a useful tool for process development.
The applicability of LbADH was successfully demonstrated using both biphasic (chap-
ter 3) and monophasic (chapter 4) approaches. Both synthesis modes led to stable
processes and ee was very good (≥ 99%) in both cases. For the biphasic setup, a
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Figure 7.1: Workflow for the development of an industrial viable, enzymatic process for
the synthesis of enantiopure, aliphatic (R)-2-alcohols
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TONNADP+ of up to 26·103 was achieved and in the monophasic approach, a TONLbADH
of up to 46·106 was possible. The total runtime and the deactivation of the entire cat-
alytic system was with 1150 h and 0.003%/h better in the EMR setup compared to the
biphasic setup where 320 h and 0.1%/h were achieved. Taking the key values for both
syntheses into account, the monophasic EMR-based approach was further optimised.
Compared to the biphasic approach, the TONNADP in the monophasic approach was at
least one order of magnitude lower (see chapter 3 and 4). A cost analysis showed that
cofactor cost is the highest contributor and to improve cofactor utilisation, NADPH-
and NADP+ stabilities were of interest. Even though literature dealing with cofactor
structure and stability dates back to their discovery, sparse quantitative data are avail-
able and are moreover contradictory. Consequently, our own experimental results were
pursued (see chapter 5). It turned out, that NADP+ is at least one order of magnitude
more stable with a minimum half-life of ≥1000 h under relevant conditions compared
to NADPH. For this reason, the research was focussed on NADPH stability. It was
discovered, that the pH of the solution, irradiation, temperature, and salt concentra-
tion influence the half-life of NADPH. As the economic analysis suggested that NADP
was the key cost factor the stability of NADPH, and initial rate experiments were then
used for cost improvement of the entire synthesis (chapter 6). By a reduction of the
cofactor-inlet concentration from 100 μmol·L−1 to 50 μmol·L−1 and recycling of the co-
factor together with the substrate/product solution, the cost for the chemicals needed
to produce 1 kg of (R)-2-octanol could be reduced from 149 e/kg to 52 e/kg which
represents a 65% reduction in total. Ultimately, the enzymes comprised less than 4% to
the overall costs.
7.2 Outlook
The cost reduction achieved in this work using computer-aided optimisation is consid-
erable. However, for the STY and final product concentration, further improvement is
mandatory to establish an economically viable process. The aforementioned TONLbADH
of 46· 106 corresponds to a catalyst productivity of ≈57 kgproduct/gLbADH, and is thus
in the range given by Pollard and Woodley 149 . The required 50-100 g·L−1 product con-
centration could not be realised here, only a value of ≈10 g·L−1 was achieved. Taking
the recycling rate into consideration, ≈100 g·L−1 product per 1 L consumed substrate
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Figure 7.2: Combination of biphasic and monophasic synthesis to enhance the phase
transfer
solution was achieved. This value could only be increased if the IL concentration was
elevated. Unfortunately, this will be accompanied by higher viscosity of the solution.
This, in combination with an interaction of the IL with the membrane is not applicable.
Here, only an improved or alternate membrane material could considerably enhance
the process. Thus, a process alternative will have to be designed. A combination of
the IL concept of the monophasic approach with the biphasic approach is promising
(Figure 7.2). Preliminary results show, that partitioning of 2-octanone and 2-octanol is
improved with increasing IL concentration in the aqueous phase and that the concen-
tration of the respective component in the aqueous phase increases with increasing IL
concentration (see Figure 7.3). This would allow for lifting constraints of the biphasic
approach. Thus, this concept will be subject of future research.
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Figure 7.3: Left: Partition coefficients of 2-octanone and 2-octanol as a function of the
IL concentration in the aqueous phase; Right: concentration of 2-octanone
and 2-octanol in the aqueous phase; 2-octanone = triangles, 2-octanol =
diamonds; starting concentration of 2-octanone and 2-octanol in the MTBE
phase: 50 mmol L−1 and acetone and 2-propanol (data not shown) 500 mmol
L−1 Experiment carried out according to Leuchs et al. 106
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Table 8.1: Substrates converted by LbADH
Subst.
No.
Residues Citation
1 R1 = CH3 R
2 = CH3 Zehentgruber et al.
220
R1 = CH3 R
2 = C6H15 Bra¨utigam et al.
19 , Eckstein et al. 41,42,43 ,
Kohlmann et al. 95 , Rioz-Martinez et al. 156
R1 = CH3 R
2 = C2H5 Schroer et al.
165 , Schumacher et al. 173 , van den
Wittenboer et al. 192
R1 = CH3 R
1 = H Kwiecie´n et al. 102 *
R1 = CH3 R
2 = C3H7 Eckstein et al.
43
R1 = CH3 R
2 = C4H9 Eckstein et al.
43
R1 = CH3 R
2 = C5H11 Eckstein et al.
43
R1 = CH3 R
2 = C7H15 Eckstein et al.
43 , Kohlmann et al. 95
R1 = CH3 R
2 = C9H19 Rioz-Martinez et al.
156
R1 = C2H5 R
2 = C5H11 Kohlmann et al.
95
R1 = CH3 R
2 = C8H17 Kohlmann et al.
95
2 R1 = CH3 R
2 = C2H4C6H5 Hummel and Riebel
73 , Hummel 74
R1 = CH3 R
2 = Naphtyl Hummel and Riebel 73 , Hummel 74
R1 = CH3 R
2 = CH2C6H5 Hummel and Riebel
73 , Schroer et al. 168
R1 = CH3 R
2 = C2H4CHC(CH3)2 Rioz-Martinez et al.
156
R1 = CH3 R
2 = C2H2C2H2C6H4pOH Boffi et al.
14
R1 = CH3 R
2 = C2H2C2H2C6H4pOMe Boffi et al.
14
R1 = CH3 R
2 = C2H2C2H2C6H4mMe Boffi et al.
14
R1 = CH3 R
2 = C2H2C2H2C6H4pCO2H Boffi et al.
14
R1 = CH3 R
2 = C2H2C2H2C6H4pNO2 Boffi et al.
14
R1 = CH2Cl R
2 = furan Bisogno et al. 12
R1 = CH3 R
2 = CH2OCH3 Bisogno et al.
13
3 R1 = CH2Phenyl R2 = C2H5 Hummel and Riebel
73
R1 = CH3 R
2 = C2H5 Hummel and Riebel
73 , Hummel 74
R1 = CH3 R
2 = CH3 Hummel and Riebel
73 , Hummel 74
4 R1 = CH3 R
2 = CH3 Daußmann et al.
33,34 , Ernst et al. 46 , Hum-
mel and Riebel 73 , Ng and Jaenicke 131 , Schroer
et al. 165,166
R1 = CH3 R
2 = CH2C6H5 Hummel and Riebel
73
R1 = CH3 R
2 = C2H5 Hummel and Riebel
73 , Jeromin 77 , Ng and
Jaenicke 131
R1 = CH2Cl R
2 = C2H5 Bra¨utigam et al.
18 , Hummel and Riebel 73 , Ng
and Jaenicke 131
R1 = CH2Cl R
2 = CH3 Bisogno et al.
12,13
R1 = CH3 R
2 = C4H9 Hummel and Riebel
73
R1 = C6H5 R
2 = C2H5 Hummel and Riebel
73
R1 = iso-C3H7 R
2 = C2H5 Hummel and Riebel
73 , Ng and Jaenicke 131
R1 = CF3 R
2 = C2H5 Hummel and Riebel
73
R1 = C2H5 R
2 = C2H5 Hummel and Riebel
73 , Hummel 74
R1 = C2H5 R
2 = CH3 Hummel and Riebel
73 , Hummel 74 , Ng and
Jaenicke 131
5 R1 = CH3 R
2 = C2H5 Hummel and Riebel
73
6 R1 = CH3 R
2 = C2H5 Hummel and Riebel
73
R1 = CH3 R
2 = H Hummel and Riebel 73
7 R1 = Cl R2 = H R3 = t-Bu Mu¨ller et al. 123 , Villela-Filho et al. 194 , Wolberg
et al. 210,211,212
R1 = H R2 = H R3 = t-Bu Drochner and Mu¨ller 38 , Mu¨ller et al. 123 , Wol-
berg et al. 211,212
R1 = CH3 R
2 = H R3 = t-Bu Mu¨ller et al. 123 , Wolberg et al. 211
R1 = C2H5 R
2 = H R3 = t-Bu Wolberg et al. 211
R1 = (E)-PhCH=CH R2 = H R3 = t-Bu Wolberg et al. 211
R1 = H R2 = H R3 = CH3; CH2CH3; nPr;
allyl; nHex; Bn; iPr;
Wolberg et al. 211
R1 = F R2 = H R3 = t-Bu Wolberg et al. 211
R1 = OCH3 R
2 = H R3 = CH3 Wolberg et al.
211
R1 = OCH3 R
2 = H R3 = t-Bu Wolberg et al. 211
R1 = BnO R2 = H R3 = t-Bu Wolberg et al. 211
R1 = H R2 = CH3 R
3 = t-Bu Ji et al. 80 , Lu¨deke et al. 103 , Mu¨ller et al. 123 ,
Wolberg et al. 211
8 R1 = CH3 R
2 = C2H5 Kurina-Sanz et al.
101
R1 = CH3 R
2 = C3H7 Kurina-Sanz et al.
101
R1 = CH3 R
2 = C4H9 Kurina-Sanz et al.
101
9 R1 = CH3 R
2= tert-C4H9 Hummel and Riebel
73
R1 = CH3 R2 = C5H11 Hummel and Riebel
73
R1 = CH3 R2 = CH3 Hummel and Riebel
73 , Hummel 74
R1 = C2H5 R2 = C3H7 Hummel and Riebel
73
R1 = CH3 R
2 = CH2CH(CH3)2 Kurina-Sanz et al.
101
R1 = CH3 R
2 = C5H11 Kurina-Sanz et al.
101
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(a) Half life of LbADH (b) Half life of NADPH (c) Half life of NADP+
Figure 8.A: Half-life of LbADH, NADPH, and NADP+ in KPi-buffer and saturated KPi-buffer
with different additives; sat. = MTBE-saturated; cKPi= 50 mmol L
−1; cMgCl2= 2.5
mmol L−1; T= 25◦C; 300 rpm
Table 8.3: Kinetic constants for GDH measured with fluorescence spectrometry at 25 ◦C . cGDH
= 5 mg L−1; cADA-buffer= 100 mmol L−1; cMgCl2 = 10 mmol L
−1; cTEGO IL K5 = 0,100,200
g L−1; pH=7.0
cIL / gL−1-1 Parameter Unit Value
0 vmax U mg
−1 5.4 ± 0.24
100 vmax U mg
−1 5.3 ± 0.32
200 vmax U mg
−1 3.1 ± 0.15
0 KM1 mmol L−1 6.756 ±1.274
100 KM1 mmol L−1 1.931 ±0.336
200 KM1 mmol L−1 1.313 ±0.312
0 KM2 mmol L−1 0.027 ±0.002
100 KM2 mmol L−1 0.026 ±0.004
200 KM2 mmol L−1 0.017 ±0.003
0 KP1 mmol L−1 ≥ 1E+4
100 KP1 mmol L−1 ≥ 1E+4
200 KP1 mmol L−1 ≥ 1E+4
0 KP2 mmol L−1 0.036 ±0.004
100 KP2 mmol L−1 0.027 ±0.006
200 KP2 mmol L−1 0.046 ±0.011
0 KS1 mmol L−1 4210 ±1068
100 KS1 mmol L−1 8366 ±3860
200 KS1 mmol L−1 9128 ±4115
G
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(a) substrate (b) cofactor
(c) ketone or alcohol (d) cofactor as product
(e) other ketone or alcohol (f) MTBE
Figure 8.B: Kinetic measurements with LbADH; full squares: reduction of 2-octanone (reaction
M); full circles: oxidation of 2-octanol (reaction M’); open triangles: oxidation of
2-propanol (reaction R); open diamonds: reduction of acetone (reaction R’); solid
lines: models for C8-reaction; dashed lines: models for C3-reactions; all reactions
carried out at 25◦C with concentrations if not stated otherwise: cKPi= 50 mmol L
−1,
cMgCl2= 2.5 mmol L
−1, pH = 7.0, cNADP(H)= 0.5 mmol L−1 , c2-octanone= 2.63 mmol
L−1 or c2-octanol= 1.32 mmol L−1 , cLbADH= 1.2 mg L−1
H
(a) Pi in ternary component systems; concentrations
in the MTBE-phase: c2-octanone= 20-100 mmol
L−1 or c2-octanol= 20-100 mmol L−1
(b) Pi in multiple component systems for
X2−octanone= 0, 20, 40, 60, 80, 100%; con-
centrations in the MTBE-phase: c2-octanone=
100-0 mmol L−1 or c2-octanol= 0-100 mmol L−1;
c2-propanol= 1000-900 mmol L
−1; cacetone= 0-100
mmol L−1
Figure 8.C: Partitioning coefficients in ternary and multiple component systems; open circles:
P2−octanol; full circles: P2−octanone; x-errors from multiple determination of concentra-
tions in the organic phase before equilibration; y-errors from multiple determination
of concentrations in both phases after equilibration; concentrations in the aqueous
phase: cKPi= 50 mmol L
−1; cMgCl2= 2.5 mmol L
−1, pH = 7.0; equilibration at 25◦C
Figure 8.D: Partitioning coefficients in ternary systems; open circles: Pacetone; full circles:
P2−propanol; y-errors from multiple determination of concentrations in both phases af-
ter equilibration; concentrations in the aqueous phase: cKPi= 50 mmol L
−1; cMgCl2=
2.5 mmol L−1, pH = 7.0; equilibration at 25 ◦C
I
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Figure 8.E: Volumetric activity in different phases (cLbADH = 1 mg mL
−1; cKPi = 50 mmol L
−1;
cMgCl2= 2.5 mmol L
−1 ;c2-propanol= 0, 1000 mmol L−1; T= RT (22-25◦C); 500 rpm;
Determination of volumetric activity: c2-octanone= 3.6 mmol L
−1 ; cNADPH= 0.5 mmol
L−1 ; cKPi= 3.6 mmol L
−1 ; cMgCl2= 3.6 mmol L
−1 ; T= 25◦C; 10 μL of sample
diluted: 1 :20 v/v)
Figure 8.F: Stability of LbADH (grey) and GDH (black) in presence of different KPi-
concentrations; pH = 7.0; T = 25 ◦C ; 300 rpm; cMgCl2 = 1 mmol L
−1
Figure 8.G: Stability of LbADH (grey) and GDH (black) in presence of different TEGO IL K5-
concentrations; pH = 7.0; T = 25 ◦C ; 300 rpm; cKPi = 100 mmol L
−1 ; cMgCl2 = 1
mmol L−1
J
Figure 8.H: Stability of LbADH (grey) and GDH (black) at different pH; T = 25 ◦C ; 300 rpm;
cKPi = 100 mmol L
−1 ; cMgCl2 = 1 mmol L
−1
Figure 8.I: Stability of LbADH (squares) and GDH (circles) in presence of different MgCl2-
concentrations in KPi-buffer (full symbols) and ADA-buffer (open symbols); pH =
7.0; T = 25 ◦C ; 300 rpm; cKPi = 100 mmol L
−1
Figure 8.J: Stability of LbADH (squares) and GDH (circles) as a function of temperature (ADA-
buffer=100 mmol L−1; pH=7)
K
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Figure 8.K: Activity of LbADH as a function of temperature and substrate-concentration;
squares: 23 ◦C, circles: 27 ◦C, triangles:33 ◦C, hexagons: 38 ◦C, diamonds:44 ◦C;
cADA = 100 mmol L
−1 ; cMgCl2 = 10 mmol L
−1; pH=7.0; cNADPH= 0.05 mmol L−1
Figure 8.L: Activity of GDH as a function of temperature and substrate-concentration; squares:
22 ◦C, circles: 29 ◦C, triangles:33 ◦C, hexagones: 38 ◦C, diamonds:43 ◦C; cADA = 100
mmol L−1 ; cMgCl2 = 10 mmol L
−1; pH=7.0; cNADPH= 0.05 mmol L−1
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8 Appendix
Figure 8.M: Stability of NADPH at various pH, pH 7.5-9.0; filled squares: ADA-buffer pH 7.5,
filled circles: ADA-buffer pH 8.0, open triangles: TRIS-buffer pH 7.5, open hexagons
: TRIS-buffer pH 8.0, open stars: TRIS-buffer pH 8.5, open squares: TRIS-buffer pH
9.0; cADA-buffer = 100 mmol·L−1, cTRIS-buffer = 100 mmol·L−1 cMgCl2 = 10 mmol·L−1,
T = 25◦C
Figure 8.N: Stability of NADPH at various pH at 5◦C, pH 6.0-7.5; squares: pH 6.0, circles: pH
6.5, triangles: pH 7.0, diamonds: pH 7.5; cADA-buffer = 100 mmol·L−1, cMgCl2 = 20
mmol·L−1, T = 25◦C
N
Figure 8.O: Stability of NADPH at various pH at 5◦C, pH 6.0-7.5; squares: pH 6.0, circles: pH
6.5, triangles: pH 7.0, diamonds: pH 7.5; cADA-buffer = 150 mmol·L−1, cTEGO IL K5 =
100 g·L−1, cMgCl2 = 20 mmol·L−1, T = 25◦C
Figure 8.P: Stability of NADPH at various pH at 30◦C, pH 6.0-7.5; squares: pH 6.0, circles: pH
6.5, triangles: pH 7.0, diamonds: pH 7.5; cADA-buffer = 100 mmol·L−1, cMgCl2 = 20
mmol·L−1, T = 25◦C
Figure 8.Q: Stability of NADPH at various pH at 30◦C, pH 6.0-7.5; squares: pH 6.0, circles: pH
6.5, triangles: pH 7.0, diamonds: pH 7.5; cADA-buffer = 150 mmol·L−1, cTEGO IL K5 =
100 g·L−1, cMgCl2 = 20 mmol·L−1, T = 25◦C
O
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Figure 8.R: Stability of NADPH at various pH at 35◦C, pH 6.0-7.5; squares: pH 6.0, circles: pH
6.5, triangles: pH 7.0, diamonds: pH 7.5; cADA-buffer = 100 mmol·L−1, cMgCl2 = 20
mmol·L−1, T = 25◦C
Figure 8.S: Stability of NADPH at various pH at 30◦C, pH 6.0-7.5; squares: pH 6.0, circles: pH
6.5, triangles: pH 7.0, diamonds: pH 7.5; cADA-buffer = 150 mmol·L−1, cTEGO IL K5 =
100 g·L−1, cMgCl2 = 20 mmol·L−1, T = 25◦C
P
Figure 8.T: Stability of NADPH in presence of different buffer-salts at pH 7.0; squares:
ACES-buffer, circles: ADA-buffer, triangles: BES-buffer, hexagons: HEPES-buffer,
stars: KPi-buffer, diamonds: PIPES-buffer; call-buffers = 100 mmol·L−1, cMgCl2 = 20
mmol·L−1, T = 5◦C
Figure 8.U: Stability of NADPH in presence of different buffer-salts at pH 7.0; squares:
ACES-buffer, circles: ADA-buffer, triangles: BES-buffer, hexagons: HEPES-buffer,
stars: KPi-buffer, diamonds: PIPES-buffer; call-buffers = 100 mmol·L−1, cMgCl2 = 20
mmol·L−1, T = 30◦C
Q
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Figure 8.V: Stability of NADPH in presence of different buffer-salts at pH 7.0; squares:
ACES-buffer, circles: ADA-buffer, triangles: BES-buffer, hexagons: HEPES-buffer,
stars: KPi-buffer, diamonds: PIPES-buffer; call-buffers = 100 mmol·L−1, cMgCl2 = 20
mmol·L−1, T = 35◦C
R
